Novel biodegradable gene carriers based on oligomerized polyamines by Klöckner, Julia
 
Dissertation 
zur Erlangung des Doktorgrades der Fakultät für Chemie und 
Pharmazie der Ludwig-Maximilian-Universität München 
 
 
 
Novel Biodegradable Gene Carriers Based on Oligomerized 
Polyamines 
 
vorgelegt von 
Julia Klöckner 
aus München 
2005
 
 
Erklärung 
Diese Dissertation wurde im Sinne von § 13 Abs. 3 bzw. 4 der Promotionsordnung 
vom 29. Januar 1998 von Prof. Dr. Ernst Wagner betreut.  
 
 
 
Ehrenwörtliche Versicherung 
Diese Dissertation wurde selbständig, ohne unerlaubte Hilfe erarbeitet. 
 
 
München,  
 
 
Dissertation eingereicht am  
1. Gutacher: Prof. Dr. Ernst Wagner 
2. Gutacher: Prof. Dr. Gerhard Winter 
Mündliche Prüfung am 24.01.2006 
 
 
Table of Contents 
1 INTRODUCTION..................................................................................................7 
1.1 Gene therapy ...............................................................................................7 
1.1.1 Viral vectors ..................................................................................................8 
1.1.2 Nonviral vectors ............................................................................................8 
1.2 Polyethylenimine: a non-degradable polymer........................................10 
1.3 Biodegradable conjugates .......................................................................11 
1.3.1 Reductive cleavage of disulfide bonds ........................................................12 
1.3.2 Hydrolysis of ester bonds............................................................................13 
1.4 Modifications of standard polyplexes .....................................................14 
1.4.1 Shielding domains.......................................................................................15 
1.4.2 Targeting domains ......................................................................................15 
1.4.3 Activation of the intracellular transport ........................................................16 
1.5 Aim of the thesis .......................................................................................19 
1.5.1 Design of new polycations for safe and efficient gene transfer ...................19 
1.5.2 Structure activity relationship ......................................................................20 
1.5.3 Optimization towards an ‘artificial virus’ ......................................................20 
2 MATERIALS AND METHODS...........................................................................21 
2.1 Chemicals and reagents...........................................................................21 
2.2 Polymer synthesis ....................................................................................22 
2.2.1 Synthesis of the polymer library (JK 10/03).................................................22 
2.2.2 Synthesis of (OEI-IP-OEI)-HD (JK 07/04) ...................................................23 
2.2.3 Synthesis of Cys-HD-1 (JK 09/04) ..............................................................23 
2.2.4 Synthesis of OEI-HD-Sper (JK 12/04).........................................................23 
2.2.5 Synthesis of OEI-HD-1 and lt-OEI-HD-1 (JK 02/05)....................................24 
2.2.6 Upscale of OEI polymer synthesis (JK 04/05).............................................24 
2.2.7 OEI-HD-modifications (JK 04/05) ................................................................25 
2.2.8 Purification ..................................................................................................27 
2.3 Polymer characterization .........................................................................28 
2.3.1 Structural analysis.......................................................................................28 
2.3.2 Molecular weight determination ..................................................................30 
 
2.3.3 DNA-binding and condensation ..................................................................31 
2.3.4 Polyplex formation.......................................................................................31 
2.3.5 Agarose gel retardation...............................................................................32 
2.3.6 Particle size measurements ........................................................................32 
2.3.7 Degradation studies ....................................................................................32 
2.4 Biological properties of the polymers.....................................................33 
2.4.1 Cell culture ..................................................................................................33 
2.4.2 Luciferase reporter gene expression...........................................................34 
2.4.3 Metabolic activity of transfected cells ..........................................................34 
2.4.4 Cytotoxicity - microscopic observations ......................................................35 
2.4.5 Endosomolytic activity of free polymer ........................................................35 
2.4.6 Hemolytic activity of polymers .....................................................................35 
2.4.7 Polymer-induced erythrocyte aggregation...................................................36 
2.5 Modification of standard polyplexes .......................................................36 
2.5.1 EGF receptor targeting................................................................................36 
2.6 Photochemical intracellular release (PCI)...............................................37 
3 RESULTS ..........................................................................................................38 
3.1 Biodegradable polymers based on oligomerized polyamines..............38 
3.1.1 Synthesis of the polymer library ..................................................................38 
3.1.2 DNA binding activity of novel polycations....................................................42 
3.1.3 Reductive cleavage of disulfide linked polymers.........................................45 
3.1.4 Hydrolytic degradation of HD-linked polymers ............................................47 
3.1.5 Gene transfer activity ..................................................................................49 
3.1.6 Lytic activity of novel polymers....................................................................52 
3.1.7 Polymer-induced erythrocyte aggregation...................................................54 
3.1.8 Endosomolytic activity of promising candidates ..........................................54 
3.2 OEI-based polymers: a comparative study.............................................56 
3.2.1 Reporter gene expression and cytotoxicity of OEI polymers.......................56 
3.2.2 Erythrocyte aggregation induced by OEI polyplexes...................................58 
3.2.3 Low temperature (lt)-OEI-HD-1: a less toxic analog of standard OEI-HD-1 60 
3.3 Modification of the OEI-HD core ..............................................................73 
3.3.1 Synthesis of OEI-HD-spermine pseudo-dendrimers ...................................73 
 
3.3.2 Reporter gene expression and cytotoxicity of OEI-HD pseudo-dendrimers 75 
3.3.3 Membrane lytic activity of OEI-HD-Sper polymers ......................................76 
3.3.4 Designing OEI-HD-5 analogs with various functional moieties ...................78 
3.4 Modification of OEI-HD-1 polyplexes for virus-like gene delivery ........80 
3.4.2 EGF-receptor targeting of OEI-HD-1 polyplexes.........................................84 
3.4.3 Improved endosomal escape of OEI-HD polyplexes...................................86 
4 DISCUSSION.....................................................................................................90 
4.1 Development of degradable polycations for optimized, nonviral gene 
delivery ......................................................................................................90 
4.1.1 DNA binding activity ....................................................................................91 
4.1.2 Polymer degradation ...................................................................................92 
4.1.3 Reporter gene expression in tumor cells.....................................................94 
4.1.4 Interaction with blood components..............................................................97 
4.2 Comparison of OEI polymers: structure activity relations....................99 
4.2.1 Temperature-dependent ester aminolysis of OEI-HD-1 ............................102 
4.3 Novel OEI-HD based pseudo-dendrimers .............................................105 
4.3.1 OEI-HD-Sper pseudo-dendrimers with high potential for virus-like gene 
delivery......................................................................................................105 
4.3.2 Membrane activity of OEI-HD-Sper pseudo-dendrimers ...........................106 
4.3.3 Modification of the OEI-HD-5 core ............................................................108 
4.4 Modification of OEI-HD polyplexes for virus-like gene delivery .........109 
4.4.1 EGFR-targeted and photochemically enhanced polyplexes......................110 
4.4.2 EGFR-targeted, melittin/OEI-HD-1 polyplexes..........................................112 
5 SUMMARY.......................................................................................................114 
6 APPENDIX.......................................................................................................116 
6.1 Abbreviations ..........................................................................................116 
6.2 Publications.............................................................................................119 
6.2.1 Original papers..........................................................................................119 
6.2.2 Reviews and book chapters ......................................................................119 
6.2.3 Poster presentations .................................................................................120 
6.2.4 Oral presentations.....................................................................................120 
 
7 REFERENCES.................................................................................................121 
8 ACKNOWLEDGEMENTS................................................................................135 
9 CURRICULUM VITAE .....................................................................................137 
 
Introduction 7 
1 Introduction 
1.1 Gene therapy 
Gene therapy is a promising strategy to treat or prevent diseases by delivering 
therapeutic genes into a patient. Expression of the introduced gene can lead to a 
controlled cell death of tumor cells, can activate prodrugs specifically within the tumor 
or can substitute nucleic acids that are responsible for certain genetic disorders, like 
cystic fibrosis or severe combined immunodeficiency disorder (SCID). 
Therapeutic nucleic acids used in gene therapy can be genes encoding therapeutic 
proteins or normal versions of defective or missing proteins. Furthermore, antisense 
oligonucleotides or double stranded small interfering RNA (siRNA) against disease 
causing proteins are investigated for gene therapeutic treatments. Most clinical trials 
in the field of gene therapy are directed towards cancer, but while first clinical 
success has been already achieved in the treatment of SCID, no clear benefit was 
obtained in gene therapy of cancer so far. Inefficient delivery to the target cells and 
severe side effects such as high immunogenicity still limit the therapeutic application 
of nucleic acid-based drugs. 
An ideal gene carrier system should protect the nucleic acid against nucleases and 
deliver the therapeutic gene to the target cell. After interacting specifically with the 
cell membranes of the target cells it should enhance cellular uptake and lead to an 
efficient expression of the gene. Since the delivery of naked DNA in vivo is in most 
cases inefficient due to high nuclease activity in the serum, a broad variety of vector 
systems have been developed which protect the DNA, and allow efficient delivery 
and expression of the gene. 
Generally there are two main categories of delivery systems: viral and non-viral 
vectors. 
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1.1.1 Viral vectors 
Viral vectors are the most commonly used gene transfer systems in clinical trials. 
They derive from viruses and are modified by replacing genes required for viral 
replication by a therapeutic gene. Viral vectors are very potent gene delivery vehicles 
because of their specific machinery to enter the cell and to deliver their nucleic acids 
into the cell and into the nucleus (Robbins 1998, Kay 2001). However, they can 
cause severe immune responses and show the great disadvantages of a limited 
insert-size and insertional mutagenesis risk. Furthermore, the production processes 
are complex and expensive.  
1.1.2 Nonviral vectors 
Non-viral vectors are receiving increasing attention as gene delivery systems 
because of several favorable characteristics. They offer enhanced biosafety and 
biocompatibility and a high flexibility regarding the size of the delivered nucleic acid 
(Niidome 2002). They can be synthesized at low cost in large quantities and with high 
consistency. Non-viral vectors expose low immunogenicity (Zuber 2001) as they can 
be generated protein-free or by using non-immunogenic proteins and peptides. A 
weakness of non-viral vectors is their low efficiency in intracellular delivery, which 
currently is partly compensated by the administration of large amounts of vector. 
Non-viral vectors are based on formulations with chemically defined DNA carriers 
such as cationic lipids (amphiphilic molecules with a hydrophilic cationic head-group 
and a hydrophobic tail) (Lee 1997) or polycations (e.g. polylysine or 
polyethylenimine) which interact electrostatically with the negatively charged nucleic 
acids. The resulting compact and positively charged structures protect DNA from 
degradation and can improve their cellular uptake by facilitating the interaction with 
negatively charged cell membranes. 
For effective polyplex-mediated gene delivery, the gene carrier has to fulfill a series 
of delivery functions in order to overcome extra- and intracellular barriers (Fig.1). The 
cationic polymer has to compact DNA into particles with virus-like dimensions and 
protect the DNA from degradation and against undesired interactions with the 
biological environment during the extracellular transport. After cell binding and 
internalization, ideally in a target cell-specific manner (Kircheis 1999, Ogris 2001, 
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Kursa 2003), it should promote endosomal escape (Plank 1998, Wagner 1999), 
vector unpacking (Schaffer 2000), and localization to the nucleus (Brunner 2002). On 
top of this, the polymer should be non-immunogenic, non-toxic and biodegradable. 
As no polymer is able to meet all these requirements in reality, it is necessary to 
generate an ‘artificial virus’ consisting of a polycationic compacting domain in 
combination with various functional domains.  
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Fig.1: Barriers that have to be overcome by virus-like gene carriers.  
During extracellular transport, the cationic polymer has to protect DNA against undesired interactions 
with the biological environment. Ideally, the polyplexes are targeted towards characteristic cell-surface 
receptors in order to achieve cell-specific uptake. After binding to their receptor, polyplexes are 
internalized by receptor-mediated endocytosis and are captured in intracellular vesicles. Degradation 
of macromolecules in endocytic vesicles is a major bottleneck, therefore fast and efficient endosomal 
escape is an urgent need for effective gene delivery. Released particles and/or the carried nucleic acid 
need to traffic towards the nucleus, enter the nucleus and expose the DNA to the cell’s transcription 
machinery. After gene delivery, the polymer has to be degraded and eliminated from the organism. To 
overcome these barriers, different functional domains can be incorporated into the polyplex.  
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Over the last three decades a variety of polycations have been employed in 
polyplexes, including natural DNA binding proteins like histones, synthetic amino acid 
polymers such as polylysine (Lee 2005) and other cationic polymers, for example 
polyethylenimines (Kichler 1999), chitosan (Mansouri 2004), polyphosphoamidates 
(Wang 2004), or poly(dimethylaminoethyl) methacrylates (Verbaan 2004). Currently 
modifications of non-degradable cationic polymers as well as first approaches for 
biodegradable compacting domains are under investigation. 
1.2 Polyethylenimine: a non-degradable polymer 
Polyethylenimine (PEI) first introduced by Behr and his group (Boussif 1995) is the 
most commonly used polycation. As it forms stable polyplexes that enter the cells 
through adhesion to negatively charged transmembrane heparanproteoglycans 
(Kopatz 2004) and can promote its escape from intracellular vesicles. PEI based 
polyplexes have an excellent transfection efficiency in vitro and significant 
transfection in vivo (Zou 2000).  Regarding non-viral polycationic vectors, linear PEI 
with an average molecular weight of about 22 kDa is the ‘golden standard’ for 
efficient gene delivery. 
The problematic characteristics of PEI are a pronounced toxicity (Moghimi 2005) both 
in cell culture (Boeckle 2004) and in vivo (Chollet 2002, Merdan 2005), and a variety 
of undesired unspecific interactions with the biological environment. Polycationic 
carriers are toxic because they not only bind to negatively charged DNA but also to 
many other negatively charged biological materials including phospholipid bilayer cell 
membranes, cell membrane-integrated and circulatory proteins, or for example, 
mediate aggregation of erythrocytes (Ogris 1999, Brownlie 2004, de Wolf 2005). The 
toxic properties increase with the number of positive charges, the hydrophobicity and 
the molecular weight of the polycation (Fischer 1999). Neutralization of the positive 
polymer charges by polyplex formation reduces toxicity, both on the cellular level and 
in the organism, however does not eliminate the problem. In addition to acute toxicity, 
the long-term fate of the polymeric carrier in the host has also be taken into 
consideration (Lecocq 2000).  
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Non-degradable polymers like PEI are ‘static’ structures which often cannot be 
metabolized. They tend to accumulate mostly in the liver or the kidney (Takakura 
1990) and lead to an uncontrollable long-term toxicity. Therefore, biocompatible 
polymers that are degradable by the host would be advantageous. 
1.3 Biodegradable conjugates 
Lack of toxicity and biocompatibility should be a major consideration in the design of 
new gene delivery systems. In fact many low molecular weight (LMW) polymers have 
been found to possess strongly reduced toxicity compared to their high molecular 
weight (HMW) counterparts (Ahn 2002). However they do not provide sufficient 
stability of the polyplexes for in vivo administration. Spermine for instance, is a 
natural LMW polyamine (MW = 202) that can be isolated from sperm in high 
concentrations and that is already known to have a stabilizing effect on nucleic acids. 
Due to its oligocationic nature it is able to condense DNA via electrostatic interaction 
with the negatively charged phosphate groups (Saminathan 1999, Deng 2000, 
Vijayanathan 2001) but it does not provide sufficient positive charge to form stable 
complexes under physiological conditions. Different strategies to enhance polyplex 
stability while maintaining the low toxicity are being explored to make use of the 
intrinsic DNA binding ability of e.g. spermine and other LMW polyamines (Blagbrough 
2003). 
One approach is the generation of biodegradable polymer conjugates where LMW 
oligomers with low toxicity are crosslinked to form larger polycationic carriers by 
conjugation with biodegradable linkers. Another possibility is the synthesis of new 
biodegradable polymers which have a labile bond in their repetitive monomeric unit. 
Both enzymatic (e.g. by esterases or hydrolases) and chemical degradation of the 
labile linkages may result in a defragmentation of the polymer into LMW units.  
Reversible linkages can be either disulfide bonds that are cleavable within the 
reducing intracellular environment or alternatively they can be hydrolytically labile 
groups such as esters, phosphoesters, hydrazones or acetals (for an overview see 
Table 1). Moreover, Petersen et al. reported the synthesis of a biodegradable PEI 
derivative based on the hydrolytic cleavage of amide bonds (Petersen 2002).  
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Based on this knowledge, the gene carrier can be constructed in a way that utilizes 
the properties of the target site to achieve site specific degradation of the polymer. 
Degradation of these HMW polymers results in LMW fragments with reduced charge 
density per molecule which are less toxic and could be eliminated from the organism. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Overview degradable linkages 
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disulfide bond will destabilize the polyplex and therefore trigger DNA release. For 
example, linear reducible polycations (RPCs) consisting of Cys(Lys)10Cys form stable 
DNA polyplexes after oxidation of the terminal cysteinyl thiol groups (Oupický 2002). 
Furthermore, lipopolyplexes containing combinations of RPC with DOTAP liposomes 
resulted in higher gene expression levels as compared to their non-reducible 
counterparts (Read 2003). Similarly, McKenzie et al. generated LMW disulfide cross-
linking peptides consisting of lysine and two terminal cysteine residues which 
polymerized by disulfide formation when bound to DNA (McKenzie 2000). ‘Caged 
DNA polyplexes’ with enhanced stability in high ionic strength were originated 
forming polylysine polyplex formation and subsequent introduction of disulfide 
crosslinks after treatment with dimethyl-3-3’-dithiobispropionimidate (DTBP) 
(Trubetskoy 1999). 
Another approach is to oligomerize LMW polyamines with disulfide bond containing 
bifunctional crosslinkers (Gosselin 2001). Low molecular weight PEI with an average 
Mw of 800 Da was linked with either dimethyl-3-3’-dithiobispropionimidate (DTBP) or 
dithiobis(succinimidylpropionate) (DSP) which converted the primary amines into 
amidines or amides, respectively, thereby generating HMW PEI’s (Mw 8 – 75 kDa) 
with improved transfection efficiency compared to the original LMW PEI.  
1.3.2 Hydrolysis of ester bonds 
Polymers with ester linkages in their backbone are characterized by an immense 
diversity and versatility (Edlund 2003). They offer many opportunities to tune the 
properties of the resulting material and, above all, esters are degradable due to their 
relative sensitivity to hydrolysis and have therefore gained substantial interest in the 
development of biocompatible and bioresponsive polymers for gene delivery.  
Lim et al. synthesized a biodegradable ester analog which displayed no cytotoxicity, 
but only modest gene expression (Lim 2000). Another biodegradable cationic 
polyester, poly (4-hydroxy-L-proline ester) showed similar characteristics (Lim 1999). 
Currently, a variety of other ester containing polymers such as network poly (ß-amino 
ester) (Lim 2002), polyphosphoesters, (Wang 2001 & 2002-1, for review see Zhao 
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2003) or polyphosphoamidates (Wang 2002-2) are under investigation and analyzed 
for further optimization.  
Ongoing research is carried out in the field of diacrylate crosslinkers which react with 
primary and secondary amines as well as with thiol groups in a Michael addition. 
Langer and his group generated a library of 2350 structurally unique degradable 
cationic polymers by addition of various di-acrylates to different, basically mono-
amine-containing monomers (Anderson 2003 & 2004, Akinc 2003). Furthermore, an 
ester linkage containing PEI derivative was synthesized through addition of 800 Da 
PEI to small diacrylate crosslinkers (Forrest 2003). Since these polymers showed 
better gene transfer efficiency in vitro than other ester containing polymers, diacrylate 
crosslinkers seem to be interesting candidates for oligomerization of LMW 
polyamines. 
Independent of the concept for the synthesis of biodegradable polymers, these 
structures just represent a DNA compacting domain which should provide polyplex 
stability and protect the nucleic acid during transport. 
1.4 Modifications of standard polyplexes 
Even the most potent non-viral vectors such as polyethylenimine (PEI) can still not 
compete with the effective transfection machinery of natural viruses. Key issues for 
optimization of polyplexes include improved specificity for the target tissue, enhanced 
cell uptake and intracellular transport, and reduced toxicity. One strategy for 
advancements in non-viral gene delivery is to learn from viral cell entry mechanisms 
and utilize similar functional domains for further modification of polyplexes (Wagner 
2004). Key steps towards an ‘artificial virus’ with enhanced specificity and optimized 
properties to overcome cellular barriers (Fig.2) are achieved by incorporation of i) 
shielding domains to generate neutral polyplexes, ii) targeting ligands which 
recognize and bind cell-specific receptors and iii) transport domains which facilitate 
endosomal release.  
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Fig.2: DNA nanoparticles with virus-like functions 
For nucleic acid protection and polyplex stability the gene carrier needs a polycationic compacting 
domain which should be biodegradable. Incorporation of shielding domains to block undesired 
interactions, targeting ligands which recognize and bind cell-specific receptors, and transport domains 
which facilitate endosomal release are the key steps towards an ‘artificial virus’. To achieve a more 
‘virus-like’ system, these domains should be activated specifically in a defined environment within the 
target tissue.  
 
1.4.1 Shielding domains 
To prevent unspecific interaction of the gene carrier with negatively charged serum 
proteins, erythrocytes or membrane proteins and to inhibit activation of the 
complement system (Plank 1996), the positive surface charge of polyplexes has to 
be shielded by hydrophilic polymers like polyethylene glycol (PEG) (Kircheis 1999, 
Kursa 2003) or hydroxypropyl methacrylate (pHPMA). Furthermore, shielding 
provides improved stability for freeze-thawing (Ogris 2003) as well as reduced toxicity 
and extended circulation time in blood (Ogris 1999). However, surface charge 
shielding can lead to a significantly reduced gene expression activity (Kichler 2002, 
Walker 2005).  
1.4.2 Targeting domains 
Target cell specificity of polyplexes can be achieved by the incorporation of a 
targeting ligand into the polyplex. Numerous cell-targeting ligands such as vitamins, 
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carbohydrates, peptides, proteins including growth factors and antibodies have been 
used to enhance cell specificity and transfection efficiency of polyplexes (for review 
see: Wagner 2005). These ligands recognize specific receptors on the plasma 
membrane of the target cells. Amongst other approaches systemic targeting of PEI 
polyplexes towards tumors was achieved by using either the transferrin receptor 
(Kircheis 2002, Kursa 2003) or the epidermal growth factor receptor (EGFR) 
(Wolschek 2002) as targets. 
Since the EGFR is overexpressed in a variety of human tumors, such as cancers of 
the liver, breast, lung and brain, it represents an interesting target for cancer gene 
therapy (Mendelsohn 2002). Epidermal growth factor (EGF) is a globular protein of 
6.4 kDa that binds specifically and with a high affinity to the EGFR inducing 
dimerization of the receptor and subsequent internalization of the activated EGFR 
complex. Based on this knowledge different polycation conjugates with either EGF or 
EGF derivatives (Lee 2001) as targeting ligands have been studied to elucidate the 
mechanism of EGFR mediated polyplex uptake (von Gersdorff 2005) as well as its 
potential for cancer specific gene delivery (Frederiksen 2000, Wolschek 2002). 
Recently, the EGFR was discovered to be the natural receptor for human 
cytomegalovirus (CMV) (Wang 2003). The fact that nature chose the EGF receptor 
for viral gene delivery makes the strategy to employ EGFR-targeted ‘artificial viruses’ 
even more promising.  
1.4.3 Activation of the intracellular transport 
1.4.3.1 Endocytosis 
The different mechanisms in mammalian cells to take up extracellular material such 
as extracellular nutrients are summarized under the term endocytosis. Endocytosis is 
subdivided into several types, namely clathrin-dependent receptor-mediated 
endocytosis, clathrin-independent endocytosis, and phagocytosis. Both, viruses and 
toxins utilize the endocytotic pathway to enter the cell. Substances taken up by 
endocytosis become enclosed within invaginations which form free vesicles that 
deliver their content to early endosomes (pH~6), then to late endosomes (pH<6) and 
finally to lysosomes (pH 5-5.5). If not released, endocytosed nucleic acids can be 
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rapidly degraded by degrading enzymes within late endosomes as well as in 
lysosomes. Therefore, liberation from endocytic vesicles is a prerequesit step for 
intracellular delivery of intact nucleic acids in order to achieve efficient transgene 
expression. 
1.4.3.2 Endosomal release 
After cell binding and endocytosis, the endosomal release presents another 
significant bottleneck in polyplex-mediated gene delivery. Approaches to improve 
endosomal release include PEI itself which acts as a ‘proton sponge’, (Sonawane 
2003), endosomolytic agents (for review see: Cho 2003), such as chloroquine 
(Cotten 1990), synthetic virus-derived fusion peptides (Plank 1994, Zauner 1995) or 
artificial membrane destabilizing peptides (Haensler 1993, Gottschalk 1996, Kichler 
2003, Thoren 2005). The bee venom peptide melittin is another example which 
displays strong membrane destabilizating activity and strongly enhances gene 
transfer of PEI polyplexes (Ogris 2001, Boeckle 2005). 
1.4.3.3 Photochemical intracellular release 
A different way to achieve improved endosomal release is the photochemical 
intracellular release technology, named PCI (Berg 1999, Hogset 2000). This 
technology is based on the accumulation of photosensitizing compounds in 
endosomal membranes, followed by a light induced rupture of endocytic vesicles 
which triggers the release of endocytosed molecules (Prasmickaite 2000) (Fig.3).   
 
 
 
 
 
 
Fig.3: Light-dependent rupture of endocytic vesicles (PCI Biotech) 
A photosensitizer (S) and the macromolecule of interest (M) are endocytosed and co-localize to 
endocytic compartments. Light exposure of the cells results in a photodynamically induced rupture of 
the vesicle membrane and subsequent cytosolic release of the macro-molecule. 
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Photosensitizers (PS) are chemical structures that become excited upon light 
absorption and transfer their energy to molecular oxygen, generating radical singlet 
oxygen (1O2) which leads to membrane destruction by oxidative processes. 
Amphiphilic PS such as TPPS2a and AlPcS2a (Fig.4) interact with membranes due 
to their amphiphilic properties and therefore are localized specifically in endocytic 
vesicles (Prasmickaite 2001; PhD thesis Lina Prasmickaite 2002). In several studies 
the group of Berg reported that PCI can improve polycation-mediated gene 
transfection, substantially increasing the fraction of transgene-expressing cells (Selbo 
2002). Furthermore, they have shown that even adenovirus-mediated gene delivery 
could be improved by PCI (Hogset 2005). Thus, PCI represents a novel principle for 
the cytosolic delivery of nucleic acids which overcomes the pivotal intracellular barrier 
of endosomes and lysosomes.  
Nevertheless, light treatment is limited to certain cell lines or easily accessible 
tumors; hence, for these applications direct incorporation of an endosomolytic 
function into DNA complexes would be preferable.  
  
 
 
 
 
 
 
 
Fig.4: Structural formula of amphiphilic photosensitizers  
Meso-tetraphenylporphine (A) and aluminium phthalocyanine (B) consist of a porphyrin skeleton with 
two sulfonate groups on adjacent phenyl rings and can be used both in vitro and in vivo. 
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1.5 Aim of the thesis 
One major focus in the development of novel gene delivery systems is to generate 
highly efficient compacting domains which can be easily degraded by the host. So far 
a variety of non-toxic, biodegradable polymers containing either disulfide or ester 
bonds have been synthesized. However, they often suffered from poor transfection 
efficiency.  
1.5.1 Design of new polycations for safe and efficient gene transfer 
The first aim of this thesis was to find novel biodegradable gene carriers which are 
highly efficient but essentially non-toxic. The idea was to oligomerize a variety of 
LMW polyamines like, for example, spermine with different labile bond-containing 
(disulfide, ester and amide bonds, respectively) crosslinkers to originate HMW 
polymers which would be degraded in a specific environment (Fig.5). 
 
 
 
 
 
 
 
 
 
 
 
Fig.5: Oligomerization of LMW polyamines with labile bond-containing linkers (concept)  
LMW polyamines are crosslinked with labile bond-containing linkers in order to generate HMW-
polymers which provide increased polyplex stability in physiological environment. Polymers are 
degraded into non-toxic fragments after cleavage of the reversible bonds and polyplex disassembly 
triggers DNA release. 
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Biophysical (DNA binding, polyplex stability, particle size) and biological (cytotoxicity, 
erythrocyte aggregation, hemolytic activity) screenings, as well as evaluation of their 
transfection efficiency should highlight promising candidates with adequate activity 
versus toxicity profiles for more detailed evaluation. 
1.5.2 Structure activity relationship 
The next step was to analyze lead candidates in detail to elucidate the influence of 
chemical structure, charge density, hydrophobicity and molecular weight on biological 
properties. This information could provide a basis for further optimization of the 
synthesized polymers. The reason why some polymers result in efficient gene 
expression whereas others are characterized by a lack of transfection activity, even if 
they provide polyplex stability, might be that some polymers have their own 
endosomal release mechanisms like the buffering capacity of PEI or intrinsic 
membrane active properties. Therefore, membrane-lytic activity of the polymers 
should be studied in order to predict their fate in the endosome, but also to obtain 
information about possible cytotoxic side effects.  
Polyplex-induced erythrocyte aggregation, as it is known for PEI polyplexes (Ogris 
1999), can cause embolism or unspecific gene expression in the lung. This suggests 
that with regard to systemic in vivo application in the future, interaction of the 
polymers with blood components is an important feature that has to be analyzed. 
1.5.3 Optimization towards an ‘artificial virus’ 
As already discussed above, no polymeric compacting domain will be able to fulfill all 
the criteria that are required for an ‘artificial virus’. To create a more virus-like gene 
delivery system, a targeting ligand for specific cell targeting should be incorporated 
into the polyplex, and transfection efficiency as well as target cell specificity should 
be compared with non-targeted polyplexes. To further improve gene transfer activity 
of targeted vectors, methods that trigger endosomal release should be applied. The 
combination of biological targeting (e.g. via the EGFR) and photochemically 
enhanced intracellular release using the PCI technology could be a promising step 
towards a ‘smart artificial virus’. 
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2 Materials and methods 
2.1 Chemicals and reagents 
Spermine (Mw 202.35), dimethyl-3.3’-dithiobispropionate x 2 HCl (DTBP; Mw 
309.28), dimethylsulfoxide puriss. (DMSO) and cystamine x 2 HCl (Mw 225.2) were 
obtained from Fluka (Fluka Chemie GmbH, Deisenhofen, Germany). 
Spermidine (Mw 145.25), pentaethylenhexamine (Mw 232.4), oligoethylenimine with 
an average molecular weight of 800 Da (OEI 800), 1,6-hexanediol-diacrylate (Mw 
226.28) and branched PEI with an average molecular weight of 25 kDa (PEI25) were 
obtained from Sigma-Aldrich (Munich, Germany). Linear PEI with an average 
molecular weight of 22 kDa (PEI22) is available from Euromedex (Exgen, 
Euromedex, Souffelweyersheim, France). Linear PEI 22 was also synthesized by 
acid-catalyzed deprotection of poly (2-ethyl-2-oxazoline) (50 kDa, Aldrich) in 
analogous form as described in Brissault et al. (2003) Gelfiltrated PEI was used as a 
1 mg/ml stock solution neutralized with HCl.  
Dithiobis(succinimidylpropionate) (DSP; Mw 404.42) was purchased from Pierce 
(Perbio Science Deutschland GmbH, Bonn, Germany). Triethylentetramine (Mw 
146.24) and tetraethylenpentamine (Mw 189.3) were purchased from Merck-
Schuchardt OHG (Hohenbrunn, Germany). Plasmid pCMVLuc (Photinus pyralis 
luciferase under control of the CMV enhancer / promoter) as described in Plank et al. 
(1992) was produced endotoxin-free by Elim Biopharmaceuticals (San Francisco, 
CA, USA) or Aldevron (Fargo, ND, USA).  
PEI22 modified with polyethylenglycol (PEG) of 20 kDa at equimolar ratio (PEI22-
PEG20) was synthesized as previously described (Kursa 2003). Conjugates of 
murine epidermal growth factor (mEGF) attached to PEG and branched PEI with an 
average molecular weight of 25 kDa (mEGF-PEG-PEI25) were synthesized as 
described by Wolschek et al. (2002). 
Mouse anti-human EGFR (anti EGFR) clone H11 and mouse IgG1 as negative 
control were purchased from Dako Corporation (CA, USA). Murine EGF (lyophilized) 
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was obtained from Prepro Tech EC (London, Great Britain) and bovine serum 
albumin (BSA) from Sigma-Aldrich Chemie GmbH (Deisenhofen, Germany). 
TPPS2a (LumiTrans®) and the corresponding light source (LumiSource®) were 
kindly provided by PCI Biotech AS (Oslo, Norway).  
Melittin-PEI25 conjugates were synthesized and purified as described (Boeckle at al., 
2005a/b). The melittin peptides containing a cysteine residue for covalent attachment 
to PEI had the following sequences: N-mel: CIGA VLKV LTTG LPAL ISWI KRKR 
QQ, NMA-3: CIGA VLKV LTTG LPAL ISWI KRKR EE, CMA-3: GIGA VLKV LTTG 
LPAL ISWI KRKR EEC. PEI conjugates of melittin and its analogs were synthesized 
as described in Boeckle 2005 (PhD thesis, chapter 2.4).   
2.2 Polymer synthesis 
2.2.1 Synthesis of the polymer library (JK 10/03) 
Polyamine (spermidine (SD), spermine (SP), triethylentetramine (TT), tetraethylen-
pentamine (TP), pentaethylenhexamine (PH) and oligoethylenimine 800 (OEI 800)) 
stock solutions were prepared in DMSOpuriss at a concentration of 500 mM. 
Crosslinkers were dissolved in DMSOpuriss shortly before use. 
2.2.1.1 Polyamine-Hexanediol-Diacrylate (PA-HD) batch 
300 mg 1.6-hexanediol-diacrylate (HD) was dissolved in 1 ml DMSO (crosslinker 
stock). 0.1 mmol polyamine was mixed with 0.05 mmol (PA-HD-0.5), 0.1 mmol (PA-
HD-1) or 0.2 mmol (PA-HD-2) crosslinker stock and incubated at 60 °C for 4 days 
under constant shaking (450 rpm, Eppendorf Thermomixer). 
2.2.1.2  Polyamine-DTBP (PA-IP) batch 
85 mg DTBP x 2 HCl (IP) was dissolved in 1 ml of DMSO and sonicated until it was 
completely dissolved (crosslinker stock). 0.1 mmol polyamine was mixed with 0.05 
mmol (PA-IP-0.5), 0.1 mmol (PA-IP-1) or 0.2 mmol (PA-IP-2) crosslinker stock and 
incubated at 15 °C for 24 h under constant shaking (450 rpm, Eppendorf 
Thermomixer). 
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2.2.1.3 Polyamine-DSP (PA-SP) batch 
250 mg DSP (SP) was dissolved in 1 ml of DMSO (crosslinker stock). 0.1 mmol 
polyamine was mixed with 0.05 mmol (PA-SP-0.5), 0.1 mmol (PA-SP-1) or 0.2 mmol 
(PA-SP-2) crosslinker stock and incubated at 15 °C for 24 h under constant shaking 
(450 rpm, Eppendorf Thermomixer). 
All polymers were purified by size exclusion chromatography (SEC) (see 2.2.8.1). 
 
2.2.2 Synthesis of (OEI-IP-OEI)-HD (JK 07/04) 
To generate an OEI-IP-OEI dimer, 480 mg OEI 800 was dissolved in 4 ml DMSO, 
85.5 mg of DTBP x 2 HCl was added directly as a powder and reacted at 15 °C for 
24 h under constant shaking. 
In a second step dimer OEI-IP-OEI was oligomerized with 1.6-hexanediol-diacrylate. 
100 mg HD was dissolved in 1 ml DMSO. 1.8 ml of OEI-IP-OEI (= 0.142 mmol OEI-
IP-OEI) was reacted with 0.142 mmol HD at 60 °C for 4 days under constant shaking. 
The product was purified by SEC (see 2.2.8.1). 
 
2.2.3 Synthesis of Cys-HD-1 (JK 09/04) 
112.6 mg cystamine x 2 HCl was dissolved in 1 ml of DMSO and was mixed with 0.1 
mmol HD crosslinker (300 mg/ml in DMSO). The reaction was carried out at 60 °C for 
4 days under constant shaking (as described for PA-HD- batch). 
The product was purified by SEC (see 2.2.8.1). 
 
2.2.4 Synthesis of OEI-HD-Sper (JK 12/04) 
a) OEI-HD core 
100 mg of OEI 800 and 100 mg of HD were each dissolved in 1 ml of DMSO. 0.05 
mmol OEI was mixed with 0.1 mmol HD (OEI-HD-2), 0.25 mmol HD (OEI-HD-5) or 
0.5 mmol (OEI-HD-10) and reacted for 30 min at 60°C under agitation. 
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b) Modification with spermine 
400 mg spermine was dissolved in 1 ml DMSO. 0.5 mmol spermine was added to 
each eppendorf tube containing the OEI-HD core and the reaction occurred at 60°C 
for 2 days. 
All polymers were purified by size exclusion chromatography (see 2.2.8.1). 
 
2.2.5 Synthesis of OEI-HD-1 and lt-OEI-HD-1 (JK 02/05) 
2.2.5.1 OEI-HD-1 
1.93 ml OEI 800 stock (400 mg/ml in DMSO) was mixed at equimolar ratio with 0.73 
ml HD stock (300 mg/ml in DMSO) and reacted for 4 days at 60°C under constant 
shaking.  
2.2.5.2 Low temperature (lt)-OEI-HD-1 
4 ml OEI 800 stock (400 mg/ml in DMSO) was mixed at equimolar ratio with 1.51 ml 
HD stock (300 mg/ml in DMSO) and reacted for 4 days at 20°C under constant 
shaking. 
Both polymers were purified by dialysis (see 2.2.8.2). Synthesis and purification 
resulted in 157 mg lyophilized OEI-HD-1 (yield 16 %) and in 224 mg lyophilized lt-
OEI-HD-1 (yield 11 %). 
 
2.2.6 Upscale of OEI polymer synthesis (JK 04/05) 
2.2.6.1 OEI-HD-1 
2.0 ml OEI 800 stock (400 mg/ml in DMSO) was mixed at equimolar ratio with 0.75 
ml HD stock (300 mg/ml in DMSO) and reacted for 4 days at 60°C under constant 
shaking.  
Synthesis and purification by dialysis (see 2.2.8.2) resulted in 92 mg lyophilized 
polymer (yield 11 %). Product that was purified by SEC (see 2.2.8.1) resulted in 86 
mg lyophilized polymer (yield 46 %). 
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2.2.6.2 OEI-SP-0.5 
2.48 ml OEI 800 stock (400 mg/ml in DMSO) was mixed 1.0 ml DSP stock (250 
mg/ml in DMSO) and reacted for 24 h at 15°C under constant shaking.  
Synthesis and purification by dialysis (see 2.2.8.2) resulted in 76 mg lyophilized 
polymer (yield 14 %). Product that was purified by SEC (see 2.2.8.1) resulted in 100 
mg lyophilized polymer (yield 54 %). 
2.2.6.3 OEI-IP-1 
0.98 ml OEI 800 stock (400 mg/ml in DMSO) was mixed 1.8 ml DTBP stock (83 
mg/ml in DMSO) and reacted for 24 h at 15°C under constant shaking. 
Synthesis and purification by dialysis (see 2.2.8.2) resulted in 76 mg lyophilized 
polymer (yield 17 %). Product that was purified by SEC (see 2.2.8.1) resulted in 42 
mg lyophilized polymer (yield 43 %). 
 
2.2.7 OEI-HD-modifications (JK 04/05) 
2.2.7.1 OEI-HD-5 core 
Working solutions of OEI 800 (100 mg/ml) and HD-linker (100 mg/ml) were prepared 
in DMSO. 0.05 mmol OEI (400 µl) was mixed with 0.25 mmol HD (566 µl) and 
reacted for 30 min at 60°C under agitation (comment: longer reaction times for the 
core synthesis resulted in gelation of OEI-HD-5 and made modification impossible). 
966 µl OEI-HD-5 core were prepared for each modification sample. 
2.2.7.2 Modifications of the core 
a) OEI-HD-5-control 
253 µl DMSO was added to the core (OEI-HD-5), reaction at 60°C for 2 days under 
agitation. This reaction generated an unsoluble gel which could not be further 
processed. 
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b) OEI-HD-5-Sper 
400 mg spermine was dissolved in 1 ml DMSO. 0.5 mmol spermine (253 µl) was 
added to the core (OEI-HD-5), reaction at 60°C for 2 days under agitation. Synthesis 
and purification by dialysis (see 2.2.8.2) resulted in 45 mg lyophilized polymer (yield 
23 %). 
c) OEI-HD-5-N-EtOH 
121 mg ethanolamine was dissolved in 1 ml DMSO. 0.5 mmol ethanolamine (253 µl) 
was added to the core (OEI-HD-5), reaction at 60°C for 2 days under agitation. 
Synthesis and purification by dialysis (see 2.2.8.2) resulted in 34 mg lyophilized 
polymer (yield 27 %). 
d) OEI-HD-5-S-EtOH 
154.4 mg ß-mercaptoethanol was dissolved in 1 ml DMSO. 0.5 mmol ß-
mercaptoethanol (253 µl) was added to the core (OEI-HD-5), reaction at 60°C for 2 
days under agitation. Synthesis and purification by dialysis (see 2.2.8.2) resulted in 
33 mg lyophilized polymer (yield 24 %). 
e) OEI-HD-5-PH 
459.3 mg pentaethylenhexamine was dissolved in 1 ml DMSO. 0.5 mmol 
pentaethylen-hexamine (253 µl) was added to the core (OEI-HD-5), reaction at 60°C 
for 2 days under agitation. Synthesis and purification by dialysis (see 2.2.8.2) 
resulted in 20 mg lyophilized polymer (yield 9 %). 
f) OEI-HD-5-His 
220 mg histamine was dissolved in 1 ml DMSO. 0.5 mmol histamine (253 µl) was 
added to the core (OEI-HD-5), reaction at 60°C for 2 days under agitation. Synthesis 
and purification by dialysis (see 2.2.8.2) resulted in 19 mg lyophilized polymer (yield 
12 %). 
g) OEI-HD-5-OEI 
790.5 mg OEI 800 was dissolved in 1 ml DMSO. 0.25 mmol OEI (253 µl) was added 
to the core (OEI-HD-5), reaction at 60°C for 2 days under agitation. Synthesis and 
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purification by dialysis (see 2.2.8.2) resulted in 30 mg lyophilized polymer (yield 10 
%). 
h) OEI-HD-5-OEI-PEG 
1/8 amount of core was synthesized (0.0063 mmol OEI + 0.0313 mmol HD). 
16.9 mg PEG (2kDa)-OEI (0.7kDa) (kindly provided by R.Weberskirch, Technical 
University Munich) was dissolved in 50 µl DMSO. 0.0063 mmol PEG-OEI (50 µl) was 
added to the core (OEI-HD-5). After 20 min at 60 °C, 200µl of DMSO were added 
and the mixture reacted for 1 h at 60 °C. In a second modification step 25.3 µl OEI 
800 (0.025 mmol) was added, reaction at 60°C for 46 h under agitation. Synthesis 
and purification by dialysis (see 2.2.8.2) resulted in 14 mg lyophilized polymer (yield 
11 %). 
2.2.8 Purification  
2.2.8.1 Size Exclusion Chromatography (SEC) 
Prior to purification polymer samples were diluted 1:4 with H20dd and the pH was 
immediately adjusted to pH 6 (with HCl conc.). Size exclusion chromatography (SEC) 
was performed using a Waters HPLC System equipped with a Waters 600 Controller 
unit, a Waters 626 pump and a Waters 996 photodiode array detector (Waters 
GmbH, Eschborn, Germany). 
For purification the polymer was separated from unreacted crosslinker and solvent 
residues on a column (10/30) packed with Sephadex G25 superfine (molecular 
weight exclusion limit 5 kDa for globular proteins; Amersham Biosciences, Freiburg, 
Germany) using H20dd as the eluent under atmospheric pressure. Volumes up to 2 
ml of diluted reaction product (maximal 100 mg crude product in maximal 20 % 
DMSO) were loaded onto the column. Size exclusion chromatography was 
performed at a flow rate of 1.0 ml/min and fractions of 1.0 ml were collected. The 
elution of polymer was monitored at various wavelengths (210, 220, 240, 260 and 
280 nm). Fractions containing the major amounts of polymer were pooled and freeze 
dried. The amount of lyophilized product was determined by weight analysis and 
working dilutions of c = 1 mg/ml and c = 5 mg/ml in H2Odd were prepared. 
Materials and methods 28 
2.2.8.2 Dialysis 
After synthesis the polymeric product was diluted 1:4 with H2Odd and the pH was 
immediately adjusted to pH 6 (with HCl conc.). The diluted un-purified polymer was 
dialyzed via a Spectra/Por® membrane (cut off 3.5 kDa; Spectrum Medical 
Industries, Inc.California, USA) for 48 h against 4 l of H2Odd at 4°C. After 24h, water 
was exchanged against 4000 ml of fresh H20dd. The purification process was 
monitored by UV spectroscopy. 
 
2.3 Polymer characterization 
2.3.1 Structural analysis 
2.3.1.1 Nuclear magnetic resonance spectroscopy (NMR) 
1H-NMR spectra were recorded in d3-MeOH or CDCl3 on an Eclipse +500 
spectrometer from JEOL, Tokyo, Japan at 500 MHz. 
 
1.6-hexanediol diacrylate: 1NMR (CDCl3), δ (ppm): 6.35 (dd, 1H, J=1.5 Hz, J=17.5 Hz, cis-
CH(H)=CH-; 6.06 (dd, 1H, J=10.5 Hz, J=17.5 Hz, CH2=CH-); 5.78 (dd, 1H, J=1.5 Hz, J=10.5 Hz, tr-
CH(H)=CH-); 4.12 (t, 2H, J=6.75 Hz, -CH2CH2CH2-); 1.65 (q, 2H, J=6.75 Hz, -CH2CH2CH2-); 1.38 (q, 
2H, J=3.75 Hz, -CH2CH2CH2-);  
 
SD-HD-0.5: 1H NMR (500MHz, d3-MeOH) δ = 4.16 (m, COOCH2 ester linker, 4aH, di-ester, 2bH, mono-
ester), 3.54 (m, 2bH, HOCH2, mono-ester), 2.7-3.3 (m, 8H of SD, 8H of  NCH2CH2COO linker),  2.1 (br 
m, 2H, HN-CH2-CH2-CH2-NH- of SD), 1.8 (br m, 4H, -HN-CH2-CH2-CH2-CH2-NH- of SD), 1,67 (m, 4aH, 
COOCH2CH2 di-ester, 2bH, mono-ester), 1,53 (m, 2bH, HOCH2CH2  monoester), 1,41 (m, 4a+bH, -
OCH2CH2CH2 linker). 
molar ratio (linker/SD) = 0.56 : 1;  di-ester/mono-ester = 45 : 55 
integrals: a+b (linker in total): 56% of SD protons ; a (di-ester): 25% ; b (mono-ester): 31%  
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SP-HD-0.5: 1H NMR (500MHz, d3-MeOH) δ = 4.15 (m, COOCH2 ester linker, 4aH, di-ester, 2bH, mono-
ester), 3.54 (m, 2bH, HOCH2, mono-ester), 2.7-3.3 (m, 12H of SP and  8H of NCH2CH2COO linker), 
2.1 (br m, 4H, H2N-CH2-CH2-CH2-NH- of spermine), 1.8 (br m, 4H, -HN-CH2-CH2-CH2-CH2-NH- of 
spermine), 1,68 (m, 4aH, COOCH2CH2 di-ester, 2bH, mono-ester), 1,52 (m, 2bH, HOCH2CH2  
monoester), 1,41 (m, 4a+bH, -OCH2CH2CH2 linker). 
molar ratio (linker/SP) = 0.61 : 1;  di-ester/mono-ester = 40 : 60 
integrals: a+b (linker in total): 61% of SP protons ; a (di-ester): 24 % ; b (mono-ester): 37%  
 
TT-HD-1: 1H NMR (500MHz, d3-MeOH) δ = 4.1 (m, COOCH2 ester linker, 4aH, di-ester, 2bH, mono-
ester), 3.54 (m, 2bH, HOCH2, mono-ester), 2.6-3.4 (br m, 20H, NCH2, of TT ethylenes and 
NCH2CH2COO linker),  1,66 (m, 4aH, COOCH2CH2 di-ester, 2bH, mono-ester), 1,55 (m, 2bH, 
HOCH2CH2  monoester), 1,41 (m, 4a+bH, -OCH2CH2CH2 linker). 
molar ratio (linker/TT) = 1 : 1;  di-ester/mono-ester = 64 : 36 
integrals: a+b (linker in total): 102% of TT protons ; a (di-ester): 65% ; b (mono-ester): 37%  
 
TP-HD-1: 1H NMR (500MHz, d3-MeOH) δ = 4.0 (m, COOCH2 ester linker, 4aH, di-ester, 2bH, mono-
ester), 3.46 (m, 2bH, HOCH2, mono-ester), 2.5-3.3 (br m, 24H, NCH2, of TP ethylenes and 
NCH2CH2COO linker),  1,59 (m, 4aH, COOCH2CH2 di-ester, 2bH, mono-ester), 1,45 (m, 2bH, 
HOCH2CH2 monoester), 1,32 (m, 4a+bH, -OCH2CH2CH2 linker). 
molar ratio (linker/TP) = 0.87 : 1;  di-ester/mono-ester = 68 : 32 
integrals: a+b (linker in total): 87% of TP protons ; a (di-ester): 59% ; b (mono-ester): 28%  
 
OEI-HD-1: 1H NMR (500MHz, d3-MeOH) δ = 4.1 (m, COOCH2 ester linker, 4aH, di-ester, 2bH, mono-
ester), 3.53 (m, 2bH, HOCH2, mono-ester), 2.6-3.5 (br m, 80H, NCH2, of OEI ethylenes and 
NCH2CH2COO linker) 1,66 (m, 4aH, COOCH2CH2 di-ester, 2bH, mono-ester), 1,52 (m, 2bH, HOCH2CH2  
monoester), 1,38 (m, 4a+bH, -OCH2CH2CH2 linker). 
molar ratio (linker/OEI) = 0.47 : 1;  di-ester/mono-ester = 20 : 80 
integrals: a+b (linker in total): 47 mol % of OEI ; a (di-ester): 9 mol % ; b (mono-ester): 38 mol %  
 
Materials and methods 30 
lt-OEI-HD-1: 1H NMR (500MHz, d3-MeOH) δ = 4.1 (m, COOCH2 ester linker, 4aH, di-ester, 2bH, mono-
ester), 3.54 (m, 2bH, HOCH2, mono-ester), 2.6-3.5 (br m, 80H, NCH2, of OEI ethylenes and 
NCH2CH2COO linker),  1,66 (m, 4aH, COOCH2CH2 di-ester, 2bH, mono-ester), 1,54 (m, 2bH, 
HOCH2CH2  monoester), 1,40 (m, 4a+bH, -OCH2CH2CH2 linker). 
molar ratio (linker/OEI) = 1.24 : 1;  di-ester/mono-ester = 50 : 50 
integrals: a+b (linker in total): 124 mol % of OEI ; a (di-ester): 62 mol % ; b (mono-ester): 62 mol %  
 
2.3.1.2 Fourier transform infrared spectroscopy (FTIR) 
FTIR spectroscopy was conducted with a FT-IR Paragon 1000 spectrometer from 
Perkin Elmer, Boston, USA using KBr pellets. 
 
2.3.2 Molecular weight determination 
2.3.2.1 Matrix-Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF) 
Measurements were carried out on a Bruker Autoflex II MALDI-TOF spectrometer 
(Bruker Daltonik GmbH, Biburg, Germany). Targets and matrices were also obtained 
from Bruker GmbH. 
Matrix solutions of either sinnapinic acid (SA) or 2.5-dihydroxybenzic acid (DHB) 
were prepared at a concentration 10 mg/ml in ACN/ 0.1% TFA (1:2). KCl was 
dissolved in methanol at a concentration of 10 mg/ml. For MALDI analysis, 
monomers and polymers in water at concentrations from 0.5 to 10 mg/ml were mixed 
with either matrix alone at a volumetric ratio of 1:1 or with matrix and cationizing 
agent KCl at a volumetric ratio of  matrix / sample / KCl (2:1:1). A 1 µl aliquot was 
applied to the MTP 384 massive aluminium target. Laser powers of 45-60 % were 
used to obtain spectra. 
2.3.2.2 SEC/Multi Angle Laser Light Scattering (MALLS) 
All SEC/MALLS measurements were performed by Dr.Bruzzano, Fraunhofer IAP, 
Golm. 
Samples were analyzed on TSK-gel guard + G-oligo-PW column using 0.2 M Na2SO4 
+ 1 % HAc (pH 3.2) as eluent (sample loop 0.1 ml, flow rate 1 ml/min) and compared 
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to commercially available PEI standards. The system was calibrated with PEG 
standards and by online viscosimetry, respectively.  Molecular weight determination 
and calculations were based on UV-, RI- and MALLS detection. 
2.3.2.2.1 Fractionation of OEI-HD-1 
Fractions of OEI-HD-1 were separated on a TSK-Gel guard + G-oligo-PW column 
and samples were concentrated via macro-separators (Omega 3k (PALL), 4000 rpm, 
20 min). The procedure was accomplished 5 times and resulting sample solutions 
were analyzed repeatedly by GPC. 
2.3.3 DNA-binding and condensation 
DNA binding and complexation of polymers to DNA (10 µg/ml) reduces DNA 
intercalation of ethidium bromide (EtBr). As only intercalated EtBr fluoresces strongly 
(λex = 510nm, λem = 590nm) (Parker 2002) DNA condensation can be expressed as 
percentage of fluorescence intensity relative to un-complexed DNA  
(% rel.F= Fcomplex/FDNA).  
Fluorescence was measured using a Cary Eclipse fluorescence spectrophotometer 
(Varian Deutschland GmbH, Darmstadt).  
EtBr was diluted in either HEPES-buffered glucose (HBG, 5 % (w/w) glucose, 20 mM 
HEPES, pH 7.1) or HEPES-buffered saline (HBS, 20mM HEPES, 150mM NaCl, pH 
7.1) to a final concentration of 0.4 µg/ml. 2ml of EtBr dilution were mixed with 20µg of 
plasmid DNA and fluorescence intensity was measured after 3 min. Polycation was 
added stepwise every 20 seconds and % rel.F. was determined as described above.  
2.3.4 Polyplex formation 
Plasmid DNA encoding luciferase was condensed with standard PEI or 
biodegradable polymers at various conjugate/ plasmid (C/P) – ratios (w/w). DNA / 
polycation polyplexes were prepared at a final DNA concentration of 20µg/ml as 
described in Kircheis et al. 1997. Briefly, indicated amounts of plasmid DNA and 
polycation were each diluted in either HBS or HBG and rapidly mixed by pipetting. 
Polyplexes were allowed to stand for at least 20 min at RT before use. 
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2.3.5 Agarose gel retardation  
Polyplexes were prepared as described above. 10 µl of complex mixed with loading 
buffer was loaded on a 0,8 % agarose gel in TBE buffer containing ethidium bromide. 
The gel was run at 80 V for 1 h and then photographed under UV light. 
2.3.6 Particle size measurements 
Particle size of transfection complexes was measured by laser-light scattering using 
a Malvern Zetasizer 3000HS (Malvern Instruments, Worcestershire, UK). Polyplexes 
were generated in either HBG or HBS at DNA concentrations of 20 µg/ml and were 
allowed to stand 30 min prior to measurement.  
2.3.7 Degradation studies 
2.3.7.1 Reduction of disulfide bonds 
2.3.7.1.1 Degradation of polymers 
Polymer stocks (c= 1mg/ml) were treated with 50 mM dithiothreitol (DTT) at 37°C for 
0-24 h. After DTT treatment, polymer/ DNA complexes were formed at C/P 4 and C/P 
10 in HBG and allowed to stand for 30 min at RT. Samples were loaded on a 0.8 % 
agarose gel (see ‘agarose gel retardation assay’) and the gel was run at 80 V for 1 h.  
2.3.7.1.2 Degradation of complexes 
Polymer stocks were diluted in HBG to a final concentration of 0.4 mg/ml. A stock 
solution of plasmid (pCMVLuc, c= 40 µg/ml) was prepared in HBG and polyplexes 
were mixed at weight ratios of conjugate to plasmid (C/P)  of 4 & 10. After complex 
formation (30min at RT) polyplexes were incubated with 50 mM DTT for 0 – 120 min 
at 37°C. Samples were analyzed by gel electrophoresis as described above. 
Hydrolysis of ester bonds 
2.3.7.1.3 Degradation of HD polymers 
Polymer stocks with a concentration of 5 mg/ml were adjusted to pH 5, pH 7 and pH 
9 and incubated at 37°C for 0 – 5 days. After hydrolysis, the pH was adjusted to pH 7 
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and polymer/ DNA complexes were formed at C/P 4 in HBG (complex formation 30 
min at RT). Samples were analyzed by agarose gel electrophoresis. 
2.3.7.1.4 Hydrolysis of OEI-HD-1 and lt-OEI-HD-1 
Degradation was studied with polymer stocks (5 mg/ml; pH 7) incubated for 0-15 
days at 37 °C in an Eppendorf Thermomixer (500 rpm). Solutions with a pH of 5 and 
9 were prepared by adding the appropriate amount of HCl and NaOH, respectively. 
After incubation, the pH was adjusted to pH 7 and sample aliquots were analyzed by 
SEC on a Sephadex G25 (10/30) column with 150 mM NaCl as eluent and a flow 
rate of 1 ml/min. Detection was carried out at 210 nm, 217 nm and 240 nm. 
 
2.4 Biological properties of the polymers 
2.4.1 Cell culture 
Cell culture media, antibiotics and fetal calf serum (FCS) were purchased from 
Invitrogen GmbH (Karlsruhe, Germany). All cultured cells were grown at 37°C in 5 % 
CO2 humidified atmosphere. B16-F10 murine melanoma cells (kindly provided by I. J. 
Fidler, Texas Medical Center, Houston, TX, USA), CT 26 murine colon carcinoma 
cells (ATCC CRL-2638) and murine neuroblastoma Neuro2A cells (ATCC CCI-131) 
were cultured in DMEM (1g glucose/l) supplemented with 10 % FCS. HUH-7 
hepatocellular carcinoma cells (JCRB 0403; Tokyo, Japan) were grown in DMEM 
high glucose/F12 (1/1) supplemented with 10% FCS. HT-22 cells were obtained from 
David Schubert (Salk Institute, San Diego, CA, USA). The HT-22 line was originally 
selected from HT-4 cells based on glutamate sensitivity. HT-4 cells were 
immortalized from primary hippocampal neurons using a temperature-sensitive SV-
40 T antigen (Morimoto and Koshland 1990). HT-22 cells were grown in Dulbecco's 
modified Eagle's medium supplemented with 10% charcoal-stripped fetal bovine 
serum (HyClone, Logan, UT, USA) and gentamicin (50 µg/mL). 
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2.4.2 Luciferase reporter gene expression  
For standard transfection screenings cells were seeded in 96 well plates (TPP, 
Trasadingen, Switzerland) at a density of 104 cells (Neuro2a cells) or 5 x 103 cells (all 
other cell lines) in 100µl culture medium per well. During transfection and for the 
following incubation until analysis, 100U/ml penicillin and 100 µg/ml streptomycin 
were present in the medium. Transfection complexes with indicated amounts of DNA 
(pCMVLuc) were added directly to the cells. Complex-containing medium was 
removed 4 h after transfection, 100µl of fresh medium were added and gene 
expression was measured after 24 h. 
Cells were washed once with phosphate-buffered saline (PBS) at 20-24 h after 
transfection, then lyzed with 50 µl (96 well-plate) of reporter lysis buffer (Promega, 
Mannheim, Germany) per well. Luciferase activity was determined from 20 µl 
samples of the lysate using the Luciferase Assay system (Promega); measurements 
were performed in a luminometer (Lumat LB9507, Berthold, Bad Wildbad, Germany). 
Values are given as relative light units (RLU) and per seeded cells (mean +/- 
standard deviations of at least triplicates). Two ng of recombinant luciferase 
(Promega, Mannheim) correspond to 107 light units. 
2.4.3 Metabolic activity of transfected cells 
Cells were grown (96-well plate) and treated with different amounts of DNA-
complexes as described in ‘cell culture’ and ‘transfection’. 
Metabolic activity of each well was determined by using a MTT / thiazolyl blue assay:  
To each well 10 µl of a 5 mg/ml solution of MTT in sterile PBS buffer were added. 
Cells were incubated at 37 °C for 2 h, medium was removed and the samples were 
frozen at – 80 °C for at least 2 h. 100 µl of DMSO was added and samples were 
incubated at 37 °C for 30 min under constant shaking. Optical absorbance was 
measured at 590 nm (reference wavelength 630 nm) using a microplate plate reader 
(Spectrafluor Plus, Tecan Austria GmbH, Grödig, Austria) and cell viability was 
expressed as a percent relative to untreated control cells. 
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2.4.4 Cytotoxicity - microscopic observations 
After incubation with polymers or polyplexes, changes in morphology and 
detachment of cells from the well plate were observed using a Zeiss Axiovert 200 
microscope (Carl Zeiss AG, Oberkochen, Germany). 
2.4.5 Endosomolytic activity of free polymer 
The efficiency of polycations to enhance the endosomal release of poly-L-lysine 
(PLL) polyplexes was analyzed similarly as previously described (Kichler 2001). 
B16F10 cells were seeded at a density of 5x103 cells in 96 well plates and were 
grown for 24 h. PLL (pLys 251, Sigma-Aldrich, Deisenhofen, Germany) polyplexes 
were prepared at a C/P-ratio of 1 in HBG. After an incubation for 20 min at RT, PLL-
polyplexes were diluted with fresh culture medium (DMEM, + 10 % FCS) to a final 
concentration of 2 µg DNA/ ml medium. Medium was removed, 100 µl of transfection 
medium was added to each well and cells were incubated at 37 °C, 5% CO2.  Two 
hours later, transfection medium was exchanged against 100 µl fresh culture medium 
and cells were incubated for another 2 h in the presence of free polycations at 
various concentrations (2.5–60 µg/ml).  After removal of the polymers cells were 
incubated for 24 h and luciferase expression was measured as described in 
“Luciferase reporter gene expression”. Luciferase expression levels were compared 
to standard PLL polyplexes in the absence of endosomolytic agents. 
2.4.6 Hemolytic activity of polymers 
Human erythrocytes were isolated from fresh citrate-treated blood and washed in 
Hepes-buffered saline (HBS) by four centrifugation cycles, each at 2200 rpm for 10 
min at 4°C. The erythrocyte pellet was diluted in either HBS pH 7.1, serum containing 
HBS or serum containing citrate buffer pH = 5 (150 mM NaCl, 15 mM citric acid) to a 
final concentration of 4 % erythrocytes. Erythrocyte concentration was determined 
using a Fuchs-Rosenthal counting chamber. Suspension of red blood cells was 
always freshly prepared and used within 24 h. PEI standards and new biodegradable 
polymers were serially diluted in 75 µl of the appropriate buffer (pH 7.1 vs. pH 5; no 
serum vs. 10 % serum) using a V-bottom 96 well plate, resulting in polymer 
concentrations of 0.25-1.0 mg/ml. For 100 % lysis, control wells contained buffer with 
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1 % Triton-X-100. Erythrocyte suspension (75 µl, containing approximately 109 
erythrocytes) was added to each well and the plates were incubated at 37°C for 
45 min under constant shaking. After centrifugation at 2200 rpm for 10 min, 80 µl 
supernatant was analyzed for hemoglobin release at 450 nm using a microplate plate 
reader (Spectrafluor Plus, Tecan Austria GmbH, Grödig, Austria) whereas the 
erythrocyte pellet was used for monitoring erythrocyte aggregation. Experiments 
were performed in triplicates. The percentage erythrocyte lysis was calculated 
according to the presented formula. 
 
2.4.7 Polymer-induced erythrocyte aggregation  
The erythrocyte pellet was resuspended in 100 µl HBS and transferred to a 24-well 
plate (Gibco) containing 1 ml HBS per well. Erythrocyte aggregation was visualized 
microscopically at a 32-fold magnification. 
 
2.5 Modification of standard polyplexes 
2.5.1 EGF receptor targeting  
HUH7 cells were seeded in 96-well plates at a density 5x103cells per well 24 h prior 
to transfection. Targeted DNA complexes were prepared by first diluting and mixing 
unmodified polycation with various amounts of EGF-PEG-PEI conjugates in HBG. 
Complexes were formed at different C/P-ratios and were allowed to stand for at least 
20 min at RT before use. The final concentration of DNA in EGF-targeted and non-
targeted complexes was 20 µg/ml and complexes were added directly to the wells. 
Complex-containing medium was removed 4h after transfection, 100µl of fresh 
medium were added and gene expression was measured after 24h as described in 
‘Luciferase reporter gene expression’. 
 
% lysis =  100% * 
Apolymer - Ablank
A100%lyse - Ablank
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2.5.1.1 Competitive inhibition of the EGFR 
2.5.1.1.1 Competition with an excess of free murine EGF 
Cells were seeded out into 24 well plates (Gibco) at a density of 2.5 x 104 cells per 
well. In case of HepG2 and HUH7 cells, the wells were previously coated with 2.5 % 
(w/v) collagen (in PBS). After 24 h, cells were preincubated with 500 µl of culture 
medium containing 12 µg murine EGF (stock solution 2 mg/ml in PBS) or 12 µg 
bovine serum albumine (BSA, stock solution 2 mg/ml in PBS) respectively, as 
previously described (Blessing 2001). After 30 min complexes were added and cells 
were incubated for 4 h before complex containing medium was replaced by fresh 
culture medium. Luciferase measurement was carried out as described in ‘Luciferase 
reporter gene expression’. 
2.5.1.1.2 Blocking the EGFR with mouse anti-human EGFR 
Cells were pre-incubated with medium containing mouse anti-human EGFR (3 µg/ 
500 µl medium) and mouse IgG1 (3 µg/ 500 µl medium), respectively. After 30 min 
complexes were added (Blessing 2001). The following procedure was identical to 
that described above. 
2.6 Photochemical intracellular release (PCI) 
Cells were seeded out into 24 well plates (Gibco) at a density of 2.5 x 104 cells per 
well. In case of HepG2 and HUH7 cells, the wells were previously coated with 2.5 % 
(w/v) collagen (in PBS). After approximately 6-8 h, medium was replaced by medium 
containing 0.2 µg /ml TPPS2a (LumiTrans®); the medium of control  cells  was 
changed with photosensitizer (PS)-free medium and all cells were incubated for 18 h 
at 37 °C. All the procedures after addition of the photosensitizer were carried out in 
subdued light. The cells were washed three times with culture medium and incubated 
in 0.5 ml PS-free medium containing plasmid complex. Treated cells were incubated 
for 4 h at 37 °C, washed once with medium and after addition of 0.5 ml culture 
medium, the cells were exposed to blue light (LumiSource®, 4*18 W Osram L 18/67, 
Blue) with a light intensity of 13.5 MW/cm2. After a light exposure of 60 s the cells 
were incubated at 37 °C for 24 h before analysis for luciferase expression. 
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3 Results 
3.1 Biodegradable polymers based on oligomerized polyamines 
3.1.1 Synthesis of the polymer library 
A library of 54 polycations was synthesized by oligomerization of LMW polyamines 
with different crosslinkers. In a combinatorial approach, six polyamines which differed 
in their molecular weight, their amine content and the distance between amino 
groups (Fig.6a) were crosslinked at three different molar ratios of polyamine to 
crosslinker in order to generate a series of degradable cationic oligoamines.  
 
 
    
 
Fig.6: Chemical structures of polyamines 
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The absence of water during synthesis should prevent hydrolysis of reactive linker 
groups. Therefore, polyamines and crosslinkers were dissolved in DMSO (absolute, 
over molecular sieve, H2O < 0.01 %) shortly before use. 
3.1.1.1 Dithiobis(succinimidylpropionate) (DSP) crosslinking 
DSP is a homobifunctional NHS (N-hydroxysuccinimide) ester-based electrophilic 
crosslinking reagent that reacts preferentially with primary amines to form amides. 
The linker is constructed around a centrally located disulfide bond, which is cleavable 
in a reducing environment (Fig.7a).  
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Fig.7: Synthesis of oligomerized polyamines.  
Reaction with the DTBP crosslinker generates amidine-linked polymers (A). DSP crosslinking 
originates amide bond-containing structures (B); for DTBP and DSP polymers, degradation is based 
on the reduction of disulfide bonds. The HD-linker reacts with primary and secondary amines to form 
amine bonds. In a second reaction, esters can be converted into amides by inter- or intramolecular 
ester aminolysis. Thus, degradation would be based on cleavage of either ester or amide bonds (C). 
All reactions are illustrated for OEI 800 as model polyamine. 
Results 40 
The reaction was carried out at 15°C for 24 hours. Use of a 2-fold molar excess of 
linker generated highly branched polymers which were only partly soluble in aqueous 
media (Table 2). Whereas other polyamine-SP-2 structures could not be further 
processed, SP-SP-2 and OEI-SP-2 were dissolved and purified by SEC. Thus, 14 
polymers of the SP series were included into the screening. 
 
3.1.1.2 Dimethyl-3-3’-dithiobispropionimidate (DTBP) crosslinking 
DTBP is very similar to DSP but it utilizes an imidoester reactive group which reacts 
with primary amines to form amidines, resulting in the retention of the positive charge 
(Fig.7b). As described for DSP crosslinking, the reaction was carried out at 15 °C for 
24 hours. Each molar crosslinking ratio of polyamine to linker resulted in soluble 
polymers (altogether 18 polyamine-IP structures) which were suitable for subsequent 
purification and analysis (Table 2). 
 
 SD SP TT TP PH OEI 800 
HD- 0.5 liquid liquid liquid liquid liquid liquid 
HD- 1 gel gel liquid liquid liquid liquid 
HD- 2 solid solid solid solid solid solid 
IP- 0.5 liquid liquid liquid liquid liquid liquid 
IP- 1 liquid liquid liquid liquid liquid liquid 
IP- 2 liquid liquid liquid liquid liquid liquid 
SP- 0.5 gel gel liquid liquid liquid gel 
SP- 1 clear gel liquid liquid liquid gel 
SP- 2 gel gel gel gel gel gel 
  
Table 2: Solubility of polymeric products after crosslinking (fat accentuated states mean that the 
product could not be further processed and was therefore excluded from the following screenings) 
Abbreviations that were defined for polyamines (PA): spermidine (SD), spermine (SP), 
triethylentetramine (TT), tetraethylenpentamine (TP), pentaethylenhexamine (PH) and 
oligoethylenimine 800 (OEI 800) (first row) 
crosslinkers (CL): hexanediol-diacrylate (HD), imidopropionate (IP) and succinimidylpropionate (SP) 
(first column) 
and molar crosslinking ratios: PA:CL=1:0.5 (-0.5), PA:CL=1:1 (-1), PA:CL=1:2 (-2) 
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3.1.1.3 Crosslinking with 1,6-hexanediol-diacrylate (HD) 
The diacrylate linker reacts with polyamines by Michael addition to either primary or 
secondary amines, generating ester-based polymers. In a following reaction, free 
amino groups might convert ester-containing polymers into amide derivatives by 
aminolysis of the esters. This side reaction will depend on reaction temperature and 
the availability of supplementary amines   (Fig.7c). For generation of the library, a 
reaction temperature of 60°C was applied for 4 days. 
An excess of crosslinker resulted in gelation and originated highly branched 
caoutchuc-like polymers insoluble in aqueous media (Table 2). This means that only 
12 polyamine-HD polymers were included into the screening. 
For the following screenings, a uniform nomenclature was established. The name of 
each polymer consisted of three parts: first, the abbreviation for the polyamine that 
was oligomerized, second, the name of the linker and third, the molar ratio of 
polyamine to linker during the crosslinking reaction (for abbreviations see Table 2). 
 
3.1.1.4 Synthesis of Cya-HD-1 and (OEI-IP-OEI)-HD 
Apart from the library, two additional polymers which combined both degradation 
strategies (site-specific reductive cleavage of disulfide bonds and time-dependent 
ester hydrolysis) were synthesized and included into the screenings. The aim was to 
find out whether a combination of both linkages optimized polymer characteristics. 
Cystamine (Cya), a disulfide-bond containing diamine (Fig.6b), was oligomerized 
with HD-linker at a molar crosslinking ratio of 1 at 60°C and purified by SEC. 
Additionally, a new OEI polymer based on OEI 800 that was dimerized in a first step 
by DTBP crosslinking (15°C) and then oligomerized by HD crosslinking (60°C) was 
synthesized (  OEI-IP-HD-1). 
 
Altogether, 44 soluble polymers of the library and 2 additionally synthesized 
structures (Cya-HD-1 and OEI-IP-HD-1) were included into the screening. 
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3.1.2 DNA binding activity of novel polycations 
First of all it was important to investigate the ability of novel oligoamines to form 
polyplexes with DNA. Fluorescence of ethidium bromide (EtBr) intercalated into 
double-stranded DNA is strongly quenched after addition of polycations which 
interact electrostatically with negatively charged nucleic acids. Therefore polyplex 
formation as well as the density of the originated complexes can be monitored by 
EtBr exclusion assay.  
DNA binding studies of each conjugate were performed in salt-free (HBG) and in 
physiological salt-containing (HBS) buffer at different conjugate/DNA ratios (Fig.8).  
 
Polymers that consisted of short polyamines with few protonable amines, such as 
spermidine or triethylentetramine, showed weak DNA binding capacity in HBG, which 
was even more pronounced in the presence of 150 mM salt (HBS). At a 
conjugate/plasmid (w/w)-ratio (C/P-ratio) of 5, TT-IP-1 only reduced the relative 
fluorescence down to 60 % (Fig.8f) whereas the corresponding OEI-polymer, OEI-IP-
1 at a C/P-ratio of 2 decreased fluorescence down to 20 % (Fig.8l). Comparison of 
different linkers elucidated that polymers that were generated by DSP crosslinking 
like e.g. PH-SP-0.5 (Fig.8i&j) were characterized by an overall weaker DNA binding 
efficiency. Within a polyamine group, IP-linked polymers always showed the 
strongest ambition to complex DNA and to exclude EtBr from the polyplex. HD-
polymers, except OEI-HD’s which had the same DNA binding affinity than OEI-IP, did 
not bind to DNA as strong as their IP counterparts, but better than their SP analogs.  
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Fig.8: DNA binding and complex density of spermidine- (A,B), spermine- (C,D), triethylentetramine- 
(E,F), tetraethylenpentamine- (G,H), pentaethylenhexamine- (I,J) and oligoethylenimine 800- (K,L) 
based polymers. Complexes were formed in the presence of EtBr in either HBG (left column) or HBS 
(right column) and inhibition of EtBr/DNA fluorescence was monitored as described in materials and 
methods. Measurements were performed in duplicates.  
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To give more detailed information about the best condensing polymer out of one 
group, the C/P-ratio at which the fluorescence signal reached 50% of the original 
value (FI50), and the minimal fluorescence intensity (FImin) values are additionally 
summarized in Table 3. 
 
C/P-ratio to reach FI50 FImin (%) C/P-ratio to reach FI50 
 
FImin (%) 
 
 
Polymer 
HBG HBS 
SD-HD-0.5 
SP-HD-0.5 
TT-HD-1 
TP-HD-1 
PH-HD-0.5 
OEI-HD-1 
1.5 
0.5 
2.3 
1.5 
2.3 
0.3 
39 
23 
48 
34 
48 
6 
2.5 
1.1 
2.5 
2.3 
2.5 
0.3 
52 
38 
56 
48 
55 
19 
SD-IP-1 
SP-IP-0.5 
TT-IP-2 
TP-IP-2 
PH-IP-1 
OEI-IP-1 
1.0 
0.5 
1.2 
1.0 
0.8 
0.4 
13 
9.4 
14 
12 
14 
5 
3.4 
1.5 
3.2 
2.7 
3.6 
0.4 
37 
27 
37 
33 
40 
22 
SD-SP-0.5 
SP-SP-0.5 
TT-SP-0.5 
TP-SP-1 
PH-SP-1 
OEI-SP-0.5 
- 
3.0 
5.0 
7.7 
3.0 
0.5 
63 
42 
32 
49 
31 
8 
- 
5.5 
- 
- 
8.2 
1.0 
86 
44 
59 
75 
50 
30 
  
Table 3: DNA condensation (in HBG and HBS) as studied by EtBr exclusion assay  
Values represent the C/P-ratio of best condensing candidates out of one polymer group at which the 
fluorescence signal reaches 50% of the original value (FI50) and the minimal fluorescence (FImin). 
 
DNA binding data of the additionally synthesized polymers OEI-IP-HD-1 and Cya-
HD-1 was in accordance with structure/activity relationships observed for the library. 
OEI-IP-HD-1 had similar DNA binding affinity as OEI-HD-1 and OEI-IP-1, whereas 
the small polyamine-containing Cya-HD-1 was characterized by poor DNA 
condensation (Fig.9). 
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Fig.9: DNA binding and complex density of Cya-HD-1 and OEI-IP-HD-1  
Complexes were formed in the presence of EtBr in either HBG (A) or HBS (B) and inhibition of 
EtBr/DNA fluorescence was monitored as described in materials and methods. DNA binding activity 
was compared to OEI-HD-1. Measurements were performed in duplicates. 
 
Generally, efficient DNA binding correlated with the number of protonable amines 
provided by the polyamine and with the type of linkage generated by the crosslinker. 
Similar trends of complexation and polyplex stability were observed using the 
agarose gel retardation assay (data not shown). For example, in case of OEI-HD-1, 
OEI-IP-1 and OEI-IP-HD-1 DNA was completely retarded at C/P 0.5. OEI-SP-0.5 
prevented DNA migration at C/P 1. All polyamine-IP polymers needed maximal C/P 4 
to retard DNA, whereas small SP-crosslinked polyamines like SD-SP-0.5 did not form 
stable polyplexes up to a C/P-ratio of 25. 
3.1.3 Reductive cleavage of disulfide linked polymers 
As disulfide bonds are relatively stable in plasma and can be cleaved within the cell 
due to high redox potential differences outside and inside the cell, they present a 
useful tool for site specific drug delivery. According to previous publications, most in-
vitro experiments dealing with polymer degradation based on the reduction of 
disulfide bonds (Read 2003 & 2005) are carried out in the presence of dithiothreitol 
(DTT) as reducing agent. 
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3.1.3.1 Degradation of polymers 
First, it was important to check if SP and IP polymers were susceptible to reduction 
as expected. Therefore, polymer dilutions (1 mg/ml) were treated with 50 mM DTT at 
37°C for 0-24 h. After reduction, polymer/DNA complexes were formed and analyzed 
by gel electrophoresis. Without DTT (t=0), SP-SP-0.5 and the control ester-based 
analog SP-HD-0.5 formed stable polyplexes which prevented electrophoretic 
migration of DNA (Fig.10a). After 2h of DTT treatment the disulfide-based polymer 
was partly degraded and was thereby not able anymore to provide polyplex stability, 
whereas polymer integrity of SP-HD-0.5 was not affected by the reducing 
environment (Fig.10b-d).  
 
 
 
 
 
 
 
 
 
Fig.10: Reduction of disulfide bonds: polymer degradation  
SP-HD-0.5 and SP-SP-0.5 were incubated with DTT at 37°C for 0 – 24 h. After DTT treatment, 
polymer/DNA complexes were formed at C/P 4 and C/P 10 in HBG and allowed to stand for 30 min at 
RT before gel electrophoresis. Incubation times t= 0 (A), t =2 h (B), t= 4h (C) and t= 24h (D) were 
analyzed separately. The first lane contains un-complexed DNA as a control. 
 
3.1.3.2 Degradation of polyplexes 
To determine the ability of polyplexes to be activated by reduction, SP-SP-0.5/DNA 
complexes with a C/P-ratio of 4 and 10 respectively, were reduced with DTT and 
polyplex stability was assessed by gel electrophoresis in the presence of 150 mM 
salt. Fig.11 shows that a relatively low percentage of DNA migrated in the gel after 
complexation at C/P 4. At a C/P-ratio of 10, DNA was entirely retained in the well 
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under non-reducing conditions. When SP-SP-0.5 polyplexes were incubated with 
DTT for 15 min, particle stability decreased and DNA was completely released from 
the polyplex. 
 
 
 
 
 
 
 
 
Fig.11: Reduction of disulfide bonds: polyplex degradation 
SP-SP-0.5 polyplexes were prepared in HBG at C/P 4 (A) and C/P 10 (B) (complex formation at RT for 
30 min) and were incubated +/- 50 mM DTT in the presence of 150 mM NaCl for 0-120 min before gel 
electrophoresis. The first lane contains un-complexed DNA as a control. 
 
3.1.4 Hydrolytic degradation of HD-linked polymers 
In contrast to site-specific cleavage of disulfide bonds, ester hydrolysis is pH- 
dependent and occurs over time. Esters are hydrolyzed in aqueous solution at basic 
as well as at acidic pH and should be more stable at neutral pH. Amides are less 
susceptible towards hydrolysis but can be degraded via base-catalyzed hydrolytic 
cleavage. In case of HD-linked polyamines, the resulting bonds could be either the 
original esters or amides (due to aminolysis of the ester) or even a mixture of both.  
1H-NMR analysis confirmed the presence of retained ester bonds as well as varying 
percentages of amide linkages for all analyzed HD polymers. Polymers containing 
small polyamines, for example TT-HD-1, had preserved 60 % of the hexanediol linker 
as diester, while in case of OEI-HD-1 80 % of the linker were hydrolyzed at one end, 
resulting in monoester formation. At crosslinker to polyamine ratios of 0.5, the 
percentage of diester relating to amount of polyamine was e.g. 14 % for SD-HD-0.5 
and 24 % for SP-HD-0.5. 
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Degradation was studied at pH 5, 7 and 9 (incubation for several days at 37 °C) with 
SP-HD-0.5 as a model HD-polymer. The ability of degraded polymer fragments to 
form stable complexes was analyzed by gel electrophoresis. After incubation at pH 7, 
SP-HD-0.5 formed stable polyplexes (C/P 4 in HBG) which prevented the migration 
of DNA at all time points. At pH 5 and 9, polymer degradation could be observed 
after 24-72 h, but while hydrolysis at pH 9 resulted in complete DNA release after 5 
days, the hydrolysis product of pH 5 treated polymers was still able to bind DNA to 
some degree (Fig.12).   
 
 
 
 
 
 
 
 
 
 
 
Fig.12:  pH dependent hydrolysis: polymer degradation 
SP-HD-0.5 was incubated at pH 5, 7 and 9 at 37°C for 1 - 5 days. After hydrolysis, polymer samples 
were adjusted to pH 7 and polymer/ DNA complexes were formed at C/P 4 in HBG. Complexes were 
allowed to stand for 30 min at RT before gel electrophoresis. Incubation times t= 24 h (A), t =3 days 
(B) and t= 5 days (C) were analyzed separately and compared to free DNA (lane 1) and untreated SP-
HD-0.5 (lane 2).   
 
DNA binding activity and degradation properties provided some information about the 
polymer and its ability to interact with nucleic acids, but for evaluation of gene 
delivery efficiency and toxicity, each polymer had to be screened in transfection 
assays using different cell lines. 
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3.1.5 Gene transfer activity 
Reporter gene expression (luciferase activity) of the polymer library was evaluated by 
screening all cationic conjugates at different C/P-ratios (weight ratio of conjugate to 
plasmid DNA) on B16F10 murine melanoma cells. Polyplexes were prepared in HBG, 
a constant DNA concentration of 4 µg/ml was applied to the cells, and after 24 h 
luciferase expression was compared to ‘golden standard’ PEI22lin polyplexes (N/P 6 
corresponding to C/P 0.8 ). 
Although small non-oligomerized polyamines were able to bind weakly to DNA, they 
did not mediate gene transfer at all (e.g. spermine), or they were characterized by 
rather low expression levels (e.g. OEI 800, 102-103 RLU/5000, B16 cells; data not 
shown). All SP-linked polyamines needed a huge excess of polymer for efficient gene 
delivery (Fig.13a). Whereas PH-SP-1 or OEI-SP-0.5 showed promising transfection 
efficiency at C/P 50 and 70 respectively, the other SP polymers were more than 10-
fold less efficient than PEI22. Similarly, IP-linked polyamines lacked activity at low 
C/P ratios (data not shown). Increasing the amount of polymer resulted in enhanced 
transfection efficiency, particularly in case of TP-IP-2, PH-IP-2 and OEI-IP-1 
(Fig.13b). Both, SP-and IP-linked polymers were essentially non-toxic (data not 
shown). With regard to gene delivery, however, most of them could not compete with 
PEI22 under these conditions. Polymers of the HD-series exhibited stronger toxicity 
at C/P 50-70. Therefore, a following transfection experiment was carried out with 
lower C/P ratios (Fig.13c). At C/P 25, SP-, SD-, TT-, TP- and PH-HD’s showed 
maximum gene expression which varied between E+02 and 8E+07 relative light units 
per 5000 cells. Interestingly, OEI-HD polymers were highly efficient at C/P 2.5 and 5, 
achieving the same transfection activity as PEI22. Cya-HD-1 needed an immense 
excess of polymer to form a polyplex and was still characterized by rather poor 
reporter gene expression (at C/P 64 it mediated gene transfer 10,000-folds lower 
than PEI22lin and OEI-HD-1, data not shown). As mentioned above, OEI-IP-HD-1 
had similar DNA binding affinity as OEI-HD-1 and OEI-IP-1, but transfection 
efficiency did not exceed that of standard OEI polymers (data not shown). 
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Fig.13: Reporter gene expression of B16F10 cells after transfection with novel polymers  
B16F10 cells were transfected with 400ng (4 µg/ml DNA) pCMVLuc complexed with SP-linked 
polyamines (A), IP-linked polyamines (B) and HD-linked polyamines (C). Complexes were mixed in 
HBG at different C/P-ratios and compared to standard PEI polyplexes (PEI22lin at C/P 0.8). Luciferase 
activity is presented as mean values +SD of triplicates. 
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In the following screenings on different cell lines (Neuro2a, HUH-7 and HT22 cells), 
C/P-ratios of polymers were optimized for each cell line in order to highlight polymers 
with an overall promising transfection activity. Step by step, polycations with very 
poor gene delivery potential were extracted and the screening was continued with the 
best performing polymer of each group. Results are shown for the most efficient C/P-
ratio of each polymer (Fig.14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.14: Transfection efficiency of novel polycations at their optimal C/P-ratio on various cell 
lines – screening  
Neuro2a (A), HUH-7 (B) and HT-22 (C) cells were transfected with 200ng (2 µg/ml DNA) pCMVLuc 
complexed with SP-, IP- and HD-linked polyamines. Complexes were mixed in HBG at various C/P-
ratios and compared to standard PEI polyplexes (PEI22lin at C/P 0.8). Values above the columns 
represent the optimal C/P-ratio for each formulation. Luciferase activity is presented as mean values 
of triplicates. 
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It became clear that some candidates performed very well in one cell type while 
exposing low efficiency in transfecting another one. To give an example, TT-HD-1 
mediated gene transfer as efficient as PEI22lin in HUH-7 cells but had very poor 
transfection efficiency in Neuro2a and HT22 cells. Other polycations like e.g. SD-IP-1 
needed huge amounts of polymer (C/P 32-110) to achieve fair reporter gene 
expression. It is important to note that OEI-HD-1 polyplexes could be applied at low 
C/P-ratios (2-8) and mediated gene transfer as efficient as PEI22lin in all analyzed 
cell lines. Cell type independent efficiency was also observed for OEI-IP-1 and OEI-
SP-0.5, however, both polymers needed high C/P-ratios (C/P 16-60) for efficient 
gene delivery and their transfection activity was sometimes 10-fold lower than OEI-
HD-1. 
 
3.1.6 Lytic activity of novel polymers 
In order to compare the membrane destabilizing activity of SP-, IP-, and HD- 
polymers at neutral pH, their lytic activity was tested on erythrocytes. Freshly isolated 
human erythrocytes were incubated with free polymers at final concentrations of 0.5 
and 1.0 mg/ml in HBS, pH 7.1, for 45 min at 37°C. Whereas SP- and IP-linked 
polymers hardly induced any erythrocyte lysis (the maximal hemoglobin release was 
10 % for OEI-SP-0.5), HD polymers exhibited distinct membrane destabilizing activity 
(up to 44 % for TT-HD-1) (Fig.15a). Hemolytic activity of HD polymers strongly 
depended on the chain length of the hydrophilic polyamine unit and therefore on the 
overall hydrophobicity of the polymer. TT-HD-1 with a polyamine Mw of 146 Da 
induced 44 % erythrocyte lysis whereas OEI-HD-1 with a polyamine Mw of 800 Da 
resulted in 20.5 % hemoglobin release. 
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Fig.15: Influence of the crosslinker on hemolytic activity  
Human erythrocytes were incubated with free polymers (final polymer concentration 1mg/ml) for 45 
min at 37°C and hemoglobin release was quantified at 450nm (A). Hemolysis induced by active 
candidates was further studied in the presence of 10% serum (B). 100% lysis refers to TritonX 
treatment of erythrocytes. Percentage of erythrocyte lysis is presented as mean values +SD of 
triplicates.  
 
 
In order to better adjust experimental conditions to the in vivo situation, hemolytic 
activity of active candidates was studied in the presence of 10 % serum (Fig.15b). In 
all cases hemolytic activity was strongly reduced when serum proteins were present. 
For instance, TT-HD-1 induced 36 % erythrocyte lysis in the absence, but only 4.5 % 
lysis in the presence of serum. Interestingly, Cya-HD-1 displayed a very strong 
hemolytic activity in the absence of serum (100 % erythrocyte lysis) which was still 
very significant (almost 40 % erythrocyte lysis) in the presence of 10 % serum. 
 
% lysis =  100% * 
Apolymer - Ablank
A100%lyse - Ablank
PEI
25br
PH-HDTP-HDTT-HDCya-HD OEI-SP OEI-IPOEI-HD
no serum
10% serum
0
20
40
60
80
100
%
 e
ry
th
ro
cy
te
ly
si
s
B
0
10
20
30
40
50
SD SP TT TP PH OEI
%
 e
ry
th
ro
cy
te
ly
si
s
HD linker
SP linker
IP linker
A
22lin
%
 e
ry
th
ro
cy
te
ly
si
s
%
 e
ry
th
ro
cy
te
ly
si
s
Results 54 
3.1.7 Polymer-induced erythrocyte aggregation 
Another important biological aspect for in vivo application is the influence of polymers 
on erythrocyte morphology. HMW polycations, such as PEI22lin, are known to induce 
erythrocyte aggregation which can result in occluded blood vessels and embolism. 
To analyze the effect on red blood cells, erythrocytes were incubated with polymers 
(final polymer concentration 1 mg/ml) and aggregation was visualized by microscopy. 
Whereas PEI22lin and PEI25br induced aggregation within 5 min, even in the 
presence of serum, the novel polymers (except OEI polymers) did not have any 
effect on erythrocytes (Table 4). In the absence of serum, the number of red blood 
cells was extremely reduced after treatment with Cys-HD, TT-HD and TP-HD due to 
their hemolytic activity. 
 
  
SD 
 
SP 
 
CYA TT TP PH OEI  
 HD–0.5 - - - - - - + 
 HD–1 - - - - - - ++ 
 IP-0.5 - -  - - - - 
 IP-1 - -  - - - - 
 IP-2 - -  - - - - 
 SP-0.5 - -  - - - + 
 SP-1 - -  - - - + 
 IP-HD-1       + 
 PEI22lin         +++ 
 PEI25br          +++ 
  
Table 4:  Polymer-induced erythrocyte aggregation  
Erythrocytes were incubated with free polymers at a final polymer concentration of 1mg/ml for 30 min 
at 37°C. Aggregation was visualized microscopically (Zeiss Axiovert 200 microscope) with a 32-fold 
magnification. 
 
3.1.8 Endosomolytic activity of promising candidates 
The fate of polyplexes in the endosome will strongly influence transfection efficiency; 
therefore, an ideal gene carrier should possess endosomolytic activity by itself.  
Recently, Kichler et al. reported that polycations with intrinsic lysosomotropic 
properties, such as PEI, can act as helper for polylysine (PLL)-mediated transfection 
(Kichler 2001). On the basis of these findings, cells were transfected with PLL 
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polyplexes (C/P 1 in HBG) and after 2 h, transfection medium was exchanged 
against polymer-containing medium. This experiment requires the localization of both 
polymers in the same vesicle and addition of the free polymer in a concentration that 
mediates endosomolytic activity without cytotoxic effects. 
The effect of standard PEI’s (PEI22lin and PEI25br) on PLL-mediated transfection 
was analyzed in order to establish a reliable method for our purpose. Fig.16a shows 
that luciferase activity increased 50-fold in the presence of PEI22lin and 100-fold in 
the presence of PEI25br (5 µg/ml free polymer). Based on these experimental 
conditions, new polymers were screened for their endosomolytic activity. Polymers 
like Cys-HD-1, TT-HD-1 and TP-HD-1 which exposed strong hemolytic activity (see 
3.1.5), showed no or only weak enhancement of PLL-mediated gene delivery. OEI-
HD-1, however, at a concentration of 15 µg/ml, resulted in 42-fold improved reporter 
gene expression compared to standard PLL polyplexes. Both, OEI-IP-1 and OEI-SP-
0.5 enhanced gene transfer efficiency 9-fold at a concentration of 60 µg/ml (Fig.16b). 
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Fig.16: Polycation-mediated gene delivery of PLL polyplexes  
B16F10 cells were transfected with 200ng (2 µg/ml DNA) pCMVLuc complexed to PLL at C/P 1 in 
HBG. After 2 hours, transfection medium was removed and fresh culture medium with 0.25 – 6.0 µg 
(2.5-60 µg/ml) free polycation was added. Enhancement of PLL mediated gene delivery is shown for 
PEI25br and PEI22lin (A) and for selected polymers of the library (B). Luciferase activity is presented 
as mean values +SD of triplicates.         
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3.2 OEI-based polymers: a comparative study 
Due to their promising transfection efficiency and their interesting endosomolytic 
properties in the first screening experiments, the OEI polymers OEI-HD-1, OEI-IP-1 
and OEI-SP-0.5 were chosen for a detailed analysis. 
3.2.1 Reporter gene expression and cytotoxicity of OEI polymers 
As demonstrated in Fig.17a, the pre-oligomer OEI 800 displayed rather poor 
transfection efficiency on B16 cells, but after crosslinking, all OEI polymers were able 
to mediate gene transfer as efficient as PEI22lin. Whereas OEI-HD-1 showed 
maximal gene expression at C/P 2, OEI-IP-1 and OEI-SP-0.5 needed a huge excess 
of polymer (C/P 64) to achieve similar luciferase activity.  
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Fig.17: Reporter gene expression of B16F10 cells after transfection with OEI polymers  
B16F10 cells were transfected with 200ng (2 µg/ml DNA) pCMVLuc complexed with LMW OEI, OEI-
HD-1, OEI-SP-0.5 and OEI-IP-1 in HBS. Control PEI22lin polyplexes were prepared at C/P 0.8. 
Luciferase activity (A) and metabolic activity (MTT Assay) (B) are presented as mean values +SD of 
triplicates. 
 
Twenty four hours after transfection, the metabolic activity of transfected cells was 
analyzed in order to evaluate toxicity profiles of OEI polyplexes. At their optimal C/P 
ratio all polymers were less toxic than PEI22lin (Fig.17b). Nevertheless, OEI-HD-1 
showed distinct toxicity at higher charge ratios. Furthermore, phase contrast 
microscopy revealed changes in cell morphology when treated with OEI-HD-1 and 
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most strikingly after PEI22lin application. In order to clarify whether these trends were 
only cell type specific, OEI polymers were tested in an additional cell line. 
Transfection of Neuro2a cells resulted in similar outputs as already described for B16 
cells (Fig.18). OEI-HD-1 displayed high gene transfer activity at low C/P-ratios and 
was less toxic (~60 % metabolic activity) than PEI22lin (~30 % metabolic activity). 
Again, OEI-IP-1 and OEI-SP-0.5 polyplexes required an excess of polymer (up to 
C/P 32) to achieve equivalent reporter gene expression. 
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Fig.18: Reporter gene expression of Neuro2a cells after transfection with OEI polymers  
Neuro2a cells were transfected with 200ng (2 µg/ml DNA) pCMVLuc complexed with OEI-HD-1, OEI-
IP-1 and OEI-SP-0.5 in HBG. Control PEI22lin polyplexes were prepared at C/P 0.8. Luciferase 
activity (A) and metabolic activity (MTT Assay) (B) are presented as mean values +SD of triplicates. 
 
Particle size measurements of OEI polyplexes at C/P 2 and 4 revealed that OEI-HD-1 
polyplexes formed small and uniform particles < 100 nm which remained small under 
physiological salt concentration. In contrast, OEI-IP-1 and OEI-SP-0.5 polyplexes 
were about 150 nm when prepared in HBG at C/P 4, but tended to aggregate in the 
presence of salt. Since OEI-IP and OEI-SP polyplexes needed higher C/P-ratios for 
efficient gene delivery, particle size for C/P 32 polyplexes was analyzed in both 
buffers. Aggregation in HBS was reduced, however particles still remained big (470 
and 650 nm respectively) in comparison to OEI-HD-1 polyplexes (Table 5). 
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Polyplex 
 
C/P-ratio  
(w/w) 
 
Size (nm) 
HBG 
  
Size (nm) 
HBS 
 
 
OEI-HD-1 
 
 
2 
 
4 
 
61 +/- 19 
 
93 +/- 19 
 
114 +/- 32 
 
115 +/- 61 
 
 
 
OEI-IP-1 
 
 
2 
 
4 
 
32 
 
2,554 +/- 508 
 
126 +/- 101 
 
105 +/- 43 
 
2,317 +/- 436 
 
837 +/- 194 
 
469 +/- 101 
 
 
 
OEI-SP-0.5 
 
 
2 
 
4 
 
32 
 
231 +/- 40 
 
175 +/- 35 
 
285 +/- 101 
 
2,262 +/- 437 
 
1,948 +/- 229 
 
647 +/- 152 
 
Table 5: Particle size of OEI polyplexes  
DNA complexes with C/P-ratios of 2, 4 and 32 were prepared in either HBG or HBS at a final DNA 
concentration of 20 µg/ml. Particles were allowed to stand for 30 min before analysis.Polyplex 
formation and particle size measurement were performed as described in ‘materials and methods’. 
 
 
3.2.2 Erythrocyte aggregation induced by OEI polyplexes 
As already shown in table 3, only OEI-based polymers induced aggregation when 
erythrocytes were incubated with rather high concentrations (1 mg/ml) of free 
polymer. Since this concentration will presumably not be reached in vivo, the amount 
of polymer was reduced to 20 µg/ml. Again, PEI22lin caused heavy aggregation of 
red blood cells resulting in ‘clots’. Erythrocyte aggregation induced by OEI-HD-1 was 
less significant but still visible whereas OEI 800, OEI-IP-1 and OEI-SP-0.5 had no 
effect on the morphology of erythrocytes (Fig.19).  
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Fig.19: Erythrocyte aggregation induced by OEI polymers  
Erythrocytes (2E+06) were incubated with 5 µg polymer in 220 µl HBS (+ 10 % FCS) at pH 7.1 for 20 
min at 37°C. Untreated control erythrocytes (A), OEI 800 (B), PEI 22lin (C), OEI-HD-1 (D), OEI-IP-1 
(E), OEI-SP-0.5 (F). 
 
Since complexation with DNA might reduce cationic charge-dependent interaction 
with negatively charged membranes, the same experiment was carried out with 
polyplexes (containing equal amount of polymer, but complexed with DNA). 
Incubation with OEI-HD-1 polyplexes resulted in a drastically decreased interaction 
whereas PEI22 polyplexes still induced erythrocyte aggregation (Fig.20).  
 
 
 
 
 
 
 
 
Fig.20: Erythrocyte aggregation induced by OEI polyplexes  
Polyplexes were formed at C/P 2 in HBG. After complex formation, erythrocytes (2E+06) were 
incubated with polyplexes corresponding to 5 µg polymer as described in figure 19. PEI22lin (C/P 0.8) 
(A), OEI-HD-1 (B), OEI-IP-1 (C), OEI-SP-0.5 (D) 
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Taken together, OEI-SP-0.5 and OEI-IP-1 were characterized by negligible toxicity 
and efficient reporter gene delivery at high C/P-ratios. OEI-HD-1 possessed superior 
transfection efficiency and could compete with the ‘golden standard’ PEI22lin, but on 
the other hand exhibited distinct cytotoxicity at high doses, and free OEI-HD-1 
polymer induced erythrocyte aggregation similar to PEI22lin. Since erythrocyte 
aggregation and cytotoxicity correlate with molecular structure, charge density and 
high molecular weight of a polymer (Fischer 2003), the next step was to elucidate 
structural properties of OEI-HD-1 which could be responsible for these toxic side 
effects. 
3.2.3 Low temperature (lt)-OEI-HD-1: a less toxic analog of standard OEI-HD-1 
The initial synthesis of OEI-HD-1, like all HD syntheses of the library, was carried out 
at 60°C in order to obtain a high degree of polymerization. But high molecular weight 
could be responsible for toxic side effects and, in addition, temperature-dependent 
aminolysis of esters could generate less degradable amide-based polymers.  
The aminolysis of esters is a basic organic reaction considered as a model for the 
interaction of the carbonyl group with nucleophiles (Ilieva 2003). According to 
chemical theory, esters are cleaved into amides and alcohols especially at high 
reaction temperatures (Beyer-Walter, 23rd edition). In case of OEI-HD-1, one could 
predict that free amino groups of the oligoethylenimine unit can attack ester bonds, 
resulting in amide-based oligomers (Fig.21) with only few esters left. Furthermore, 
aminolysis of esters could finally seperate the whole hexanediol moiety from the 
polymer resulting in amide-derivatives of polyethylenimine and free hexanediol.  
In order to circumvent this side-reaction and to generate pure ester-containing 
polymers, a new OEI-HD-1 derivative was synthesized at low temperature (20°C 
instead of 60°C). The generated polycation namely lt-OEI-HD-1 was purified and 
processed as described for standard OEI-HD-1. 
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Fig.21: Mechanism of the ester aminolysis (reaction scheme) 
Free amino groups of the OEI unit can attack ester bonds and thus mixed ester/amide-based 
oligomers are generated. In a second step, aminolysis of the ester could separate the whole 
hexanediol moiety from the polymer resulting in amide-derivatives of polyethylenimine and free 
hexanediol. This side reaction can occur inter- and intramolecular. 
 
3.2.3.1 Structural analysis by FTIR 
To confirm the original structure of 1.6-hexanediol-diacrylate, the linker was analyzed 
by FTIR spectroscopy. The spectrum clearly showed an ester (1731 cm-1) and the 
alkene (1636 cm-1) (data not shown). FTIR spectra of standard OEI-HD-1 verified the 
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formation of amide bonds (1638 cm-1) and a weak signal of remaining ester bonds 
(1718 cm-1) (signal c, d & e in Fig.22b). 
As expected, lt-OEI-HD-1 contained  ester bonds (1725 cm-1) and conjugation to OEI 
800 could be observed due to a broad N-H signal (3422 cm-1) (signal a & b in 
Fig.22a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                               
 
 
Fig.22: FT-IR analysis of OEI-HD-1 and lt-OEI-HD-1 
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3.2.3.2 Structural analysis by 1H NMR 
HD-crosslinking was confirmed by observing ester bond formation in the final product 
using 1H NMR. Although FTIR spectra indicated extensive ester aminolysis in case of 
OEI-HD-1, both polymers (OEI-HD-1 and lt-OEI-HD-1) clearly showed the protons 
belonging to ester adjacent –CH2 groups (signal a & b in Fig.23). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.23:1H-NMR analysis of OEI-HD-1 and lt-OEI-HD-1 
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Moreover, the hexane chain of the HD-linker was still present in both polymers. NMR 
spectra of OEI-HD-1 and lt-OEI-HD-1 showed the same signals, while the ratio 
between their integrated areas differed (signal a & b for protons belonging to ester 
adjacent - CH2 groups and signal a’ & b’ for -CH2 next to hydroxyl groups). 
Calculations based on the integration of NMR spectra resulted in a molar ratio of 
linker to OEI of 1.24 in case of lt-OEI-HD-1 and a ratio of only 0.47 for OEI-HD-1. 
Moreover, lt-OEI-HD-1 had preserved 50 % of the hexanediol linker as diester, while 
in the OEI-HD-1 polymer 80 % of the hexanediol diester was converted into the 
monoester. 
 
3.2.3.3 Degradation studies 
Degradation kinetics of both polymers were studied in aqueous solutions at pH 5, 7 
and 9 at 37°C. The results of size exclusion chromatography demonstrated that 
molecular weight distribution of lt-OEI-HD-1 changed rapidly when incubated at pH 7 
and even more pronounced after pH 9 treatments (Fig.24a). SEC elution profiles 
showed a shift from larger fractions towards oligomer structures with smaller size.  
As expected, OEI-HD-1 was less susceptible to hydrolysis. After 5 days, the elution 
pattern of pH 9 incubated polymers changed slightly, whereas incubation at pH 5 and 
pH 7 had no visible effect (data not shown). Alterations in peak symmetry after 10 
days indicated initial degradation processes (Fig.24b) however, it was not clear 
whether these changes would have any effect on biological activity of the polycation. 
Therefore, biological activity of non-treated OEI-HD-1 and lt-OEI-HD-1 was compared 
to their ‘degraded’ analogs. Since molecular weight usually correlates with cytotoxic 
properties of a polycation, molecular weight decrease attributable to degradation 
should result in reduced toxicity of the polymer.  
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Fig.24: Degradation of OEI-HD-1 and lt-OEI-HD-1 (SEC) 
Polymer samples (5 mg/ml) were analyzed by size exclusion chromatography (Sephadex G25 
superfine) with 150 mM NaCl as eluent and a flow rate of 1ml/min. Black curves represent the elution 
profiles of untreated OEI-HD-1 (A & C) and untreated lt-OEI-HD-1 (B & D). Polymers were incubated 
at pH 5 (red curves), pH 7 (blue curves) and pH 9 (green curves) for 0 -15 days (37°C) and neutralized 
before SEC analysis. pH dependent degradation is shown for OEI-HD-1 after 10 days (C) and for lt-
OEI-HD-1 after 5 days (D). 
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3.2.3.4 Toxicity of degraded polymers 
B16F10 cells were incubated with various amounts of free polymer for 4 h. Twenty 
four hours after polymer treatment their metabolic activity was determined by MTT 
assay and compared to untreated control cells. At a concentration of 50 µg/ ml, 
PEI22 and OEI-HD-1 decreased metabolic activity down to 3 % (PEI22) and 15 % 
(OEI-HD-1) whereas cells that were treated with the same amount of lt-OEI-HD-1 
retained 88 % of their metabolic activity (Fig.25).  
 
 
 
 
 
 
 
 
 
 
Fig.25: Cytotoxicity induced by degraded polymers 
OEI-HD-1 and lt-OEI-HD-1 (5 mg/ml) were incubated at pH 9 for 5 days at 37 °C. B16F10 cells (5000 
cells/well) were treated with various concentrations of hydrolyzed and non-hydrolyzed polymer. After  
4 h polymer-containing medium was exchanged and 24 h later, metabolic activity was determined by 
MTT assay. Metabolic activity is presented as mean values +/- SD of triplicates. 
 
Degradation of OEI-HD-1 significantly reduced its toxicity when the polymer was 
applied at lower doses (5 – 50 µg/ml). However, concentrations above 500 µg/ ml 
strongly disturbed viability and resulted in 2-3 % metabolic activity. After lt-OEI-HD-1 
hydrolysis the degraded fragments exhibited negligible toxicity even at polymer 
concentrations up to 1000 µg/ml. 
As mentioned above, high temperatures during synthesis will not only promote side 
reactions, but will also influence the degree of polymerization. This would suggest a 
higher molecular weight for standard OEI-HD-1 (60°C) and a lower degree of 
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polymerization in case of lt-OEI-HD-1 (20°C). Our preliminary SEC data suggested a 
bimodal molecular weight distribution for OEI-HD-1 with one HMW fraction eluting at 
the void volume. In contrast, the main peak of lt-OEI-HD-1 appeared at a later 
retention time which implies a lower molecular weight of this polymer. 
However, our standard size exclusion chromatography did not present an accurate 
method for molecular weight determination and could only provide preliminary 
information. 
 
3.2.3.5 Molecular weight determination  
There are various methods to analyze the molecular weight of macromolecules. 
Depending on the analyt (size, hydrophobicity, charge, polydispersity) the molecular 
weight can be determined by viscosity measurement, Nuclear magnetic resonance 
spectroscopy (NMR), Multi Angle Laser Light Scattering (MALLS), Asymmetrical Flow 
Field Flow Fractionation (AF4), mass spectroscopy or size exclusion chromatography 
(SEC). 
While reliable methods exist for the analysis of LMW substances, peptides, proteins 
or even hydrophobic polymers, however, molecular weight determination of cationic 
polymers is still a challenge.  
 
3.2.3.5.1 Matrix-Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF) 
MALDI-MS is a powerful tool to determine the molecular weight of proteins but also 
of some polymers like e.g. polyethylenglycol (Whittal 1997). With the use of an 
appropriate matrix and sample preparation protocol, HMW polymers with masses up 
to 1.5 MDa can be studied (Schriemer 1996).  Due to high sensitivity even small 
quantities of polymer can be analyzed. Therefore, MALDI-TOF-mass spectroscopy 
was a promising method to analyze the composition of educts as well as the 
molecular weight of novel polymers. 
OEI 800 Da and OEI 2000 Da were used as standards to establish a method for the 
analysis of cationic oligomers. Spectra of OEI 800 showed molecular weight 
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distribution of the polymer and also the mass of one ethylene unity. Similar results 
were obtained for OEI 2000 (data not shown). Analysis of standard HMW polymers 
like PEI25br resulted in spectra with signals which could not be interpreted for mass 
determination due to high signal/noise ratios. According to the literature, molecular 
weight determination of strongly basic or strongly acidic components is difficult or 
impossible by MALDI (Juhasz 1994). One approach to solve this problem was the 
use of KCl as cationizing agent (as described by Lim et al. 1999) but no better 
spectra were obtained for HMW PEI standards or OEI-based polymers. As high 
polydispersity is another reason for problems in MALDI-TOF analysis, PEI25br was 
fractionated by SEC (Sephadex G25) and fractions were analyzed separately, but 
even this did not result in interpretable spectra. 
MALDI-TOF mass spectroscopy did not provide reliable data, thus size exclusion 
chromatography should give information about the molecular weights of OEI 
polymers. 
 
3.2.3.5.2 Size exclusion chromatography (SEC/MALLS) 
SEC/MALLS measurements were performed by Dr. Bruzzano, Fraunhofer IAP, Golm. 
Polymer molecular weights were analyzed by aqueous phase gel permeation 
chromatography (GPC), employing 0.2 M Na2SO4 + 1 % formic acid as eluent. 
Samples of different molecular weights were successfully separated on a TSK-Gel 
Guard + G-Oligo-PW column. Absolute molecular weights of OEI 800 (pre-oligomer), 
OEI-IP-1, OEI-HD-1 and lt-OEI-HD-1 (Fig.26a) were determined with a MALLS 
detector (dn/dc (PEI) = 0.195 ml/g at 633 nm) and compared to commercially 
available LMW PEI’s.  
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Fig.26: Molecular weight determination of OEI-based polymers by SEC/MALLS 
Elution profiles of OEI 800 (green), OEI-IP-1 (blue), lt-OEI-HD-1 (black) and standard OEI-HD-1 (red) 
after SEC analysis (A). Fractionation of bimodal distributed OEI-HD-1 (B). 
 
Unfortunately, molecular weight of OEI-SP-0.5 could not be analyzed properly by 
SEC/MALLS. OEI-IP-1 showed a monomodal distribution with an average molecular 
weight of 5.1 kDa. As expected, lt-OEI-HD-1 had a low degree of polymerization, 
resulting in a molecular weight of 8.7 kDa, whereas high molecular weight of 53.0 
kDa was determined for standard OEI-HD-1. In fact, OEI-HD-1 showed a bimodal 
molecular weight distribution (Fig.26b) with a HMW fraction of 53.0 kDa and smaller 
fraction of 8.1 kDa (Table 6). 
 
B
A
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Table 6: Molecular weight determination (SEC/MALLS) 
Vp: elution volume at peak maximum, Mp: molecular weight at peak maximum, Mw: average molecular 
weight 
3.2.3.6 Reporter gene expression and toxicity of lt-OEI-HD-1 
Neuro2a cells were transfected with either standard OEI-HD-1 or lt-OEI-HD-1 in order 
to investigate if these structural differences will influence transfection efficiency and 
cytotoxicity of polyplexes. At C/P 2, standard OEI-HD-1 achieved maximum reporter 
gene expression, which decreased with increasing amount of polymer due to 
cytotoxicity. Although higher charge ratios (C/P 8 and more) were needed for 
optimum gene delivery, lt-OEI-HD polyplexes were able to mediate gene transfer as 
efficient as standard OEI-HD-1 without reducing the metabolic activity of transfected 
cells (Fig.27). 
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Fig.27: Reporter gene expression of Neuro2a cells after transfection with lt-OEI-HD-1  
Neuro2a cells were transfected with 200ng (2 µg/ml DNA) pCMVLuc complexed with standard OEI-
HD-1 or lt-OEI-HD-1 in HBS. Control PEI22lin polyplexes were prepared at C/P 0.8. Luciferase activity 
(A) and metabolic activity (MTT Assay) (B) are presented as mean values +SD of triplicates. 
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Additionally, different DNA concentrations were tested on B16F10 cells in order to 
verify these biological effects on a second cell line. According to previous 
experiments, standard OEI-HD-1 polyplexes prepared at C/P 2 were as efficient as 
PEI22lin. Again, lt-OEI-HD-1 needed higher polymer concentrations (C/P 4) to 
mediate equivalent reporter gene expression (Fig.28a).  
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Fig.28: Reporter gene expression of B16F10 cells after transfection with lt-OEI-HD-1  
B16F10 cells were transfected with 100 – 800 ng (1-8 µg/ml DNA) pCMVLuc complexed with standard 
OEI-HD-1 or lt-OEI-HD-1 at C/P 2 and 4 in HBS. Control PEI22lin polyplexes were prepared at C/P 
0.8. Luciferase activity (A) and metabolic activity (MTT Assay) (B) are presented as mean values +SD 
of triplicates. 
 
With regard to toxicity it was obvious that PEI22lin and OEI-HD-1 exhibited 
pronounced toxicity even at low DNA concentrations, whereas lt-OEI-HD-1 did not 
influence the metabolic activity of B16F10 cells at these concentrations. Generally, 
these cells were more affected in their viability than Neuro2a cells when treated with 
PEI22lin or OEI-HD-1 containing polyplexes. PEI22lin reduced metabolic activity 
determined 24 h after transfection to less than 20 % of the un-transfected control 
cells (Fig.28b). When cells were transfected with C/P 2 polyplexes containing 800ng 
DNA, OEI-HD-1 reduced metabolic activity to 22 % while cells transfected with lt-OEI-
HD-1 polyplexes maintained 100 % of their metabolic activity. Cell viability was only 
affected by lt-OEI-HD-1 when high doses of polymer and DNA were applied. 
Transfection with 400ng DNA and 1.6 µg polymer (corresponding to C/P 4) resulted 
in 54 % metabolic activity which dropped to 20 % at the maximum DNA dose of  
800 ng. 
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3.2.3.7 Bimodal molecular weight distribution of OEI-HD-1 
According to SEC analysis, OEI-HD-1 showed a bimodal molecular weight 
distribution with a HMW fraction of 53.0 kDa and smaller fraction of 8.1 kDa. To find 
out whether one fraction is more efficient than the other or if a mixture of both is 
needed for optimum transfection activity, fractions were analyzed separately with 
regard to their gene transfer efficiency. B16F10 cells were transfected with standard 
OEI-HD-1 (bimodal), fraction 1 (F1), fraction 2 (F2) and lt-OEI-HD-1 (Fig.29). While 
standard OEI-HD-1 showed maximal reporter gene expression at C/P 2 and 4, both, 
F1 and F2 needed higher C/P-ratios for efficient gene delivery. At C/P 8, F1 resulted 
in luciferase expression equivalent to PEI22lin and standard OEI-HD-1. lt-OEI-HD-1-
mediated efficient gene transfer at all analyzed C/P-ratios and achieved maximal 
reporter gene expression at C/P 8 whereas F2 was characterized by poor 
transfection activity at low C/P-ratios. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.29: Reporter gene expression and toxicity of OEI-HD-1 after fractionation by SEC/MALLS  
B16F10 cells were transfected with 200ng (2 µg/ml DNA) pCMVLuc complexed with standard OEI-HD-
1 (bimodal), lt-OEI-HD-1 (8.7 kDa), OEI-HD-1-fraction 1 (53 kDa) and fraction 2 (8.1 kDa) in HBS. 
Control PEI 22lin polyplexes were prepared at C/P 0.8. Luciferase activity (A) and metabolic activity 
(MTT Assay) (B) are presented as mean values +SD of triplicates. 
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A clear correlation between molecular weight and toxicity was observed for all 
polymers (Fig.29b). Cell viability decreased rapidly when cells were transfected with 
standard OEI-HD-1 or F1 polyplexes, while low molecular weight polymers (lt-OEI-
HD-1 and F2) were far less toxic. 
Taken together, OEI polymers, particularly OEI-HD structures were characterized by 
efficient DNA condensation and high gene transfer activity in various cell lines; thus 
they presented a very promising basis for further chemical modification. 
 
3.3 Modification of the OEI-HD core 
When OEI-HD synthesis was carried out at high concentrations with crosslinking 
ratios above one, unsoluble network polymers with a high degree of polymerization 
were generated. By increasing the amount of linker and carrying out the synthesis at 
lower concentrations we wanted to generate low molecular weight oligomers 
equipped with free linker ends. These reactive OEI-HD cores could be easily 
modified with charge-bearing compounds (e.g. spermine), with ligands (e.g. EGF) or 
even with PEG chains to build up pseudo-dendritic structures.  
3.3.1 Synthesis of OEI-HD-spermine pseudo-dendrimers 
OEI-HD cores with different ratios of crosslinker to polyamine were synthesized in a 
two-step procedure. First, the core was synthesized by mixing OEI 800 and HD linker 
at low concentrations (in contrast to the standard OEI-HD-1 synthesis). A 2-fold, 5-
fold or 10-fold molar excess of linker should prevent the formation of branched un-
soluble polymers and should provide free acrylate end groups for the following 
modification. In this second step, spermine was linked to free linker ends in order to 
generate pseudo-dendritic structures (see Fig.30). 
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Fig.30: Concept of the pseudo-dendrimer synthesis 
A highly branched core equipped with free linker ends for further modification is generated by adding 
an excess of HD-linker to LMW OEI. In a second step spermine is coupled to the free linker ends in 
order to provide additional positive charges for DNA complexation. 
 
Polymers were purified by SEC as described in 2.3.1. In case of OEI-HD-10-Sper the 
polymeric product showed a bimodal distribution. Therefore, both fractions OEI-HD-
10-Sper-A and OEI-HD-10-Sper-B were freeze dried and analyzed separately. All 
pseudo-dendritic polymers showed similar DNA binding characteristics in HBG and 
HBS as OEI-HD-1 (data not shown).  
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3.3.2 Reporter gene expression and cytotoxicity of OEI-HD pseudo-dendrimers 
In a first screening in B16F10 cells, OEI-HD-Sper polymers except OEI-HD-10-Sper-
B showed promising transfection efficiency but also a pronounced toxicity at high 
C/P-ratios (data not shown). Therefore, the polymer to DNA ratio was reduced for the 
following transfection experiments. At C/P 2 and 4, OEI-HD-2-Sper lacked efficient 
gene delivery whereas OEI-HD-5-Sper and OEI-HD-10-Sper-A mediated gene 
transfer as efficiently (HD-10-Sper-A) or even 3-fold better (OEI-HD-5-Sper, C/P 2) 
than PEI22 at all analyzed DNA concentrations (Fig.31a). Although pseudo-
dendrimers were less toxic than PEI, OEI-HD-5-Sper and OEI-HD-10-Sper-A both 
exposed pronounced cytotoxicity which correlated with increasing DNA concentration 
as well as with increasing polymer concentration (Fig.31b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.31: Reporter gene expression and cell viability after transfection with OEI-HD-Sper pseudo-
dendrimers 
B16F10 cells were transfected with various amounts of DNA (1.0 – 8.0 µg/ml) complexed at C/P 2 and 
C/P 4 respectively (HBS). Standard PEI22lin polyplexes were prepared at C/P 0.8. Luciferase activity 
(A) and metabolic activity (B) (MTT Assay) are presented as mean values +SD of triplicates. 
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3.3.3 Membrane lytic activity of OEI-HD-Sper polymers 
High gene transfer efficiency but also cytotoxicity can result from intrinsic membrane 
activity. To find out whether OEI-HD-Sper polymers possess this membrane lytic 
activity which damages cell membranes but also enhances endosomal release, 
erythrocyte lysis assays (as described in 3.1.5) were performed in the presence and 
in the absence of serum.  
3.3.3.1 Erythrocyte lysis induced by OEI-HD-Sper polymers 
While neither standard PEI’s nor any polymer of the library exhibited hemolytic 
activity in the presence of serum, OEI-HD-5-Sper and OEI-HD-10-Sper-A caused a 
very significant lysis of erythrocyte membranes (84 % lysis after incubation with OEI-
HD-10-Sper-A and 56 % lysis induced by OEI-HD-5-Sper) even in the presence of 10 
% serum (Fig.32).  
 
 
 
 
 
 
Fig.32: Hemolytic activity of OEI-HD-Sper polymers  
Human erythrocytes were incubated with free polycations (final concentration 1 mg/ml) for 45 min at 
37°C and hemoglobin release was quantified at 450nm. 100 % lysis refers to Triton X treatment of 
erythrocytes. % erythrocyte lysis is presented as mean values +SD of triplicates. 
 
 
With regard to endosomolytic activity it would be desirable to generate polymers that 
are inactive at pH 7 and that gain membrane activity at endosomal pH 5. To monitor 
pH-dependent hemolysis, erythrocytes were incubated with various concentrations of 
OEI-HD-5-Sper and OEI-HD-10-Sper-A in either HBS pH 7.1 or in citrate buffer pH 5 
(both with 10 % serum). Fig.33 shows that both polymers induce distinct erythrocyte 
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lysis at pH 7 (~ 60 % for OEI-HD-5-Sper and ~ 70 % for OEI-HD-10-Sper-A) whereas 
no hemolytic activity was detected at pH 5 at all tested concentrations.  
 
 
 
 
 
 
 
 
 
Fig.33: pH dependent hemolytic activity of OEI-HD-Sper polymers 
Human erythrocytes were incubated with free polycations (final concentration 0.25 –1.0 mg/ml) for 45 
min at 37°C in the presence of 10 % serum in either HBS pH 7.1 or citrate buffer pH 5 and hemoglobin 
release was quantified at 450nm. 100 % lysis refers to Triton X treatment of erythrocytes. % 
erythrocyte lysis is presented as mean values +SD of triplicates. 
 
 
3.3.3.2 Endosomolytic activity of OEI-HD-Sper pseudo-dendrimers 
As described in 3.1.7, polycations with intrinsic endosomolytic properties, such as 
PEI, can act as helper for polylysine (PLL)-mediated transfection. With regard to their 
strong hemolytic activity, there was the need to find out whether these membrane-
active properties of OEI-HD-Sper pseudo-dendrimers could also induce 
destabilization of endosomal membranes and thus trigger endosomal release.  B16 
cells were transfected with standard PLL polyplexes (C/P 1 in HBG) and 2 h later 
different amounts of free polymer were added (Fig.34).  
At a concentration of 30 µg/ml, OEI-HD-10-Sper-B did not influence the transfection 
efficiency of PLL polyplexes whereas OEI-HD-2-Sper improved PLL-mediated gene 
delivery up to 5-fold. Importantly, OEI-HD-5-Sper and OEI-HD-10-Sper-A mediated 
more than 20-fold enhanced reporter gene expression of PLL polyplexes.   
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Fig.34: Polycation-mediated gene delivery of PLL polyplexes  
B16F10 cells were transfected with 200ng pCMVLuc (2 µg/ml) complexed with PLL at C/P 1 in HBG. 
After 2 hours, transfection medium was removed and fresh culture medium with 0.5 – 6.0 µg free 
polycation was added. Luciferase activity is presented as mean values +SD of triplicates.         
 
3.3.4 Designing OEI-HD-5 analogs with various functional moieties 
Based on the synthesis of OEI-HD-5-Sper, preliminary experiments were performed 
to modify the OEI-HD-5 core in order to generate OEI-HD-based pseudo-dendrimers 
with various functionalities (Fig.35).  
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Fig.35: Modifications of the OEI-HD-5 core - concept  
The first step (core synthesis) is performed as described for OEI-HD-5-Sper pseudo-dendrimers. In a 
second step, the OEI-HD-5 core is modified with various functional moieties which saturate the core 
(ethanolamine and ß-mercaptoethanol), provide additional charge-bearing groups (spermine, 
pentaethylenhexamine, OEI 800 and histamine) or generate partially shielded pseudo-dendrimers 
(OEI-PEG). 
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Since the OEI-HD-5 core tended to gelate after ~ 50 min reaction at 60°C, core 
synthesis was shortened to 30 min and modifications were performed immediately. 
The core structure itself (OEI-HD-5 core that was diluted with DMSO after 30 min) 
formed an unsoluble network polymer and could not be further processed. Reaction 
with ethanolamine only quenched free acrylate linker ends and was therefore similar 
to the OEI-HD-5 core itself. This unmodified core-like structure was synthesized in 
order to compare the OEI-HD-5 core with its functionalized derivatives. With regard to 
peptide attachment like melittin-SH, ß-mercaptoethanol was utilized as a model to 
monitor thiol-addition to acrylate groups. Pentaethylenhexamine, OEI 800 and 
histamine displayed charge-providing moieties similar to spermine and PEG 2000-
OEI 700 was a first approach towards shielded OEI-HD particles. 
All novel polymers showed similar DNA binding characteristics in HBG. DNA binding 
of OEI-HD-5-OEI (~ 25 % at C/P 3) and OEI-HD-5-OEI-PEG (~ 30 % at C/P 3) in 
HBS was significantly better than DNA binding activity of OEI-HD-5-His (54 % at C/P 
3). Other dendrimers ranged between 35 and 43 % relative fluorescence.  
A preliminary transfection experiment highlighted the potential of OEI-HD-5-Sper. 
Optimum reporter gene expression of B16 cells was achieved at C/P 8 (HBG; Fig.36) 
and C/P 2 (HBS; Fig.31), whereas OEI-HD-5-His showed more than 100-fold lower 
transfection efficiency.  
 
 
1E+3
1E+4
1E+5
1E+6
1E+7
1E+8
Sper N-EtOH S-EtOH PH OEI PEG-OEI His
R
LU
/ 5
00
0 
ce
lls
C/P=2
C/P=4
C/P=8
R
LU
/ 5
00
0 
ce
lls
 
Fig.36: Preliminary transfection experiments with novel OEI-HD-5 polymers 
B16F10 cells were transfected with 200ng pCMVLuc (2 µg/ml) complexed with novel pseudo-
dendrimers in HBG at various C/P-ratios. Luciferase activity is presented as mean values +SD of 
triplicates. 
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However, this transfection experiment should only provide some very basic 
information about the potential of OEI-HD-functionalized polymers. More detailed 
studies will be performed by Verena Russ in the context of her PhD-thesis. 
 
3.4 Modification of OEI-HD-1 polyplexes for virus-like gene 
delivery 
Since no polymer was able to meet all requirements for highly effective gene 
delivery, it was necessary to further modify the polycationic compacting domain with 
virus-like functions and to find novel strategies to boost reporter gene expression. 
Generally, polyplexes which are positively charged can interact unspecifically with 
negatively charged proteins of the cell surface as well as with circulating plasma 
proteins. However, cellular uptake is not cell specific when polyplexes are 
internalized due to electrostatic interactions with membrane proteins. For cancer 
gene therapy it is important to specifically target the disease causing tumor cells 
without affecting normal tissue cells. Therefore, the aim was to incorporate epidermal 
growth factor (EGF) as a ligand to target EGF receptor (over)-expressing tumor cells. 
Furthermore, tumor cell targeting should be combined with new strategies to trigger 
endosomal release in order to make the whole system more efficient. Primarily, these 
techniques should be developed for standard PEI/DNA complexes and subsequently 
transferred to the novel OEI-HD polyplexes. 
 
3.4.1 Photochemically enhanced gene transfer of EGFR-targeted PEI 
polyplexes  
According to previous observations, our concept was based on the strategy of 
receptor mediated endocytosis via EGFR-targeted PEI polyplexes. After 
internalization into endocytic vesicles, the release into the cytosol should be triggered 
by light-induced rupture of endosomal membranes (Fig.37). 
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Fig.37: Photochemical intracellular release of EGF polyplexes  
Amphiphilic photosensitizers (PS) are localized into membranes of the endocytic compartment. EGF 
polyplexes bind to the EGFR and enter the cell by receptor-mediated endocytosis. After illumination of 
cells, the membrane associated PS is activated and transfers its energy to molecular oxygen 
generating radical singlet oxygen. (1O2) 1O2 leads to oxidative damage of endocytic membranes, 
resulting in the rupture of the vesicular membrane and therefore promotes the release of EGF 
polyplexes into the cytosol. 
 
3.4.1.1 Effect of photochemical intracellular release (PCI) on PEI polyplex 
transfection efficiency 
pCMVLuc polyplexes in various formulations of PEI with or without conjugated EGF-
PEG or PEG were applied for transfection of HUH-7 hepatocellular carcinoma cells 
(Fig.38), HepG2 hepatocellular carcinoma, or A431 epidermoid carcinoma cells (data 
not shown; for all details see Kloeckner et al. 2004). Transfection experiments were 
carried out with or without photochemical treatment. This photochemical treatment 
termed ‘PCI’, resulted in enhanced gene expression in all tested cell lines. In HUH-7 
cells, PCI improved PEI22 polyplexes by 600-fold at the lowest DNA concentration 
(0.2 µg/ml) (Fig.38a) and about 10-fold at the higher more effective DNA 
concentrations (1 µg/ml) (Fig.38 b & c). EGF-conjugated PEGylated PEI polyplexes 
showed the most pronounced (30-fold) enhancement of reporter gene expression at 
the lowest DNA concentration and the highest degree of PEGylation (Fig.38c). 
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Fig. 38: EGF-mediated gene transfer enhanced by photochemical intracellular release 
HUH-7 cells were transfected with 100ng (0.2 µg/ml) (A), 250ng (0.5 µg/ml) (B) or 500ng (1.0 µg/ml) 
(C) pCMVLuc plasmid complexed with either PEI22 alone, PEI conjugates containing 10 molar % 
PEG-PEI and 25 molar % PEG-PEI +/- 10 molar % EGF-PEI. All formulations were prepared at N/P 6 
in HBG. Cells were treated with PS (c(TPPS2a) = 0.2 µg/ml) (dark bars) and without PS (light bars). 
Luciferase activity is shown as mean +SD of at least triplicates. 
 
3.4.1.2 Effect of EGF ligand in PCI-enhanced transfection 
To evaluate the contribution of EGF to gene transfer efficiency, PEGylated 
complexes with or without EGF ligand were compared (Fig.38). Without PCI, the 
EGF polyplexes were approximately 10-fold more effective than the corresponding 
ligand-free polyplexes. With PCI treatment, the EGF ligand mediated a 3-100-fold 
enhanced transfection (depending on the cell line) as compared to the ligand-free 
controls. 
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3.4.1.3 Competitive inhibition of EGF polyplexes by proteins blocking the EGFR 
To confirm that enhanced efficiency of EGF polyplexes was mediated by attachment 
to the EGF receptor, competition experiments were performed by pre-treatment of 
the cells with free EGF (Fig.39a) or an anti-EGFR antibody (Fig.39b). Competition of 
EGF-containing DNA complexes with free EGF (1000-fold molar excess) decreased 
gene transfer efficacy down to the values found for the corresponding ligand-free 
PEG-PEI polyplexes. On the other hand, addition of BSA, a protein that does not 
interact with EGFR, did not significantly affect gene transfer activity. A strong 
reduction of EGF-polyplex-mediated transfection was also observed after blocking 
with an EGF receptor antibody, but not with an irrelevant control antibody (mouse 
IgG1).  
 
1E+4
1E+5
1E+6
1E+7
1E+8
PEG/PEI EGF-PEG/PEI 
R
LU
/ 2
50
00
 c
el
ls
normal
+ EGF
+ BSA
A
1E+4
1E+5
1E+6
1E+7
1E+8
EGF-PEG/PEI EGFR-Ab IgG-Ab
R
LU
/ 2
50
00
 c
el
ls
B
R
LU
/ 2
50
00
 c
el
ls
R
LU
/ 2
50
00
 c
el
ls
 
Fig. 39: Competitive inhibition of EGF receptor-mediated gene transfer  
HUH-7 cells were transfected with 250ng (0.5 µg/ml) pCMVLuc plasmid complexed with PEG-
PEI/PEI22 (10 molar % PEG) or EGF-PEG-PEI/PEI22 (10 molar % EGF-PEI, 10 molar % PEG-PEI) at 
N/P 6 (C/P 0.8) in HBG. Competition experiments were carried out in the presence of free murine EGF 
(12 µg/well) or BSA (12 µg/well) (A) and anti-EGFR antibody or control IgG antibody (3 µg/well) (B) 
respectively. All experiments were performed with photochemical enhancement. Luciferase activity is 
shown as mean +SD of triplicates. 
 
Taken together, competitive inhibition experiments highlighted the role of EGFR-
mediated polyplex uptake and ruled out that photochemical treatment could interfere 
with the ligand receptor interaction. Furthermore it was demonstrated that the 
combination of the targeting ligand EGF with photochemical treatment strongly 
enhanced gene expression.  
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3.4.2 EGF-receptor targeting of OEI-HD-1 polyplexes 
Given that OEI-HD-1 was as efficient as the golden standard PEI22lin on many 
different cell lines and that it could be generated as a fast degrading ester as well as 
a rather slow degrading amide, it presented an interesting candidate to follow up the 
strategy of photochemically enhanced EGFR-targeted gene delivery. 
Polyplexes consisting of different OEI-HD-1 and EGF-PEI25 ratios (5 and 10 % EGF-
PEI25) were generated in order to evaluate whether OEI-HD polyplexes can be 
targeted specifically to EGF-receptor over-expressing cells. Figure 40 shows the 
effect of 10 % EGF-PEI on OEI-HD-1 mediated gene delivery in HUH-7 cells. 
Incorporation of EGF resulted in 20-fold enhanced gene expression compared to 
standard OEI-HD polyplexes (Fig.40a).  
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Fig. 40: EGF-mediated gene transfer of PEI22 and OEI-HD-1 polyplexes 
HUH-7 cells (A) and control B16F10 cells (B) were transfected with 200ng (2 µg/ml) pCMVLuc plasmid 
complexed with either OEI-HD-1 or PEI22 alone, or with conjugates containing 10 molar % EGF-
PEI25br and 10 molar % PEI25br respectively. All complexes of OEI-HD-1(C/P 2) and PEI22 (C/P 0.8) 
were prepared in HBG. Luciferase activity is shown as mean +SD of at least triplicates. 
 
To rule out that PEI25 contributed to this improved reporter gene expression, 
transfection of OEI-HD/EGF polyplexes were compared with polyplexes containing 
equivalent amounts of PEI25 without EGF. PEI25 incorporation had no effect on OEI-
HD-1-mediated gene delivery. Moreover, a control experiment was performed on 
B16F10 cells which do not express the EGFR, in order to test whether enhanced 
gene expression with EGF is actually mediated by the interaction of EGF ligand with 
the EGF receptor (Fig.40b). As expected, no EGF effect was observed. 
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EGFR-targeting of ester-based lt-OEI-HD-1 polyplexes was even more effective. 
Reporter gene expression of targeted polyplexes increased up to 940-fold (C/P 2, 50 
ng DNA) after incorporation of EGF (Fig.41b). According to previous experiments 
with PEI polyplexes, there was a clear correlation between DNA concentration and 
EGF receptor specificity. The EGF effect was very pronounced at low DNA doses 
(0.5 and 1 µg/ml) and decreased with increasing DNA concentration (2 – 4 µg/ml) 
(Fig.41a&b). In case of standard OEI-HD-1, a DNA concentration of 4 µg/ml resulted 
in negligible differences of ligand-free and EGF-containing polyplexes (Fig.41a). 
Importantly, none of the applied formulations did affect the metabolic activity of target 
cells (Fig.41c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 41: EGFR-specificity of OEI-HD-1 polyplexes subject to DNA concentration 
HUH-7 cells were transfected with various amounts of pCMVLuc plasmid complexed with either OEI-
HD-1 (A) or lt-OEI-HD-1 (B) alone, or with conjugates containing 10 molar % EGF-PEI25br. All 
complexes were prepared at C/P 2 in HBG. Luciferase activity (A & B) and metabolic activity (C) are 
shown as mean +SD of at least triplicates. 
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EGFR-mediated uptake of targeted polyplexes was confirmed by competitive 
inhibition of the EGF receptor as described in 3.4.1.3. Pre-treatment with excessive 
EGF resulted in reduced transfection efficiency of EGFR-targeted polyplexes (4-fold 
reduction for EGF/lt-OEI-HD-1 and 4.5-fold reduction for EGF/OEI-HD-1), whereas 
reporter gene expression mediated by ligand-free polyplexes was not affected 
(Fig.42). 
 
 
 
 
 
 
 
 
Fig. 42: Competitive inhibition of EGF receptor-mediated gene transfer  
HUH-7 cells were transfected with 100ng (1.0 µg/ml) pCMVLuc plasmid complexed with lt-OEI-HD-1 
and OEI-HD-1 or EGF-containing polyplexes (10 molar % EGF-PEI) at C/P 2 in HBG. Competition 
experiments were carried out in the presence of free murine EGF (2.4 µg/well) or BSA (2.4 µg/well). 
Luciferase activity is shown as mean +SD of triplicates. 
 
3.4.3 Improved endosomal escape of OEI-HD polyplexes 
After receptor-mediated endocytosis, polyplexes are entrapped within intracellular 
vesicles and become rapidly degraded if not released from the endosome. For this 
reason the endosomal membrane is the next and maybe most important barrier that 
has to be overcome by an ‘artificial virus’. 
There are different ways to improve the release of endocytosed molecules into the 
cytosol. Amongst other approaches, their release can either be triggered by 
photochemical treatment as reported in the previous chapter or drug carriers can be 
combined with membrane active peptides which help to destabilize the endosome. 
 
1E+3
1E+4
1E+5
1E+6
OEI-HD-1 EGF/OEI-HD-1 lt-OEI-HD-1 EGF/lt-OEI-HD-1
R
LU
/1
00
00
 c
el
ls
normal
+ EGF
+ BSA
R
LU
/1
00
00
 c
el
ls
Results 87 
3.4.3.1 Photochemically triggered gene delivery of OEI-HD/EGF polyplexes 
As described for EGFR targeted PEI polyplexes, the influence of photochemical 
treatment on OEI-HD/EGF polyplexes was studied on HUH-7 cells. The most 
pronounced effect of PCI (200-fold enhancement) could be observed for standard 
OEI-HD polyplexes at low DNA concentrations (Fig.43). Ligand containing 
polyplexes were 40-fold more effective with PCI than without PCI. Transfection 
efficiency of PEI polyplexes was improved up to 50-fold for standard PEI polyplexes 
and up to 150-fold for EGF/PEI polyplexes. 
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Fig. 43: EGF-mediated gene transfer enhanced by photochemical intracellular release 
HUH-7 cells were transfected with 200ng (0.8 µg/ml) pCMVLuc plasmid complexed with either PEI22 
or OEI-HD-1 alone, or conjugates containing 10 molar % EGF-PEI25br. All complexes of OEI-HD-
1(C/P 2) and PEI22 (C/P 0.8) were prepared in HBG. Cells were treated with PS (c(TPPS2a  0.3 
µg/ml) (dark bars) and without PS (light bars). Luciferase activity is shown as mean +SD of at least 
triplicates. 
 
3.4.3.2 Polyplex activity after incorporation of endosomolytic melittin conjugates 
Another approach to overcome the endosomal membrane barrier is the incorporation 
of membrane active peptides, such as melittin into the polyplex. Recently, different 
melittin peptide conjugates were generated and tested in combination with standard 
PEI22lin (Boeckle 2005, Persson 2005). First, we wanted to evaluate which 
conjugate performed best together with OEI-HD-1. Therefore, the peptide-PEI 
conjugates were incorporated into OEI-HD polyplexes and their gene transfer activity 
was tested in HUH-7 and CT26 cells at varying OEI-HD-1/ peptide-PEI ratios (the 
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melittin experiments were performed by Daniel Persson in the context of his master 
thesis). As shown in Fig.44, OEI-HD-1 polyplexes containing 10 % CMA-3-PEI and 
NMA-3-PEI resulted in the highest gene expression in both cell lines. Luciferase 
activity with CMA-3-PEI containing OEI-HD-1 polyplexes was 42-fold higher on CT26 
cells compared to OEI-HD polyplexes without melittin (Fig.44a) and 3-fold higher in 
HUH-7 cells (Fig.44b).  
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Fig.44: Combination of endosomolytic melittin peptides and OEI-HD-1 
CT26 cells (A) and HUH-7 cells (B) were transfected with 100ng pCMVLuc (1 µg/ml) complexed with 
OEI-HD-1 at C/P 2 in HBG.  Complexes contained indicated ratios of peptide-PEI conjugates. 
Luciferase activity is presented as mean values + SD of triplicates.  
 
After incorporation of NMA-3-PEI, gene expression was enhanced up to 14-fold in 
CT26 and up to 3-fold in HUH-7 cells. Since transfection with CMA-3-PEI polyplexes 
was associated with higher toxicity (data not shown), the decision was to continue 
the studies with NMA-3-PEI. 
3.4.3.3 Melittin enhanced gene delivery of OEI-HD/ EGF polyplexes 
Incorporation of either EGF or NMA-3-PEI into OEI-HD-1 polyplexes resulted in 
enhanced reporter gene expression. Therefore, the next question was whether a 
combination of OEI-HD-1 with EGF as ligand and NMA-3-PEI as endosomolytic 
domain could further improve transfection efficiency. 5 % EGF and 10 % NMA-3-PEI 
were incorporated into OEI-HD-1 polyplexes (C/P 2) and compared with standard 
OEI-HD-1 polyplexes as well as with polyplexes containing only EGF or NMA-3-PEI. 
Luciferase expression of OEI-HD/EGF/NMA-3-PEI polyplexes was 2.6-fold higher 
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than reporter gene expression of EGF-containing polyplexes and 9-fold higher than 
that of NMA-3-PEI containing polyplexes (Fig.45). 
 
 
 
 
 
 
 
 
Fig. 45: Combination of NMA-3-PEI (10 %), EGF-PEI (5 %) and OEI-HD-1   
HUH-7 cells were transfected with standard polyplexes containing either PEI25br (dark grey bars) or 
EGF (black bars) complexed with 100ng pCMV (1 µg/ml) at C/P 0.8 (PEI22) and  
C/P 2 (OEI-HD-1). Luciferase activity is presented as mean values + SD of triplicates.  
 
In summary, ligand incorporation into OEI-HD polyplexes allowed cell specific and 
highly efficient gene transfer. Importantly, this enhanced transfection efficiency was 
not associated with toxic side effects. Furthermore, the combination of EGFR-
targeting with a light-induced rupture of endocytic vesicles boosted gene transfer 
efficiency tremendously. In addition, incorporation of membrane active melittin 
conjugates into EGF/OEI-HD-1 polyplexes promoted their endosomal release and 
thus improved transfection activity. 
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4 Discussion 
 
Gene therapy is a very promising approach to treat or prevent diseases. However, 
progress in this field is hindered by lack of suitable vectors. Nonviral vectors, 
including liposomes and polymers, can be readily modified by the incorporation of 
ligands for cell-targeting (Dash 2000) and are typically safer but much less efficient 
than recombinant viruses (Davies 2002, Thomas 2003, and Wagner 2004). 
Nevertheless, many cationic polymers exhibit significant cytotoxicity. Therefore, a 
major challenge is to develop novel vector systems which are highly efficient and well 
tolerated regarding acute toxicity and long-term effects. Since efficiency but also 
toxicity depend on the structure and the molecular weight of a polymer, polycations 
that are chosen to deliver nucleic acids have to be carefully selected for optimum 
gene transfer. Currently, biocompatible polymers emerge as most promising 
candidates for efficient gene delivery, since they could be degraded by the host, are 
less toxic and may also have advantages in other steps of the gene delivery pathway 
that further improve transfection efficiency.  
 
4.1 Development of degradable polycations for optimized, 
nonviral gene delivery  
 
The first aim of this thesis was to generate a variety of novel degradable polycations 
for safe and highly efficient gene delivery. In a combinatorial approach various LMW 
polyamines were oligomerized via different bifunctional linkers. Crosslinking of these 
small polycations using potentially degradable linkages was conceived as a way of 
increasing molecular weight and thus enhance DNA binding capacity and polyplex 
stability while maintaining their nontoxic nature. The polyamines used in this study 
were either natural polyamines like spermine and spermidine, or ethylenimine-based 
structures with different molecular weights. Since there are all sorts of labile linkages, 
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two different linkage types were chosen as basis for degradable polymers: site-
specific reducible disulfide bonds and labile esters that can be hydrolyzed in a time-
dependent manner.  
Disulfide bonds were incorporated by DTBP and DSP crosslinking, and ester bond-
containing oligoamines were obtained by the use of 1.6-hexandioldiacrylate as 
crosslinking moiety. For the latter case, free amino groups of crosslinked oligoamines 
converted the esters into amides by inter- or intramolecular aminolysis, mixed 
ester/amide-linked or pure amide-based polymers were generated. According to 1H 
NMR analysis, the extent of ester-aminolysis strongly depended on the amount of 
amino groups provided by the polyamine. Amide bonds are enzymatically degradable 
and hydrolyze slowly at basic pH; notably, these polymers degrade much slower than 
their ester-based analogs.  
Overall, a library of 46 degradable polycations was synthesized and carefully 
analyzed in order to investigate how structural properties impact degradability, gene 
transfer activity and toxicity. All polymers which could be processed and purified in 
aqueous media were analyzed for DNA binding activity and transfection efficiency.  
4.1.1 DNA binding activity 
One feature that has to be fulfilled by the compacting domain is high DNA binding 
affinity and, moreover, the ability to form stable DNA complexes. As DNA binding 
activity of polymers is strongly influenced by charge density and molecular weight 
(Plank 1999) this biophysical characterization provided preliminary information about 
the originated structures. Generally, there are two methods to examine complex 
formation. Ethidium bromide fluorescence induced by its intercalation into double 
stranded DNA is strongly reduced when polycation/ DNA interaction results in DNA 
condensation and complex formation. Thus, this method is useful to monitor DNA 
binding activity and to obtain information about the density of the originated complex 
(Parker 2002). Furthermore, complex formation and stability can be analyzed by 
agarose gel electrophoresis. As neutrally or positively charged polyplexes prevent 
DNA shift in an electrical field, this method is suitable to monitor complex integrity. 
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Non-crosslinked polyamines like e.g. spermine weakly bind to DNA, however, as a 
result of their low molecular weight, they do not provide sufficient charges for DNA 
condensation. Binding experiments and gel retardation studies revealed that small, 
crosslinked polyamines required large amounts of polymer were needed for polyplex 
formation and resulted in loose complexes. In contrast, polymers that contained 
polyamines with a high number of cationic groups exposed significantly higher DNA 
binding activity (Fig.8 and 9). With regard to the linker, it was obvious that IP-linked 
polymers, as a result of positively charged amidine groups, generally had the most 
pronounced DNA binding affinity within one polyamine group..Polycations that were 
generated by DSP crosslinking showed overall weak DNA binding efficiency. This 
can be explained by the loss of protonable amines due to amide formation. 
Comparison of IP-and SP-crosslinked polycations indicated that there was a clear 
correlation between charge density and DNA binding activity. DNA binding efficiency 
of HD-polymers strongly depended on the chain length of the polyamine that was 
used for oligomerization. Furthermore, the extent of ester aminolysis, may have 
influenced DNA binding since protonable nitrogens were lost after amide formation. 
It was shown that oligomerization of LMW polyamines resulted in polycationic 
structures which efficiently bound to DNA and provided polyplex stability similar to 
commonly used non-degradable polymers. Since one important purpose of this study 
was to create biodegradable polycations which could be metabolized and eliminated 
by the host, the next step was to confirm their potential degradability. 
4.1.2 Polymer degradation 
Biodegradability of drug delivery systems does not imply breakdown of the carrier 
molecule immediately after application, but rather a slow degradation in order to 
circumvent longterm toxicity in the organism. In case of gene delivery vectors it would 
be desirable to achieve either site-specific degradation within the target cell or time-
dependent degradation which triggers polyplex destabilization and DNA release at 
the target site.  
First, one has to admit that the generation of polymers which are potentially 
degradable is one part, but the proof of such properties and therefore the 
confirmation of their degradability in vivo is another point. There is still a lack of 
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feasible methods to proof biodegradation within the cell or the organism. Therefore, it 
becomes necessary to imitate the environment (pH, presence of reducing agents, 
ionic strength and temperature) of a specific cellular compartment in vitro and to find 
an indirect way of monitoring degradation. Fragmentation of polymers which results 
in a molecular weight decrease can be followed for instance by capillary viscosity 
measurements (Y.H.Kim 2005), SEC/MALLS (Petersen 2002), mass spectroscopy 
(Zhong 2005), or NMR (Forrest 2003). In addition, the decreased ability of polymers 
to form stable polyplexes (Gosselin 2001, T.i.Kim 2005) is another piece of evidence 
for degradation.  
In case of disulfide-linked polymers (SP- and IP-group), it was shown here that 
reducing agents like DTT mediated the formation of products which lost their ability to 
form stable DNA complexes. Reductive cleavage of the polymers was confirmed by 
gel electrophoresis which clearly demonstrated that reduction of either polymers or 
polyplexes facilitated DNA release. This strategy to proof the reductive cleavage 
confirmed previously described analysis of disulfide-based polymers (Read 2005, 
Pichon 2002, Gosselin 2001, Oupicky 2001). 
For HD-linked polymers, the kinetics of ester hydrolysis strongly depend on ester 
type, adjacent groups and pH of the environment. Having in mind that HD-linked 
polymers contained both ester bonds and varying amounts of amides, it was even 
more difficult to predict degradation kinetics.  
Complex formation properties of HD-linked polymers were not affected by incubation 
at neutral pH for 5 days. Treatment at either basic (pH 9) or acidic (pH 5) pH 
however, resulted in destabilization of polyplexes and DNA release. Since hydrolytic 
cleavage of amides would need harsh conditions (strong basic pH, high temperature, 
long incubation times), degradation of HD-linked polymers was likely based on ester 
hydrolysis. According to H-NMR spectra, HD polymers generated at 60°C contained 
varying ratios (~15-80 % diester relating to 100 % polyamine) of esters to amides. 
With regard to hydrolysis studies, one could assume that cleavage of only a few 
bonds resulted in fragmentation of the polymer. Apparently, this was sufficient to 
substantially reduce DNA binding activity of the polymer and confirmed the potential 
degradability of HD-linked polymers. To minimize polymer-induced toxicity in vivo, it 
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would not be necessary that every linkage of the polymer is cleaved. It is very 
probable that various enzymes like e.g. peptidases promote complete polymer 
degradation over time. In addition, stepwise degradation was reported to allow 
advantageous DNA release kinetics (Lim 2002, T.i.Kim 2005).  
DNA binding activity and degradation properties indeed provided information about 
polymers and their ability to interact with nucleic acids, but the main goal in this 
thesis was the development of safe, degradable, but still efficient gene delivery 
vectors. Therefore, extensive transfection screenings were performed to elucidate 
the potential of these novel nonviral vectors. 
4.1.3 Reporter gene expression in tumor cells 
The novel polycations generated in this work were biodegradable and should be able 
to compete with the ‘golden standard’ PEI22lin (Boussif 1995, Zuber 2001) in terms 
of gene delivery. Ideally, they possess at least equivalent transfection efficiency while 
being less toxic than the non-degradable HMW-PEI. In order to obtain optimum 
transfection activity for each polymer, the whole library was screened at varying 
weight ratios of conjugate to plasmid (C/P-ratios) in different cell lines. Polymers 
based on small polyamines like e.g. spermidine or triethylentetramine were overall 
characterized by poor transfection activity or had to be applied at very high 
concentrations. These findings were in accordance with transfection studies 
described by Anderson et al. (2003) where weight ratios (polymer / DNA) up to 100 
were needed for efficient gene delivery. Polyamines with a higher number of 
protonable nitrogens like pentaethylenhexamine (PH) or oligoethylenimine (OEI 800) 
achieved luciferase expression levels similar to PEI22lin when applied at their 
optimal C/P-ratios. It is important to note that differences in DNA binding activity of 
oligoamidines and oligoamides (IP- vs. SP-polymers) are not reflected in their gene 
transfer efficiency. This suggests that, depending on the polycation, effective DNA 
binding is important but does not necessarily correlate with high transfection activity 
in vitro. For example, DNA binding of polyphosphoramidates was strongly influenced 
by the type of charge group, however it did not correlate with transfection efficiency 
(Wang 2004). 
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Structural differences like hydrophobicity of the HD-linker, its reactivity towards 
primary and secondary amines and the ester/amide linkages were the reason why 
HD-polymers could not be compared directly with IP- and SP-polymers. While OEI-
HD-1 and OEI-HD-0.5 showed very promising transfection results even at low charge 
ratios, HD-linked small polyamines SD-HD or TT-HD possessed poor gene transfer 
activity. But, exceptions confirmed the rule since, for example TT-HD-1 showed very 
high transfection efficiency on HUH-7 cells. This clearly demonstrated that 
transfection results strongly depend on the cell type and that optimal C/P-ratios have 
to be investigated for every cell line.  
With regard to degradation and biological properties we were interested to find out 
whether a polymer consisting of disulfide and ester linkages had any functional 
advantages in comparison to standard IP-, SP-, or HD-linked polymers. Cystamine, a 
disulfide bond containing LMW diamine was oligomerized by HD-crosslinking and the 
originated polycation was included into the screening of the library. DNA binding 
experiments revealed that Cys-HD-1 did not form stable complexes with DNA. This 
lack of DNA binding affinity is in accordance with poor DNA condensation properties 
of other small polyamines. It is even better explicable when taking into account that 
each cystamine unit only provides two protonable nitrogens, whereas e.g. OEI 800 is 
equipped with ~16 nitrogens within one unit. Moreover, poor transfection rates even 
at high C/P-ratios confirmed its inability to provide enough polyplex stability for potent 
gene delivery.  
In contrast, OEI-IP-HD-1 (via the IP-linker dimerized OEI 800 that was further 
oligomerized by HD-crosslinking) showed high DNA binding activity and provided 
polyplex stability at low C/P-ratios. With regard to transfection efficiency, this polymer 
had no advantages in comparison to standard OEI-HD or OEI-IP polyplexes. 
However, the idea of such combined polymers seemed interesting and optimization 
of the OEI-IP-HD-1 synthesis could result in improved biological properties. 
 
Taken together, it became clear that some novel polycations, e.g. OEI-based 
polymers, possessed very promising transfection activity in all analyzed cell lines and 
that they provided an interesting basis for further analysis. Recently published work 
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highlighted the overall interest to develop degradable gene carriers. Furthermore, the 
strategy to oligomerize LMW amines via reversible crosslinkers as performed in this 
thesis turned out to be followed by many other groups (Table 7). 
 
  
Polymer Labile bond 
 
Potential as gene carrier 
 
Petersen 2002 
Poly(ethylenimine-co-L-
lactamide-co-
succinamide 
amide Low toxicity; improved TE compared to PEI 1.2 kDa 
Lim 2000 Poly(α-(4-aminobutyl)-L-glycolic acid (PAGA) ester 
No toxicity; 2-fold higher TE than PLL 4 
kDa 
Lim 2002 Network poly(amino ester) ester Low toxicity; similar TE as PEI25br 
Jon 2003 Poly(amino alcohol esters) ester 
Less toxic than PEI; no transfection 
experiments 
Akinc 2003 Linear poly(ß-amino esters) ester 
Higher TE than PEI25br and 
Lipofectamine 2000 
Forrest 2003 Crosslinked 800-Da PEI  ester Low toxicity; 2-16-fold higher TE than PEI25br 
Anderson 2004 Library of linear poly(ß-amino esters) ester 
Higher TE than PEI25br and 
Lipofectamine 2000 
Li 2004 Poly(D,L-lactide-co-4-hydroxy-L-proline) ester 
Lower toxicity than PEI25br and PLL; 
higher TE than PEI25br after 5 days 
(sustained activity) 
Ahn 2004 Multi-block copolymers of PLL and PEG ester Low toxicity; similar TE as PLL 
Kim 2005 
Branched poly(ß-amino 
esters) mod. with amino-
hexanoic acid or lysine 
 
ester Low toxicity; high TE in primary cells 
Thomas 2005 Crosslinked 2-kDa &  423- Da PEI ester/amide 
Low toxicity; 2-fold higher TE than 
PEI25br; activity in vivo 
Zhong 2005 Hyperbranched poly(ester amine)s ester 
Low cytotoxicity; TE comparable to that 
of PEI25br or pDMAEMA 
Kim 2005 Crosslinked 1.8 kDa PEI acid labile imines Low toxicity; lower TE than PEI25br 
Oupický 2001 
Crosslinked 19.6 kDa 
PLL 
(crosslinking after 
polyplex formation) 
 
disulfide 
Similar TE for crosslinked and 
standard PLL polyplexes; extended 
circulation time in vivo 
Gosselin 2001 
Crosslinked 800-Da PEI 
via amide or amidine 
bonds 
disulfide Low toxicity; lower TE than PEI25br 
Pichon 2002 Poly(Lys-(AEDTP)) disulfide 10-50-fold higher TE than PLL 
Read 2005 
Reducible polycations 
based on His and pLys 
residues 
disulfide Higher TE than PEI25br, activity in mediating mRNA and siRNA delivery 
  
Table 7: Overview: biodegradable polymers for gene delivery 
Currently developed degradable polymers are summarized in terms of degradability and their potential 
as nontoxic gene carriers. Abbreviation: TE  Transfection Efficiency  
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For example, Langer and co-workers generated a library of 2350 structurally unique 
degradable cationic polymers. In a combinatorial approach, various diacrylates were 
added to different amine-containing monomers via Michael addition, and the resulting 
structures were characterized in large-scale transfection screenings (Anderson 2003 
& 2004). Further studies with two promising candidates were carried out to 
investigate the effect of end group, molecular weight and polymer/DNA ratio (w/w) on 
transfection efficiency and cytotoxicity (Akinc 2003). Recently, a new library of 486 
second-generation poly(ß-amino esters) was synthesized and structure activity 
studies were performed in order to elucidate the role of chemical properties on gene 
transfer efficiency (Anderson 2005). High-throughput syntheses and transfection 
screening allowed the generation of these impressive libraries. However, transfection 
activity was only evaluated for a single cell line and there was a lack of detailed 
biocompatibility studies. 
Potential degradability, efficient DNA binding and a high gene transfer activity are 
very important features of novel nonviral vectors. Nevertheless, it is highly desirable 
to develop low toxic vector systems which do not interact unspecifically with e.g. 
blood cells in vivo.  
4.1.4 Interaction with blood components 
During in vivo gene therapy, a vector system is brought into the bloodstream of a 
patient. It is therefore of the utmost importance that vectors are biocompatible and 
show a minimal interaction with blood components. Positively charged compounds 
with a certain molecular weight tend to induce erythrocyte or platelet aggregation 
because of electrostatic interaction with negatively charged membrane proteins 
(Peterson 2002b). These aggregates may just result in high lung expression as often 
caused by HMW PEI (Kircheis 2001) or can even induce vascular obliteration 
(Chollet 2002) and embolism. Monitoring in vitro erythrocyte aggregation is a 
preliminary, but easy method to analyze whether a polymer or polyplex tends to 
interact with red blood cells or not. However, hemocompatibility studies were only 
described for commonly used polycations (Ogris 1999, Dubruel 2003-part B, Verbaan 
2003) and did not belong to the standard screening of novel degradable polymers up 
to now. 
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Agglutination experiments demonstrated that none of the oligomerized polyamines 
induced erythrocyte aggregation as pronounced as PEI22lin. Generally they had no 
negative effect on erythrocyte morphology although the experiment was carried out 
at very high, almost ‘artificial’ concentrations. This indicated that the novel polymers 
possessed an advantageous toxicity profile with regard to hemocompatibility. 
Destabilization of the erythrocyte membrane by free polycations or polyplexes results 
in hemolysis (Malik 2000, Brownlie 2004), which would have severe consequences in 
vivo (Moreau 2002). Screening the library with regard to hemolytic activity revealed 
that neither IP- nor SP-polymers had any adverse effect on erythrocyte membrane 
integrity, whereas HD-linked polymers induced pronounced hemolysis. This 
membrane activity was attributed to the linker structure. As hexandiol-diacrylate 
consisted of a hydrophobic carbon chain, the originated oligomerized polyamines 
were composed of hydrophilic as well as hydrophobic moieties. Therefore, they could 
integrate into erythrocyte membranes resulting in membrane damage and 
hemoglobin release. However, hemolysis was strongly reduced when the experiment 
was carried out in the presence of serum.  
Generally, distinct membrane activity of polymers is not desirable regarding 
erythrocyte lysis, but displays an interesting feature concerning the lysis of 
endosomal membranes. As previously described by Kichler et al. (2001), polycations 
with intrinsic endosomolytic properties, such as PEI, can act as helpers for PLL-
mediated transfection. Assuming that endosomal release is the major bottleneck for 
gene transfer, polycations with intrinsic membrane activity should mediate gene 
expression very efficiently. In fact, OEI-based polymers which possessed high 
transfection activity significantly enhanced PLL-mediated gene delivery. This 
suggests that OEI-polymers provide polyplex stability and are able to overcome the 
cellular membrane. Moreover, they exposed an intrinsic endosomal release 
mechanism. In addition, this clear correlation between endosomolytic properties and 
high gene transfer activity underlined the importance of mechanistical studies in 
order to better understand the potential of novel gene carriers. 
Recapitulating, a small library of novel degradable polycations was generated and 
analyzed for its potential to mediate efficient gene transfer. All polymers were 
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significantly less toxic than non-degradable PEI22. It is important to note that several 
new polymers showed interesting biological activity with reporter gene expressions 
comparable to the ‘golden standard’ PEI22. For instance, degradable PEI derivatives 
were highly active transfection agents and exhibited advantageous activity/toxicity 
profiles.  
According to current research reports there is an overall tendency to oligomerize 
LMW PEI with different linker types. For example, a recent approach to generate 
biodegradable polyethylenimine was reported by Kim et al. (2005). Low molecular 
weight PEI (1.8 kDa) was crosslinked with glutadialdehyde resulting in polymers 
containing acid-labile imine linkages. The half-life of acid-labile PEI`s was 1.1 h at pH 
4.5 and 118 h at pH 7.4, suggesting that it is rapidly degraded in the acidic 
endosome. Polyplexes exhibited low toxicity and their transfection efficiency was 
almost comparable to standard PEI25 kDa (Kim 2005).  
Another report described the crosslinking of small polyethylenimines (branched PEI 
2kDa and linear PEI 0.4kDa) with ethylene glycol bis(succinimidylsuccinate) (EGS) 
and disuccinimidyl suberate (DSS) which generated degradable ester- or amide-
based PEI derivatives. In vitro and in vivo gene delivery efficiency of the most potent 
formulations exceeded that of PEI25br while being significantly less toxic (Thomas 
2005). 
Encouraging reports from other groups as well as results shown in this thesis 
highlighted the great potential of these degradable PEI derivatives. Many factors 
such as charge density, functional groups, molecular weight and degree of branching 
influence transfection activity as well as toxicity. For this reason the next aim was to 
design experiments which allowed to analyze and to compare directly structure-
activity relationships of OEI-based polymers.  
4.2 Comparison of OEI polymers: structure activity relations 
Careful analysis of different LMW-PEI derivatives was performed in order to elucidate 
structural features that influence biophysical and biological properties of cationic 
polymers.  
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One would expect that linker structure and its specificity towards primary and/or 
secondary amines will control reaction kinetics and therefore have an impact on 
molecular weight and the degree of branching. High molecular weight polycations 
provide polyplex stability and exhibit in most cases higher transfection efficiency than 
their LMW counterparts (Dubruel 2003-Part A). On the other hand they tend to 
induce erythrocyte aggregation, cell membrane damage, and are hardly eliminated 
by the organism (Lecocq 2000). In combination with high charge density, the polymer 
will tightly bind to DNA and ensure polyplex stability during transport; however, it 
might also prevent intracellular DNA release. Moreover, structural properties like 
amphiphilicity can affect membrane damage on one hand, but it can also trigger 
endosomal release. Hence, one can often find a clear correlation between membrane 
activity, transfection efficiency and cytotoxicity (Boeckle 2005). Degradability in 
general and degradation kinetics will rather impact longterm toxicity than having an 
obvious influence on transfection efficiency or acute cytotoxicity. Nevertheless, in 
some cases (e.g. intracellular disulfide reduction) cytosolic polymer degradation 
might trigger DNA release and thus boost reporter gene expression (Read 2005). 
With this background, some functional peculiarities of OEI-based polymers were 
analyzed in detail. 
Based on the same pre-oligomer, namely OEI 800, OEI-HD-1, OEI-IP-1 and OEI-SP-
0.5 were crosslinked via different reversible linkers. Thus, varying biophysical and 
biological properties of the originated polycations could be directly attributed to 
differences in linker chemistry.  
All polymers bound tightly to DNA and provided polyplex stability at low C/P-ratios. 
Detailed transfection screenings demonstrated that OEI-HD-1 mediated highly 
efficient gene delivery at low C/P-ratios whereas OEI-IP-1 and OEI-SP-0.5 needed 
increased C/P-ratios to achieve equivalent reporter gene expression. According to 
previous reports (Kunath 2003), it was possible to obtain efficient reporter gene 
expression when LMW polycations were applied in huge excess. In contrast, HMW 
analogs were inherently active at low polymer concentrations. This is in agreement 
with molecular weight determination of our OEI-based polymers. OEI-IP-1 and most 
likely OEI-SP-0.5 have significantly lower masses than OEI-HD-1 and, therefore, 
needed high amounts of polymer for efficient gene delivery. Moreover, a similar 
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correlation was observed for polymer-induced cytotoxicity. HMW polycations such as 
OEI-HD-1 and particularly PEI22 resulted in a rapid decrease of cell viability when 
applied at high polymer concentrations. OEI-based polymers with lower molecular 
weight did not affect metabolic activity to this extent and could therefore be utilized at 
high C/P-ratios. Analog results were obtained for polymer-induced erythrocyte 
aggregation (fig.19). 
Similar to the OEI-HD-1 synthesis described in this work, Pack and co-worker 
previously generated ester linkage-containing PEI derivatives by addition of OEI 800 
to small diacrylate crosslinkers (1,3-butanediol diacrylate and 1,6-hexanediol 
diacrylate)(Forrest 2003). Identical reactants were utilized, but their synthesis 
protocol was different in terms of solvent (methylene chloride), concentration (417 
mM), reaction temperature (45°C) and reaction time (6 h). Their OEI-HD-1 analog 
(Mw ~30 kDa) had a half-life of 30 h and mediated gene expression two- to 16-fold 
more efficient than PEI25br. While OEI-HD-1 (described in this work) and their OEI-
HD-1 analog possessed different molecular weights and most likely differed in ester 
content, their transfection efficiency appeared to be comparable. 
The idea to oligomerize 800-Da OEI via reversible linkages by crosslinking with either 
DSP or DTBP as described in this thesis was also previously reported by Gosselin 
and his group. Their PEI conjugates showed improved transfection activity compared 
to the starting LMW OEI, but were less effective than PEI25br (Gosselin 2001). 
Apparently, our synthesis protocol generated different polymer structures because 
we needed higher polymer (OEI-IP-1 and OEI-SP-0.5) to DNA ratios for efficient 
gene delivery. For instance, their OEI-IP-1 analog had a molecular weight of 23 kDa 
(viscosity measurement) whereas OEI-IP-1 synthesized according to our protocol 
was smaller (Mw 8 kDa / SEC/MALLS analysis). This indicated once more that 
varying reaction conditions has a strong impact on molecular structure and therefore 
on biological activity of a polycation. 
Nevertheless, our OEI-IP and OEI-SP polymers were as efficient as PEI22lin and 
slightly better than PEI25br while having significantly reduced cytotoxicity as 
compared to HMW PEI. Altogether, it became clear that apart from structural 
properties (Fischer 2003) the molecular weight of OEI-based polymers played an 
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important role for gene transfer activity, but also for toxic side effects. This was in 
agreement with previous reports about molecular weight-dependent properties of 
different PEI’s (Fischer 1999). 
4.2.1 Temperature-dependent ester aminolysis of OEI-HD-1 
Reaction temperature does not only influence the degree of polymerization 
(molecular weight) and the specificity of the reaction, but also side reactions such as 
ester aminolysis. At high temperatures, primary or secondary amines can react in a 
nucleophilic substitution with esters and form amides which are enzymatically 
degradable too, but which are less susceptible to hydrolysis than esters (Petersen 
2002a). As mentioned in chapter 3.2.3, the reason for choosing such harsh reaction 
conditions (4 days at 60°C) was the aim to obtain HMW polymers with high potential 
for efficient gene delivery.  
It is important to note that Pack and co-workers synthesized their OEI-HD-1 analog at 
45°C for 6 h (Forrest 2003).  In order to analyze the influence of high reaction 
temperature on molecular structure and to elucidate properties of a faster degrading 
polymer, OEI-HD-1 was synthesized at 20°C and 60°C respectively. According to FT-
IR analysis, lt-OEI-HD-1 (synthesized at 20°C) largely had the predicted ester 
structure whereas OEI-HD-1 (synthesized at 60°C) contained mainly amides with few 
esters left. 1H NMR revealed that even OEI-HD-1 had remaining ester bonds 
although to a much lower extent than the “pure” ester based lt-OEI-HD-1. The 
observation of remaining hexane linker residues was in consistence with these 
results. However, partial degradation was observed by the appearance of protons 
belonging to -CH2 adjacent to hydroxyl groups and OEI-HD-1 lost 60 % of 
hexanediol residue due to ester aminolysis. 
As far as presented in the publication, similar NMR results were obtained by Forrest 
et al. for their OEI-HD-1 analog (Forrest 2003).   
In consideration of structural differences (ester content), a rapid molecular weight 
decrease under hydrolytic conditions was expected for lt-OEI-HD-1, whereas the 
amide bonds of OEI-HD-1 should be more stable. Degradation studies at pH 5, 7 and 
9 revealed that hydrolysis kinetics of both polymers were accelerated with increasing 
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pH. This suggests enhanced polyplex stability at acidic conditions (pH 5) that are 
typical for where DNAses are extremely active. Moreover, during the analyzed period 
of time (15 days), only slight alterations (elution time, peak symmetry, AUC) were 
observed for OEI-HD-1. This slow amide hydrolysis of OEI-HD-1 was in accordance 
with results previously reported by Kissel and his group. Their copolymer 
poly(ethylene-co-L-lactamide-co-succinamide) degraded via base-catalyzed 
hydrolytic cleavage of amide bonds over months (Petersen 2002).  
Hydrolysis of lt-OEI-HD-1 was confirmed by a rapid change in size distribution. After 
5 days, a major part of the larger fraction was cleaved into smaller fragments when 
incubated at pH 7 or pH 9. Incubation at pH 5 did barely influence the molecular 
weight distribution of lt-OEI-HD-1 within the first 15 days. This data is in accordance 
with degradation profiles observed for hyperbranched poly (amino esters) (Zhong 
2005). They explained rapid degradation at pH 7.4 and slow-going hydrolysis at pH 
5.1 by the fact that at pH 7.4 a higher fraction of unprotonated amino groups in the 
polymer catalyze the hydrolysis of ester groups. 
Nevertheless, it has not been shown yet whether small changes in polymer integrity 
would have any effect on transfection efficiency or cytotoxicity. To elucidate the 
impact of polymer degradation on toxicity, we analyzed metabolic activity of cells 
treated with either original or partially degraded polymer. In fact, changes in 
molecular weight distribution that seemed unimportant with regard to SEC data had 
significant impact on the cytotoxicity of polymers. Even OEI-HD-1-induced toxicity 
(which was very significant at high polymer concentrations) was strongly reduced 
after 5 days of hydrolysis. Degradation of originally less toxic lt-OEI-HD-1 resulted in 
nontoxic oligomer fragments. It should be noted that cytotoxicity induced by free 
polymers gives a worst case estimate for the interaction with cells and tissues. 
Toxicity of nonviral vectors usually decreases when polymers are complexed to DNA 
(Fischer 1999, Dubruel 2003-Part B); however as complex formation at high polymer 
to DNA ratios is accompanied with excessive polymer loosely associated to the 
polyplex, it is important to check toxic activities of such free polymers. In case of 
pronounced toxicity of free polymer, polyplexes could be purified in order to remove 
the unbound polycations (Boeckle 2004), especially for in vivo applications. 
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Apart from ester aminolysis, the chosen reaction conditions proposed a high degree 
of polymerization in case of standard OEI-HD-1, whereas lt-OEI-HD-1 should have a 
significantly lower molecular weight. Size exclusion chromatography (SEC) showed a 
bimodal size distribution for OEI-HD-1 as well as for lt-OEI-HD-1. A huge peak at the 
void volume indicated that OEI-HD-1 had an overall higher molecular weight than lt-
OEI-HD-1. Since standard SEC was no appropriate procedure for absolute molecular 
weight analysis, we tried several methods commonly used for molecular weight 
determination. MALDI-TOF mass spectroscopy was only suitable for molecular 
weight determination of protein and PEG standards and LMW-polycations like 
oligoethylenimines with 0.8 and 2 kDa. Size exclusion chromatography (SEC) 
/MALLS analysis of OEI-HD-based polymers confirmed the influence of reaction 
temperature on the degree of polymerization. As expected, the molecular weight of lt-
OEI-HD-1 was significantly lower than that of standard high temperature-generated 
OEI-HD-1. As shown here, synthesis at 20°C (4 days) generated 8.7 kDa polymers 
and a reaction temperature of 60°C (4 days) resulted in polymers with a molecular 
weight up to 53 kDa. According to the literature, synthesis at 45°C (6 hours) yielded 
in 30 kDa polymers (Forrest 2003). 
With regard to structure, molecular weight and degradation kinetics, one would 
predict differences in polyplex stability, gene transfer activity and cytotoxicity. Ester 
conversion into amide bonds would reduce the number of potentially charge-bearing 
amines. On the other hand, high molecular weight and the presence of various 
secondary amines might provide enough positive charges for efficient DNA 
condensation. Whereas DNA-binding activity was similar for OEI-HD-1 and lt-OEI-
HD-1, their biological activities showed significant differences.  Standard OEI-HD-1 
mediated high transfection levels at low C/P-ratios and was characterized by a rapid 
decrease in cell viability at high polymer concentrations. Furthermore, free OEI-HD-1 
polymer induced erythrocyte aggregation; this can be easily explained by its high 
molecular weight and its overall charge density. In contrast, the lower molecular 
weight lt-OEI-HD-1 had no adverse effect on erythrocyte morphology and was 
applied at high concentrations without inducing OEI-HD-1-analog toxicity. However, 
more polymer was needed for efficient gene transfer. It is important to note that both 
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polymers exceeded the golden standard PEI22lin in terms of transfection efficiency 
and cytotoxicity when applied at optimal doses. 
In fact, the aim of this thesis to generate novel, degradable polycations with 
advantageous biological activity was achieved by crosslinking LMW OEI via 
bifunctional reversible linkers, especially in case of HD-linking. However, the idea 
was to further improve transfection activity and also toxicity profiles of these 
polycations by modification of the synthesis protocol. As a result of the performed 
biophysical and biological screenings, it appeared interesting to follow the strategy of 
an OEI-HD-based polymer. One approach would be the design of LMW OEI-HD 
oligocations which could be subsequently equipped with DNA compacting moieties to 
generate pseudo-dendritic structures. 
 
4.3 Novel OEI-HD based pseudo-dendrimers 
It was previously reported that highly branched dendrons (Banerjee 2004) showed 
promising characteristics with regard to transfection efficiency and cytotoxicity.  
Similar results were found for dendritic polyamines with tree-like structures which 
could be functionalized by a two-step procedure (Krämer 2004).  
4.3.1 OEI-HD-Sper pseudo-dendrimers with high potential for virus-like gene 
delivery 
Crosslinking with a 2-fold molar excess of HD-linker at high reactant concentrations 
resulted in insoluble HMW polymers. As our aim was to generate LMW cores, novel 
syntheses were carried out at lower concentrations and in the presence of a huge 
excess of linker. We designed branched LMW OEI-HD cores which provided the 
opportunity for subsequent functionalization. The first step of the synthesis, the 
reaction of OEI 800 with an excess of HD-linker, generated reactive OEI-HD units 
with different ratios of free diacrylate end groups. In a second step, these free linker 
ends were saturated with spermine and the originated polymers were purified by size 
exclusion chromatography. All OEI-HD pseudo-dendrimers possessed high DNA 
binding activity, but preliminary in vitro studies revealed that a definite excess of HD-
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linker was advantageous with regard to transfection activity. Furthermore, it was 
obvious that the larger fraction of OEI-HD-10-Sper, namely OEI-HD-10-Sper-A, was 
significantly more powerful in gene delivery than its LMW counterpart OEI-HD-10-
Sper-B. Importantly, the novel pseudo-dendrimers OEI-HD-5-Sper and OEI-HD-10-
Sper-A had an outstanding potential as gene carriers as they mediated gene delivery 
as efficient as PEI22lin while being less toxic. Nevertheless, OEI-HD-Sper polymers, 
especially OEI-HD-10-Sper-A, induced severe damage of cellular membranes when 
applied at DNA doses above 400ng (C/P > 2). Microscopic observations of cell 
membrane damage together with their overall high transfection activity indicated an 
intrinsic membrane activity of the novel pseudo-dendrimers. 
4.3.2 Membrane activity of OEI-HD-Sper pseudo-dendrimers 
Polymer-induced erythrocyte lysis is one strategy to monitor membrane activity in 
general and moreover, to gain information about possible toxic side effects in vivo. In 
comparison to PEI22lin and PEI25br, OEI-HD-5-Sper as well as OEI-HD-10-Sper-A 
initiated complete erythrocyte lysis which resulted in 100 % hemoglobin release. 
Whereas other hemolytic polymers like e.g TT-HD-1 or Cys-HD-1 lost their activity in 
the presence of serum, the pseudo-dendritic structures still maintained a significant 
membrane activity. One possible explanation for this extreme membrane lytic 
potential is their proposed amphiphilic micelle-like structure: a hydrophilic core of 
crosslinked OEI equipped with various hydrophobic HD-chains that are linked to 
hydrophilic spermine moieties. This design might favour membrane integration, 
subsequent destabilization and disruption of the membranes.  
During transport and in extracellular compartments high lytic activity is considered as 
a toxic side effect that has to be eliminated by modification (e.g. shielding) of the 
gene carrier. On the other hand, such lytic activity is highly desirable within the cell 
when membrane destabilization is needed for efficient endosomal release (Boeckle 
2005). Therefore, an optimal gene carrier should be inactive at physiological pH and 
should gain lytic activity in the acidic endosomal environment. To evaluate pH-
specific membrane activity of OEI-HD-Sper derivatives, an erythrocyte leakage assay 
was performed at pH 5 as described in Plank et al. (1994). As novel pseudo-
dendrimers did not show any lytic activity at pH 5, one could assume that their ability 
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for membrane destabilization was limited to neutral pH. This would imply unspecific 
damage of cellular membranes and at the same time loss of lytic activity within the 
endosome. Otherwise, it was possible that erythrocyte incubation at acidic pH 
caused protonation of membrane proteins whereupon polycations were incapacitated 
to interact with these artificially charged membranes. To rule out that our results were 
just experimental artefacts, a more practical study should elucidate the 
endosomolytic properties of OEI-HD-Sper pseudo-dendrimers. 
As already described for the polymer library in chapter 3.1.8, endosomolytic activity 
of polycations can be characterized by analyzing their effect on PLL-mediated gene 
delivery. In fact, OEI-HD-5-Sper and OEI-HD-10-Sper-A were able to enhance the 
activity of PLL polyplexes more than 20-fold. This clearly confirmed their intrinsic 
endosomolytic properties and somehow disproved the reliability of erythrocyte 
leakage assays carried out at pH 5. One has to keep in mind that polymer 
concentrations resulting in distinct hemolysis (1 mg/ml) were 17 - 400-folds higher 
than concentrations needed for endosomolytic activity (2.5-60 µg/ml). Thus, for in 
vivo applications there would a therapeutical range of polymer doses which could 
potentially trigger endosomal release while being non-hemolytic. These very 
successful results encouraged us to utilize the core-modification strategy for novel 
approaches towards virus-like gene carriers. 
Very recently, dendrons with spermine surface groups were reported to efficiently 
bind to DNA and to form concrete particles; however these novel structures lacked 
gene transfer in the absence and were still characterized by poor reporter gene 
expression in the presence of chloroquine, which promotes the escape from 
endocytic vesicles (Hardy 2005). Apparently their originated structures could not 
overcome the endosomal membrane barrier; this was rather surprising when having 
in mind that OEI-HD-Sper pseudo-dendrimers (based on a similar concept) as 
described in this thesis mediated gene transfer very efficiently and possessed 
pronounced membrane activity. Hence, this emphasizes again the impact of 
structural particularities of potential gene carriers on their biological activity.  
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4.3.3 Modification of the OEI-HD-5 core 
Since the core-modification strategy opened up manifold variations for further 
developments, some preliminary studies on OEI-HD-5 modification were performed 
in order to complete this work.  
Overall, the OEI-HD core can be modified with either supplementary charge-bearing 
moieties, with PEG chains, with targeting ligands or even with membrane active 
peptides. As primary and secondary amines or thiol groups react with free linker ends 
by Michael addition, potential functional domains only required one of these reactive 
groups. Since OEI-HD-5 gelated after approximately 1 hour reaction at 60°C it was 
not possible to synthesize an unmodified core. With regard to successful spermine 
modification, polyamines such as pentaethylenhexamine and OEI 800 were attached 
as DNA-binding domain. According to previous reports, polycationic gene delivery 
could be enhanced when PLL was partially substituted with histidyl residues which 
become cationic upon protonation of the imidazole groups at pH below 6 (Midoux 
1999). To check whether imidazole groups favor the endosomal release and thus 
enhance transfection activity, we attached histamine to the OEI-HD core. The 
originated polymers showed weaker DNA binding activity which was in accordance 
with previous reports (Chen 2005). Moreover, they mediated gene transfer less 
efficient than other dendrimers. One could assume that core modification with 
imidazole-bearing histidine residues in combination with DNA binding e.g. spermine 
moieties would provide advantageous properties for efficient gene delivery. 
Finally, a novel PEG(2k)-OEI(0.7k) oligomer was utilized to generate partially 
shielded OEI-HD structures. The OEI-HD-5 core was modified with 20 % OEI-PEG 
and subsequently saturated with 80 % OEI 800. DNA binding activity was similar to 
OEI-HD-5-OEI, but OEI-HD-5-OEI-PEG mediated gene delivery approximately 10-
fold less efficient than its non-PEGylated analog. This is in agreement with previous 
reports showing that PEGylation of polyplexes generally resulted in decreased 
transfection efficiency in vitro (Kursa 2003); however it prolonged circulation time in 
vivo and reduced unspecific side effects (Ogris 1999). To evaluate the suitability of 
these short PEG oligomers, one will have to vary the degree of PEGylation. 
Furthermore, PEG-shielding and de-shielding of the polyplexes due to ester 
hydrolysis would have to be confirmed by zeta potential measurements. With regard 
Discussion 109 
to improved transfection efficiency it would be desirable to generate reversible PEG 
shields which would fall apart after internalization. A very successful approach 
towards environment-sensitive shielding was recently described by Walker et al. 
(Walker 2005). 
The OEI-HD core-modification strategy is a completely novel approach and 
presented a great step towards the development of multifunctional, bioresponsive 
gene carriers. Modification of the core is easy and there are many options to 
incorporate functional domains into the dendrimers. As further combinations would 
go beyond the scope of this thesis, the pseudo-dendrimer project will be continued in 
a successional work. 
Taken together, OEI based polymers, especially OEI-HD containing structures 
possessed very promising biophysical and biological properties and were able to 
compete with the ‘golden standard’ PEI22lin. However, as no polycation alone is able 
to fulfill all requirements for virus-like gene delivery, the next step was to further 
modify these novel compacting domains.  
 
4.4 Modification of OEI-HD polyplexes for virus-like gene delivery 
In cancer gene therapy specificity for the tumor target can be achieved in several 
ways: targeted delivery of the gene into the tumor is accomplished by incorporation 
of targeting ligands which specifically bind to a receptor that is overexpressed in 
certain tumors. Other strategies are transductional targeting e.g. intracellular uptake 
into the nucleus of only dividing tumor target cells or transcriptional targeting which 
implies the use of an expression cassette that is switched on by tumor-specific 
transcription factor combinations (Lipinski 2001).  
With regard to intracellular delivery, specificity can be obtained with different physical 
strategies such as electroporation (Goto 2004), gene gun (Wang 2001), 
magnetofection (Scherer 2002), ultrasound (Tomizawa 2001) and photodynamic 
therapy (Prasmickaite 2002, Hogset 2003) where either directed electric or 
magnetical field, light, or mechanical impact can be exploited for specific localization. 
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Photochemical reactions for therapeutic purposes have already been applied in 
patients. For example, photodynamic therapy (PDT) is a form of light-activated 
chemotherapy, clinically tested for treatment of cancer as well as for various non-
oncological diseases (Huang 2005). Since there was already significant clinical 
experience utilizing photosensitizers for treatment of various tumor types, 
photochemically triggered gene delivery in vitro appeared to be a promising approach 
with high potential for in vivo application.  
The combination of biological (EGFR-targeting) and physical (photochemical 
intracellular release) targeting was a promising step towards specific and efficient 
gene delivery. 
4.4.1 EGFR-targeted and photochemically enhanced polyplexes 
EGFR was selected as biological cell surface target, which is over-expressed in a 
variety of human tumors and which has been selected by nature as receptor for viral 
gene delivery (Wang 2003). First, EGF as ligand was incorporated into standard PEI- 
or PEGylated PEI polyplexes. Transfections were carried out in the presence of 
photosensitizers in order to investigate the effect of combined biological and physical 
targeting. In accordance with previous reports (Blessing 2001), transfection efficiency 
of small PEG-shielded polyplexes which normally gene transfer in vitro could be 
significantly improved by incorporation of EGF ligand. Furthermore, application of the 
photochemical intracelluar release technology tremendously enhanced EGF/PEG-
PEI polyplex-mediated gene delivery. Specific uptake via the EGF-receptor, even in 
combination with PCI, was confirmed by competitive inhibition of the EGFR with 
either EGFR-antibody or an excess of free EGF. Receptor blockade resulted in 
reduced reporter gene expression, while unspecific antibodies or serum proteins had 
no effect on EGF/PEG-PEI-mediated gene delivery. 
For commonly used PEI or PLL polymers, various approaches have been described 
in terms of specific tumor targeting (Wolschek 2002, Kursa 2003, Kunath 2003, Ogris 
2003, for review see Lungwitz 2005) and also with regard to improved endosomal 
escape (Prasmickaite 2000, Boeckle 2005). Up to now, however, none of these 
modification strategies was performed for novel biodegradable polymers. Since the 
strategy to trigger endosomal release of EGFR-targeted polyplexes by PCI was really 
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promising, the applicability of this method was tested for our novel OEI-HD-1 
polyplexes. Combination of ligand EGF-PEI with OEI-HD-1 as well as with lt-OEI-HD-
1 resulted in significantly enhanced reporter gene expression in EGF-receptor rich 
HUH-7 cells (Fig.42). Similarly as described for standard EGF/PEG-PEI polyplexes 
(Kloeckner 2004), there was a clear correlation between DNA concentration and 
EGF-effect. This proposed that target cell receptor specificity decreased with 
increasing amounts of DNA-complexes. The positive effect of EGFR-targeting at low 
DNA doses was even more pronounced in case of lt-OEI-HD-1; ligand-free 
polyplexes of this LMW ester-based polymer lacked transfection activity at low C/P-
ratios, whereas incorporation of EGF resulted in dramatically enhanced reporter gene 
expression. It seemed that lt-OEI-HD-1 provided polyplex stability, but, in contrast to 
standard OEI-HD-1, could not mediate cellular uptake and/or endosomal release 
when applied at low polymer concentrations. It is noteworthy that EGFR-targeted 
OEI-HD-1 and lt-OEI-HD-1 polyplexes showed almost equal reporter gene 
expression while being nontoxic. These results were independent from structure and 
molecular weight of OEI-HD polymers. Blocking the EGFR with an excess of free 
EGF clearly demonstrated that enhanced transfection efficiency of EGF/OEI-HD 
polyplexes was the result of improved receptor-mediated uptake. In addition, 
unspecific effects like e.g. polyplex aggregation were ruled out by particle size 
measurements of EGF-containing and ligand-free polyplexes. Moreover, EGF-ligand 
incorporation had no effect on reporter gene expression of EGFR-lacking B16F10 
cells.  
Incorporation of EGF ligand into OEI-HD polyplexes was the first step to design more 
‘virus-like’ systems with enhanced specificity and reduced toxicity. To further improve 
OEI-HD-1-mediated gene delivery the maybe most crucial barrier, i.e. endosomal 
release, should be overcome by photochemically triggered disruption of endosomal 
membranes. Photochemical intracellular release significantly enhanced transfection 
activity of ligand-free as well as of EGF/OEI-HD-1 polyplexes. Interestingly, gene 
delivery mediated by standard PEI22 polyplexes, which are known to mediate 
intrinsic endosomal escape mechanisms (Sonawane 2003), was also dramatically 
increased after photosensitizer treatment. This suggested that endosomal release is 
still a major bottleneck even for efficient vectors like PEI22lin. A similar observation 
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was made by Engesaeter and his group. Even though adenoviral infection is a highly 
efficient process with up to 90 % of the endocytosed viral particles escaping from the 
endosome (Leopold 1998), they demonstrated that the PCI method increased gene 
expression compared to conventional adenovirus infection (Engesaeter 2005).  
Taken together, the photochemical intracellular release technology was a very 
efficient method to trigger the endosomal release of endocytosed polyplexes and 
significantly enhanced EGF/OEI-HD-1 mediated gene transfer. However, application 
and subsequent light-induced activation of photosensitizers was somehow limited on 
special cell species in vitro and on the treatment of subcutaneous or easily 
accessible tumors in vivo. For some applications such as systemic administration, the 
direct incorporation of an endosomolytic function into DNA complexes would be 
preferable. Therefore, alternative light-independent strategies to improve the release 
of endosomally entrapped polyplexes were tested.  
4.4.2 EGFR-targeted, melittin/OEI-HD-1 polyplexes 
As described in detail by Boeckle et al. (Sabine Boeckle PhD thesis, Boeckle 2005) 
membrane active peptides such as the bee-venom-derived melittin and its analogs, 
can trigger endosomal release after destabilization of the endosomal membrane. N-
mel-PEI25, with melittin coupled to PEI25 at the N-terminus and CMA-3-PEI, with a 
melittin analog coupled to PEI25 via the C-terminus have previously shown to be 
promising transfection agents (Boeckle 2005). First, studies were performed to 
incorporate NMA-3-PEI, a novel melittin analog coupled to PEI25 at the N-terminus 
and two other melittin conjugates into OEI-HD-1 polyplexes (Persson 2005). Optimal 
combinations of melittin conjugates with OEI-HD-1 mediated an up to 40-fold 
enhanced gene expression over standard OEI-HD-1 polyplexes. Finally, OEI-HD-1 
was combined with the efficient and least toxic melittin analog NMA-3-PEI and the 
targeting conjugate EGF-PEI25. The originated more ‘virus-like’ vectors exceeded 
the transfection efficiency of polyplexes containing only EGF or NMA-3-PEI. 
Taken together, modification of OEI-HD polyplexes by incorporation of EGF as 
targeting ligand in combination with membrane active moieties like NMA-PEI resulted 
in specific and very potent non-viral vectors. Since EGF- and melittin conjugates 
were covalently attached to non-degradable PEI25, the resulting polyplexes were 
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only partly degradable and heterogeneous regarding the structure of the binding 
polymers. This should be kept in mind, but nevertheless, the present results clearly 
demonstrate the potential of virus-like OEI-HD-1 particles. Furthermore, it was 
demonstrated that minor amounts of PEI25 had no influence on transfection 
efficiency, targeting specificity and cytotoxicity.  
For future developments it would be desirable to generate conjugates with targeting 
moieties and endosomolytic domains covalently attached to biodegradable DNA-
binding polycations. OEI-HD dendrimers showed a great potential in terms of 
transfection efficiency and could be easily modified with various functional moieties. 
The present results therefore suggest that one could utilize the OEI-HD core-
modification strategy to design degradable polycationic dendrimers which are not 
only equipped with DNA compacting moieties like spermine, but which also possess 
targeting ligands and membrane active domains. This could be achieved by attaching 
thiol reactive EGF-SH or melittin-SH via Michael addition to the OEI-HD core. Ideally, 
one would employ membrane active moieties which are activated upon acidification 
of the endosome, since they will allow a safe transportation in the blood stream while 
becoming highly active within endocytic vesicles (Boeckle 2005, PhD thesis). To 
ensure polyplex stability and to reduce unspecific interactions with e.g. blood 
components, the polyplex could be reversibly shielded with bioresponsive PEG 
conjugates. For example, one could follow the strategy to couple PEG chains via 
hydrazone bonds to the polyplex in order to generate shielded polyplexes which de-
shield in the acidic environment of the endosome (Walker 2005). 
These virus-like particles (as described here) in combination with bioresponsives 
conjugates which sense their biological micro-environment and undergo programmed 
structural changes compatible with the different gene delivery steps present a great 
step towards nontoxic and efficient nonviral gene delivery systems. The whole 
construct exploits intelligent activation/inactivation mechanisms, thus provides a 
broader therapeutical range and will therefore allow safe application of nucleic acid-
based drugs.  
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5 Summary 
Gene therapy is a very promising approach to treat or to prevent diseases. However, 
progress in this field is hindered by lack of suitable vectors. Current research focuses 
on the development of novel nonviral biodegradable gene carriers with improved 
gene transfer activity and low toxicity. 
In the course of this thesis, a library of degradable DNA compacting domains based 
on oligomerized polyamines was synthesized and analyzed. Degradation of the 
originated polymers was either based on site-specific reductive cleavage of disulfide 
bonds or on time-dependent ester/amide hydrolysis. DNA binding activity, polyplex 
stability, transfection efficiency, toxicity, and hemocompatibility studies were 
performed in order to identify promising candidates. Some of the novel gene carriers, 
especially the degradable oligoethylenimine (OEI) derivatives were successfully 
applied for in vitro transfection and could easily compete with the current ‘golden 
standard’ linear polyethylenimine with an average Mw of 22 kDa (PEI22lin). 
Furthermore, screening results revealed critical structure activity relationships which 
were very helpful for improving the polymer design. According to transfection and 
biocompatibility results, efficiency and toxicity correlated to some degree. Polymers 
with an overall high charge density and a high molecular weight like OEI-HD-1 
provided polyplex stability and formed small uniform particles. On the other hand 
these polymers tended to induce erythrocyte aggregation and exhibited a 
pronounced cytotoxicity when applied at high concentrations. Polycation with a lower 
molecular weight (~ 10 kDa) like e.g. OEI-IP-1 were essentially nontoxic, but had to 
be applied at high concentrations in order to achieve efficient gene transfer. Intrinsic 
membrane activity of certain polymers could damage cellular membranes but may 
also trigger endosomal release and therefore boost transfection activity.  
Crosslinking of OEI 800 with 1,6-hexanedioldiacrylate resulted in highly efficient 
degradable polycations. Different reaction temperatures during OEI-HD-1 synthesis 
had a strong impact on molecular weight and the ester/amide ratio. Despite structural 
differences, both OEI-HD-1 (synthesized at 60°C) and lt-OEI-HD-1 (synthesized at 
20°C) possessed equal gene transfer activity as the ‘golden standard’ PEI22lin when 
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applied at their optimal polymer/DNA-ratio (w/w). It was important to note that lt-OEI-
HD-1, the LMW-derivative which is predominantly based on ester linkages, was 
significantly less toxic than its HMW amide-linked counterpart. OEI-HD displayed a 
very promising basis for the development of further powerful gene carriers. A two-
step synthesis protocol was established in order to generate OEI-HD cores bearing 
excessive linker which could be subsequently modified with various functionalities 
like spermine. OEI-HD-Sper pseudo-dendrimers were characterized by a pronounced 
intrinsic membrane activity and possess high transfection efficiency. 
Since current nonviral vectors are still very inefficient as compared to their viral 
competitors, natural viruses present an ideal example educating us how to further 
optimize polycationic gene carriers in terms of specific cell-targeting and improved 
endosomal release. Modification of polyplexes towards a “smart” virus-like system 
was achieved in the following way. Degradable DNA compacting domains  
(OEI-HD-1) were utilized for complex formation. Furthermore, epidermal growth 
factor (EGF) was incorporated as targeting ligand into OEI-HD-1 polyplexes and thus 
allowed cell-specific cellular uptake via the EGF receptor (EGFR). Gene transfer 
potential of EGFR-targeted degradable polyplexes was further improved by applying 
technologies which promoted the endosomal release of endocytosed particles. 
Photochemical intracellular release (PCI) is based on accumulation of amphiphilic 
photosensitizers (PS) in endosomal membranes. Illumination of PS pre-treated 
transfected cells results in activation of the PS and subsequent light-induced rupture 
of endocytic vesicles. Combination of biological (EGFR) and physical (PCI) targeting 
greatly enhanced reporter gene delivery mediated by OEI-HD-1 polyplexes. Finally, 
the incorporation of membrane active melittin derivatives into EGF/OEI-HD-1 
polyplexes was the first example of a biodegradable synthetic virus for gene delivery. 
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6 Appendix 
6.1 Abbreviations 
 
ACN   Acetonitril 
CL   Crosslinker 
CMV   Cytomegalovirus 
C/P-ratio  Weight ratio of conjugate to plasmid  
Cya   Cystamine 
DMEM  Dulbecco’s Modified Eagle’s Medium 
DMSO  Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
DSP   Dithiobis(succinimidylpropionate) 
DTBP   Dimethyl-3-3’-dithiobispropionimidate 
DTT   Dithiothreitol 
EDTA   Ethylendiaminetetraacetic acid 
EGF   Epidermal growth factor 
EGF-PEG-PEI25 EGF covalently linked to PEI25br with a heterobifunctional  
3.4 kDa PEG spacer 
EtBr Ethidium bromide 
FCS Fetal calf serum 
FT-IR Fourier transformed infrared spectroscopy 
GPC Gel permeation chromatography 
GSH Glutathione 
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HBG HEPES-buffered glucose 
HBS HEPES-buffered saline 
HD Hexanediol-diacrylate 
HEPES N-(2-hydroxyethyl) piperazine-N’-(2-ethansulfonic acid) 
HMW High molecular weight  
HPLC High pressure liquid chromatography 
IP Imidopropionate 
LMW Low molecular weight 
MALDI-TOF Matrix Assisted Laser Desorption Ionization Time of Flight 
MTT Methylthiazoletetrazolium 
Mw Molecular weight 
MQ De-ionized water (Millipore) 
NMR Nuclear magnetic resonance 
N/P-ratio Molar ratio of PEI nitrogen to DNA phosphate 
1O2 Singlet oxygen 
OEI Oligoethylenimine 800 Da 
PBS Phosphate-buffered saline 
PCI Photochemical intracellular release 
pCMVLuc Plasmid encoding for luciferase under control of the CMV 
promoter/enhancer 
PEG Polyethylene glycol 
PEI 25br branched polyethylenimine 25 kDa 
PEI 22lin linear polyethylenimine 22 kDa 
PH Pentaethylenhexamine 
PLL Polylysine 
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PS Photosensitizer 
RNA Ribonucleic acid 
RLU Relative light units 
RT Room temperature 
SD Spermidine 
SP Spermine 
SP Succinimidylpropionate 
siRNA small interfering RNA 
SEC Size exclusion chromatography 
TBE Tris borate EDTA 
TP Tetraethylenpentamine 
TPPS2a meso-tetraphenylporphine disulfonate on adjacent phenyl rings 
TT Triethylentetramine 
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6.2 Publications 
6.2.1 Original papers 
 Zwiorek, K., Kloeckner, J., Wagner, E., Coester, C. (2005)  
Gelatin nanoparticles as a new and simple gene delivery system  
J Pharm Pharmaceut Sci. 7(4), 22-28 
 Kloeckner, J., Prasmickaite, L., Hogset, A., Berg, K., Wagner, E. (2004) 
Photochemically enhanced gene transfer of EGF receptor-targeted DNA 
polyplexes  
J Drug Targeting, 12(4) 205-214 
 
Manuscript in preparation 
 Kloeckner, J., Wagner, E., Ogris, M.  
Novel degradable gene carriers based on oligomerized polyamines 
 Kloeckner, J., Bruzzano, S., Ogris, M., Wagner, E. 
Gene carriers based on hexanedioldiacrylate crosslinked oligoethylenimine 
– effect of chemical structure and size of polymer on biological properties 
 Kloeckner, J., Persson, D., Boeckle, S., Roedl, W., Ogris, M., Wagner, E. 
Improved endosomal release of EGF receptor-targeted oligoethylenimine 
polyplexes for efficient gene delivery 
 
 
6.2.2 Reviews and book chapters 
 Wagner, E., Kloeckner, J. and Ogris, M. (2005) Optimizing polyplexes into 
synthetic viruses for tumor-targeted gene therapy in “Non-viral Gene Therapy-
Gene Design and Delivery”, Eds. K.Taira, K.Kataoka, T.Niidome 
Springer-Verlag Tokyo 2005 
 
 Wagner, E. and Kloeckner, J. (2005) Gene delivery using polymer 
therapeutics in “Advances in Polymer Science” 
Springer-Verlag Berlin, Heidelberg 
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6.2.3 Poster presentations 
 Kloeckner, J., Ogris, M., Wagner, E. (2005)  Biodegradable polyamines as 
efficient gene delivery vectors: Effects of the oligomerizing linker chemistry on 
biophysical and biological properties 
Controlled Release Society, Annual Meeting, Miami, USA 
 Kloeckner, J., Walker, G., Wagner, E., Ogris, M. (2003)  Development of an 
intelligent biodegradable gene carrier – ‘a smart artificial virus’ 
Controlled Release Society, German Chapter Annual Meeting, Munich, 
Germany  
 
6.2.4 Oral presentations 
 Kloeckner, J., Fahrmeir, J. (2005)  Development of novel nonviral vectors for 
tumor-targeted gene delivery – towards an ‘artificial virus’ 
Scientific colloquium, Bulgarian Academy of Science, Sofia, Bulgaria 
 Kloeckner, J., Walker, G., Ogris, M., Wagner, E. (2004) Development of a 
biodegradable gene carrier based on oligomerized polyamines, European 
Conference of Drug Delivery and Pharmaceutical Technology, Sevilla, Spain 
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